Citations

Citations to this article as recorded by  

• Evaluation of chicken chorioallantoic membrane model for tumor imaging and drug development: Promising findings
  Lizhen Wang, Junjie Yan, XinyuWang, Yuping Xu, Donghui Pan, Chongyang Chen, Ying Shao, Xiangjun Song, Kezong Qi, Min Yang, Jian Tu
  Animal Models and Experimental Medicine.2025; 8(2): 287.     CrossRef
• Model-based analysis for investigating the impact of tumor size, lymphocyte and neutrophil on the survival of breast cancer 4T1 tumor-bearing mice
  Qing-yu Yao, Xin-yu Hou, Wei-zhe Jian, Tian-yu Wang, Ping-yao Luo, Jun-sheng Xue, Rong Chen, Tian-yan Zhou
  Toxicology and Applied Pharmacology.2025; 494: 117176.     CrossRef
• Patient-derived xenograft models: Current status, challenges, and innovations in cancer research
  Min qi Liu, Xiaoping Yang
  Genes & Diseases.2025; : 101520.     CrossRef
• Investigating proteogenomic divergence in patient-derived xenograft models of ovarian cancer
  Jesenia M. Perez, Jolene M. Duda, Joohyun Ryu, Mihir Shetty, Subina Mehta, Pratik D. Jagtap, Andrew C. Nelson, Boris Winterhoff, Timothy J. Griffin, Timothy K. Starr, Stefani N. Thomas
  Scientific Reports.2025;[Epub]     CrossRef
• Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient‐Derived Tissue Laden Tissue‐Specific Bioink
  Yoo‐mi Choi, Deukchae Na, Goeun Yoon, Jisoo Kim, Seoyeon Min, Hee‐Gyeong Yi, Soo‐Jeong Cho, Jae Hee Cho, Charles Lee, Jinah Jang
  Advanced Science.2025;[Epub]     CrossRef
• Establishment and characterization of a sigmoid colon cancer organoid with spinal metastasis
  Jingyao Chen, Shumin Cheng, Liang Gu, Zhangsen Huang, Changhua Zhang, Chunhui Sun, Songyao Chen
  Frontiers in Cell and Developmental Biology.2025;[Epub]     CrossRef
• Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
  Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, Nayla Alfarafisa, Julia Ramadhanti
  Breast Cancer: Targets and Therapy.2025; Volume 17: 1.     CrossRef
• Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites
  Mariana Gallo, Elena Ferrari, Federica Brugnoli, Anna Terrazzan, Pietro Ancona, Stefano Volinia, Valeria Bertagnolo, Carlo M. Bergamini, Alberto Spisni, Thelma A. Pertinhez, Nicoletta Bianchi
  International Journal of Molecular Sciences.2025; 26(3): 969.     CrossRef
• Non-Coding RNAs in Cancer: Structure, Function, and Clinical Application
  Éva Márton, Alexandra Varga, Dóra Domoszlai, Gergely Buglyó, Anita Balázs, András Penyige, István Balogh, Bálint Nagy, Melinda Szilágyi
  Cancers.2025; 17(4): 579.     CrossRef
• The latest progress of personalized drug screening and therapy research for common clinical tumors through the PDX model platform
  Yitong Yuan, Hongling Gao, Yanhong Li, Xiangying Jiao
  Journal of Pharmaceutical Analysis.2025; : 101225.     CrossRef
• The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinoma
  William P. Katt, Cheryl E. Balkman, Scott D. Butler, Michael Byron, Patrick C. Carney, Amy B. Todd-Donato, Matthew E. Drozd, Gerald E. Duhamel, Jacquelyn M. Evans, Nadine Fiani, Jordan C. Ford, Jennifer K. Grenier, Jessica J. Hayward, Kristiina Heikinheim
  Scientific Reports.2025;[Epub]     CrossRef
• Modeling patient-specific adenocarcinoma as spheroids enhances the authenticity of cancer hallmarks and therapeutic susceptibility
  Andres S. Espinoza, Rachael N. McVicar, Darren Finlay, Rabi Murad, Kristiina Vuori, Bethany A. Grimmig, Anne Bush, Emily Smith, Thomas Mandel-Clausen, Heather M. McGee, Evan Y. Snyder, Sandra L. Leibel
  Heliyon.2025; 11(6): e42977.     CrossRef
• Microfluidic Organoid Cultures Derived from Pancreatic Cancer Biopsies for Personalized Testing of Chemotherapy and Immunotherapy
  Daheui Choi, Alan M. Gonzalez‐Suarez, Mihai G. Dumbrava, Michael Medlyn, Jose M. de Hoyos‐Vega, Frank Cichocki, Jeffrey S. Miller, Li Ding, Mojun Zhu, Gulnaz Stybayeva, Alexandre Gaspar‐Maia, Daniel D. Billadeau, Wen Wee Ma, Alexander Revzin
  Advanced Science.2024;[Epub]     CrossRef
• Statistical classification of treatment responses in mouse clinical trials for stratified medicine in oncology drug discovery
  Hélène Savel, Florence Meyer-Losic, Cécile Proust-Lima, Laura Richert
  Scientific Reports.2024;[Epub]     CrossRef
• Biomaterials for Drug Delivery and Human Applications
  Paolo Trucillo
  Materials.2024; 17(2): 456.     CrossRef
• Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma
  Niki M. Zacharias, Luis Segarra, Keiko Akagi, Natalie Wall Fowlkes, Huiqin Chen, Angelita Alaniz, Carolyn de la Cerda, Pedro Pesquera, Yuanxin Xi, Jing Wang, Jad Chahoud, Xin Lu, Priya Rao, Magaly Martinez-Ferrer, Curtis A. Pettaway
  Cancers.2024; 16(5): 1066.     CrossRef
• A Case Study of a Rare Undifferentiated Spindle Cell Sarcoma of the Penis: Establishment and Characterization of Patient-Derived Models
  Ariane Cavalcante dos Santos Sousa, Bruno Leonardo Nascimento Correa Fernandes, Jeronimo Paulo Assis da Silva, Paulo Roberto Stevanato Filho, Luiza Bitencourt de Carvalho Terci Coimbra, Adriano de Oliveira Beserra, Ana Luiza Alvarenga, Giovanna Maida, Cam
  Genes.2024; 15(4): 424.     CrossRef
• Burning down the house: Pyroptosis in the tumor microenvironment of hepatocellular carcinoma
  Chi Cheng, Sheng-Kai Hsu, Yen-Chun Chen, Wangta Liu, En-De Shu, Ching-Ming Chien, Chien-Chih Chiu, Wen-Tsan Chang
  Life Sciences.2024; 347: 122627.     CrossRef
• PDX Models in Theranostic Applications: Generation and Screening for B Cell Lymphoma of Human Origin
  Shayla Shmuel, Sébastien Monette, Dina Ibrahim, Patrícia M.R. Pereira
  Molecular Imaging and Biology.2024; 26(4): 569.     CrossRef
• A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights
  Parham Soufizadeh, Vahid Mansouri, Naser Ahmadbeigi
  Laboratory Animal Research.2024;[Epub]     CrossRef
• Applied models and molecular characteristics of small cell lung cancer
  Gabriella Mihalekné Fűr, Kolos Nemes, Éva Magó, Alexandra Á. Benő, Petronella Topolcsányi, Judit Moldvay, Lőrinc S. Pongor
  Pathology and Oncology Research.2024;[Epub]     CrossRef
• Advances in the study of gastric organoids as disease models
  Yi-Yang Liu, De-Kun Wu, Ji-Bing Chen, You-Ming Tang, Feng Jiang
  World Journal of Gastrointestinal Oncology.2024; 16(5): 1725.     CrossRef
• Cancer research revolutionized: Unveiling the power of organoids and their therapeutic potential in oncology
  Yingxin Zhang, Ming Liu, Na Xie, Zhoufeng Wang, Chuanjiang Yu, Jing Li, Xikun Zhou
  hLife.2024;[Epub]     CrossRef
• The potential of organoids in renal cell carcinoma research
  Qiuyang Chen, Xuan Sun, Yubei Li, Xinyue Yang, Xuejian Yang, Haifei Xu, Hongzhou Cai, Jun Hu
  BMC Urology.2024;[Epub]     CrossRef
• Zebrafish Xenographs in Oncology and Personalized Medicine
  N. A. Lunina, D. R. Safina, S. V. Kostrov
  Molecular Biology.2024; 58(3): 381.     CrossRef
• Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
  Zhian Xiu, Qian Yang, Fusheng Xie, Feng Han, Weiwei He, Weifang Liao
  Journal of Tissue Engineering.2024;[Epub]     CrossRef
• Prodrug-inspired adenosine triphosphate–activatable celastrol-Fe(III) chelate for cancer therapy
  Hanrong Li, Yifan Li, Lingpu Zhang, Nan Wang, Dong Lu, Dongsheng Tang, Yitong Lv, Jinbo Zhang, Heben Yan, He Gong, Ming Zhang, Kaili Nie, Yi Hou, Yingjie Yu, Haihua Xiao, Chaoyong Liu
  Science Advances.2024;[Epub]     CrossRef
• Reversion of pathogenic BRCA1 L1780P mutation confers resistance to PARP and ATM inhibitor in breast cancer
  Se-Young Jo, Jeong Dong Lee, Jeongsoo Won, Jiho Park, Taeyong Kweon, Seongyeon Jo, Joohyuk Sohn, Seung-Il Kim, Sangwoo Kim, Hyung Seok Park
  iScience.2024; 27(8): 110469.     CrossRef
• Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges
  Antonio Cigliano, Weiting Liao, Giovanni A. Deiana, Davide Rizzo, Xin Chen, Diego F. Calvisi
  Biomedicines.2024; 12(7): 1624.     CrossRef
• Recent advances in lung cancer organoid (tumoroid) research (Review)
  Qiang Zhang, Mingyang Zhang
  Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
• Cannabinoid combination targets NOTCH1-mutated T-cell acute lymphoblastic leukemia through the integrated stress response pathway
  Elazar Besser, Anat Gelfand, Shiri Procaccia, Paula Berman, David Meiri
  eLife.2024;[Epub]     CrossRef
• Radiobiological Applications of Vibrational Spectroscopy: A Review of Analyses of Ionising Radiation Effects in Biology and Medicine
  Jade F. Monaghan, Hugh J. Byrne, Fiona M. Lyng, Aidan D. Meade
  Radiation.2024; 4(3): 276.     CrossRef
• The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine
  Venkatachalababu Janitri, Kandasamy Nagarajan ArulJothi, Vijay Murali Ravi Mythili, Sachin Kumar Singh, Parteek Prasher, Gaurav Gupta, Kamal Dua, Rakshith Hanumanthappa, Karthikeyan Kaliappan, Krishnan Anand
  MedComm.2024;[Epub]     CrossRef
• Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers
  Aamir Mehmood, Mohd Sajid Ali, Daixi Li, Aman Chandra Kaushik, Dong‐Qing Wei
  Chemical Biology & Drug Design.2024;[Epub]     CrossRef
• Mimicking and analyzing the tumor microenvironment
  Roxane Crouigneau, Yan-Fang Li, Jamie Auxillos, Eliana Goncalves-Alves, Rodolphe Marie, Albin Sandelin, Stine Falsig Pedersen
  Cell Reports Methods.2024; 4(10): 100866.     CrossRef
• Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma
  Julianna Korns, Christina A. Wicker, Maria Lehn, Shreya Shyamsunder, Samuel Thompson, Carissa Lester, Trisha M. Wise-Draper, Susan E. Waltz, Vinita Takiar
  Cancer Letters.2024; 606: 217320.     CrossRef
• Zebrafish xenographs in oncology and personalized medicine
  N. A. Lunina, D. R. Safina, S. V. Kostrov
  Molekulârnaâ biologiâ.2024; 58(3): 363.     CrossRef
• Engineering liquid metal-based nanozyme for enhancing microwave dynamic therapy in breast cancer PDX model
  Qiong Wu, Yongnian Yu, Xiaorui Yu, Qijun Du, Li Gou, Longfei Tan, Changhui Fu, Xiangling Ren, Jun Ren, Kai Xiao, Xianwei Meng
  Journal of Nanobiotechnology.2023;[Epub]     CrossRef
• An integrated PK/PD model investigating the impact of tumor size and systemic safety on animal survival in SW1990 pancreatic cancer xenograft
  Qing-yu Yao, Jun Zhou, Ye Yao, Jun-sheng Xue, Yu-chen Guo, Wei-zhe Jian, Ren-wei Zhang, Xiao-yan Qiu, Tian-yan Zhou
  Acta Pharmacologica Sinica.2023; 44(2): 465.     CrossRef
• Opportunities for pharmacoproteomics in biomarker discovery
  Rebecca C. Poulos, Zhaoxiang Cai, Phillip J. Robinson, Roger R. Reddel, Qing Zhong
  PROTEOMICS.2023;[Epub]     CrossRef
• Hydrogel Microtumor Arrays to Evaluate Nanotherapeutics
  Yiling Liu, Stephanie Nemec, Chantal Kopecky, Martina H. Stenzel, Kristopher A. Kilian
  Advanced Healthcare Materials.2023;[Epub]     CrossRef
• Patient‐derived xenograft model in colorectal cancer basic and translational research
  Xiaofeng Liu, Zechang Xin, Kun Wang
  Animal Models and Experimental Medicine.2023; 6(1): 26.     CrossRef
• AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells
  Songbin Li, Woochan Lee, Woohang Heo, Hye-Youn Son, Yujeong Her, Jong-Il Kim, Hyeong-Gon Moon
  Journal of Breast Cancer.2023; 26(1): 60.     CrossRef
• Spotlight on P2X7 Receptor PET Imaging: A Bright Target or a Failing Star?
  Stephan Schmidt, Andreas Isaak, Anna Junker
  International Journal of Molecular Sciences.2023; 24(2): 1374.     CrossRef
• Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
  Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, Ze-Xin Chen, Jun-Wei Su, Yu-Fa Li, Wen-Feng Li, Qing-Yun Gao, Shi-Ling Zhang, Yu-Qing Chen, Qing Zhou, Cong Xu, Chong-Rui Xu, Zhen Wang, Jian Su, Hong-Hong Yan, Xu-Chao Zhang, Hua-Jun Chen, Yi-Long Wu, Jin-Ji
  Cell Reports Medicine.2023; 4(2): 100911.     CrossRef
• On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models
  Hélène Savel, Sandrine Barbier, Cécile Proust-Lima, Virginie Rondeau, Rodolphe Thiébaut, Florence Meyer-Losic, Laura Richert
  Cancer Research Communications.2023; 3(1): 140.     CrossRef
• Development and characterization of patient-derived xenograft models of colorectal cancer for testing new pharmacological substances
  A. S. Goncharova, E. N. Kolesnikov, G. Yu. Egorov, A. Yu. Maksimov, A. N. Shevchenko, E. M. Nepomnyashchaya, D. Yu. Gvaldin, L. Z. Kurbanova, D. V. Khodakova, S. O. Kit, O. Yu. Kaymakchi, A. V. Snezhko
  Bulletin of Siberian Medicine.2023; 21(4): 37.     CrossRef
• Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer
  Yuanqiao He, Jiaqi Mei, Hua Hao, Fanrong Liu, Yun Yi, Chao Hu, Fangxing Zou, Xiongbing Lu
  Journal of Cancer Research and Clinical Oncology.2023; 149(10): 6931.     CrossRef
• Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells
  Maryam Farzaneh, Ava Nasrolahi, Farhoodeh Ghaedrahmati, Tariq Masoodi, Sajad Najafi, Mohadeseh Sheykhi-Sabzehpoush, Mahrokh Abouali Gale Dari, Klaudia Radoszkiewicz, Shahab Uddin, Shirin Azizidoost, Seyed Esmaeil Khoshnam
  Clinical and Translational Oncology.2023; 25(7): 2015.     CrossRef
• Experimental mouse models for translational human cancer research
  Yinxi Zhou, Jinghua Xia, Shuonan Xu, Tao She, Yanning Zhang, Ying Sun, Miaomiao Wen, Tao Jiang, Yanlu Xiong, Jie Lei
  Frontiers in Immunology.2023;[Epub]     CrossRef
• A novel method to identify and characterize personalized functional driver lncRNAs in cancer samples
  Xuan Zheng, Feng Li, Hongying Zhao, Yongjuan Tang, Ke Xue, Xiaomeng Zhang, Weixin Liang, Rui Zhao, Xingyu Lv, Xinyu Song, Chunlong Zhang, Yanjun Xu, Yunpeng Zhang
  Computational and Structural Biotechnology Journal.2023; 21: 2471.     CrossRef
• Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma
  Lisa Kristina Isbell, Cordula Tschuch, Soroush Doostkam, Silvia Waldeck, Geoffroy Andrieux, Khalid Shoumariyeh, Dorothee Lenhard, Hans Eckart Schaefer, Peter Christoph Reinacher, Ingrid Bartsch, Milena Pantic, Janaki Manoja Vinnakota, Vinodh Kakkassery, E
  Neuropathology and Applied Neurobiology.2023;[Epub]     CrossRef
• Towards an optimal model for gastric cancer peritoneal metastasis: current challenges and future directions
  Zehui Li, Jin Wang, Zhenning Wang, Yan Xu
  eBioMedicine.2023; 92: 104601.     CrossRef
• Effects of Mouse Kidney Parvovirus on Pharmacokinetics of Chemotherapeutics and the Adenine Model of Chronic Kidney Disease
  Amanda C Ritter, Rodolfo Ricart J Arbona, Robert S Livingston, Sébastien Monette, Neil S Lipman
  Comparative Medicine.2023; 73(2): 153.     CrossRef
• Alteration in molecular properties during establishment and passaging of endometrial carcinoma patient-derived xenografts
  Toshio Imai, Hiroshi Yoshida, Yukino Machida, Mizuki Kuramochi, Hitoshi Ichikawa, Takashi Kubo, Mami Takahashi, Tomoyasu Kato
  Scientific Reports.2023;[Epub]     CrossRef
• Exploratory study on the efficacy of bortezomib combining mitoxantrone or CD22-CAR T therapy targeting CD19-negative relapse after CD19-CAR T cell therapy with a simpler cell-line-based model
  Diandian Ba, Hongzhe Li, Rongrong Liu, Ping Zhang, Yongmin Tang
  Apoptosis.2023; 28(11-12): 1534.     CrossRef
• Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice
  Mingtang Zeng, Zijing Ruan, Jiaxi Tang, Maozhu Liu, Chengji Hu, Ping Fan, Xinhua Dai
  Cancer Cell International.2023;[Epub]     CrossRef
• Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer
  Fan Liang, Hongyan Xu, Hongwei Cheng, Yabo Zhao, Junhe Zhang
  Cancer Gene Therapy.2023; 30(11): 1443.     CrossRef
• Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer
  Haechan Lee, SungWook Jung, Gyungyub Gong, Bora Lim, Hee Jin Lee, Irina V. Lebedeva
  PLOS ONE.2023; 18(8): e0289627.     CrossRef
• Development of a small cell lung cancer organoid model to study cellular interactions and survival after chemotherapy
  Chandani Sen, Caroline R. Koloff, Souvik Kundu, Dan C. Wilkinson, Juliette M. Yang, David W. Shia, Luisa K. Meneses, Tammy M. Rickabaugh, Brigitte N. Gomperts
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• The challenge of making the right choice: patient avatars in the era of cancer immunotherapies
  Charlotte Kayser, Annika Brauer, Sebens Susanne, Anna Maxi Wandmacher
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy
  Yue Lang, Yanan Lyu, Yehui Tan, Zheng Hu
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research
  Danyal Daneshdoust, Mingjue Luo, Zaibo Li, Xiaokui Mo, Sahar Alothman, Bhaskar Kallakury, Richard Schlegel, Junran Zhang, Deliang Guo, Priscilla A. Furth, Xuefeng Liu, Jenny Li
  Cells.2023; 12(19): 2388.     CrossRef
• Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin
  Laura Martinez-Ruiz, Alba López-Rodríguez, Javier Florido, Cesar Rodríguez-Santana, José M. Rodríguez Ferrer, Darío Acuña-Castroviejo, Germaine Escames
  Biomedicine & Pharmacotherapy.2023; 167: 115581.     CrossRef
• Modeling Liver Development and Disease in a Dish
  Waqas Iqbal, Yaru Wang, Pingnan Sun, Xiaoling Zhou
  International Journal of Molecular Sciences.2023; 24(21): 15921.     CrossRef
• BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model
  Jean Courcier, Ingrid Leguerney, Baya Benatsou, Sibylle Pochon, Isabelle Tardy, Laurence Albiges, Paul-Henry Cournède, Alexandre De La Taille, Nathalie Lassau, Alexandre Ingels
  International Journal of Molecular Sciences.2023; 24(22): 16211.     CrossRef
• Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts)
  Tatiana Hernández Guerrero, Natalia Baños, Laura del Puerto Nevado, Ignacio Mahillo-Fernandez, Bernard Doger De-Speville, Emiliano Calvo, Michael Wick, Jesús García-Foncillas, Victor Moreno
  Cancers.2023; 15(22): 5402.     CrossRef
• Comparative RNA-Seq Analysis Revealed Tissue-Specific Splicing Variations during the Generation of the PDX Model
  Eun Ji Lee, Seung-Jae Noh, Huiseon Choi, Min Woo Kim, Su Jin Kim, Yeon Ah Seo, Ji Eun Jeong, Inkyung Shin, Jong-Seok Kim, Jong-Kwon Choi, Dae-Yeon Cho, Suhwan Chang
  International Journal of Molecular Sciences.2023; 24(23): 17001.     CrossRef
• PC Kz is the novel human prostate cancer model in vitro and in vivo
  Darina V. Sokolova, Irina I. Khan, Dmitry D. Zhdanov, Elena A. Demidova, Valery O. Krivchenko, Chingis Aidossov, Vadim S. Pokrovsky
  Russian Journal of Oncology.2023; 28(1): 37.     CrossRef
• Predicting chemosensitivity based on mini patient-derived xenografts in osteosarcoma patients: A retrospective study
  Zuoyao Long, Yajie Lu, Minghui Li, Chuanlei Ji, Guojing Chen, Jing Li, Liangbi Xiang, Hailong Yu, Qi Wang, Zhen Wang
  Journal of Cancer Research and Therapeutics.2023; 19(1): 71.     CrossRef
• A rapid and simple procedure for the isolation and cultivation of fibroblast-like cells from medaka and zebrafish embryos and fin clip biopsies
  Lars Beedgen, Andreas Hüllen, Sevinç Gücüm, Thomas Thumberger, Jochen Wittbrodt, Christian Thiel
  Laboratory Animals.2022; 56(3): 270.     CrossRef
• Harnessing the predictive power of preclinical models for oncology drug development
  Alexander Honkala, Sanjay V. Malhotra, Shivaani Kummar, Melissa R. Junttila
  Nature Reviews Drug Discovery.2022; 21(2): 99.     CrossRef
• The Cell‐Isolation Capsules with Rod‐Like Channels Ensure the Survival and Response of Cancer Cells to Their Microenvironment
  Lanlan Hui, Deng Wang, Zhao Liu, Yueqi Zhao, Zhongzhong Ji, Man Zhang, Helen He Zhu, Wenqing Luo, Xiaomu Cheng, Liming Gui, Wei‐Qiang Gao
  Advanced Healthcare Materials.2022;[Epub]     CrossRef
• Des sphéroïdes aux organoïdes : modèles de cancers solides pour la découverte de molécules anticancéreuses
  George Alzeeb, Laurent Corcos, Catherine Le Jossic-Corcos
  Bulletin du Cancer.2022; 109(1): 49.     CrossRef
• Inhibition of Musashi-1 enhances chemotherapeutic sensitivity in gastric cancer patient-derived xenografts
  Fan Liu, Huan Yang, Xinyu Zhang, Xianglin Sun, Jiamin Zhou, Yuan Li, Yifei Liu, Zhixiang Zhuang, Guohua Wang
  Experimental Biology and Medicine.2022; 247(10): 868.     CrossRef
• Inhibition of growth of colorectal cancer patient-derived subcutaneous xenografts using combined Wnt signaling pathway inhibitor and 5‑fluorouracil
  A. S. Goncharova, A. V. Galina, D. V. Khodakova, G. Yu. Egorov, A. Yu. Maksimov, E. N. Kolesnikov, E. F. Komarova, A. A. Kiblitskaya, E. V. Zaikina, L. Z. Kurbanova, M. V. Mindar
  Research and Practical Medicine Journal.2022; 9(1): 33.     CrossRef
• Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients
  Monika Pizon, Dorothea Schott, Ulrich Pachmann, Rainer Schobert, Marek Pizon, Marta Wozniak, Rafal Bobinski, Katharina Pachmann
  Cancers.2022; 14(6): 1476.     CrossRef
• Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies
  Pei-Yu Chu, Angele Pei-Fern Koh, Jane Antony, Ruby Yun-Ju Huang
  Cells Tissues Organs.2022; 211(2): 222.     CrossRef
• Comparison of classical tumour growth models for patient derived and cell-line derived xenografts using the nonlinear mixed-effects framework
  Dimitrios Voulgarelis, Krishna C. Bulusu, James W. T. Yates
  Journal of Biological Dynamics.2022; 16(1): 160.     CrossRef
• Three-dimensional models of the lung: past, present and future: a mini review
  Chandani Sen, Delilah Freund, Brigitte N. Gomperts
  Biochemical Society Transactions.2022; 50(2): 1045.     CrossRef
• The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
  JuneSung Bae, Yun Sik Choi, Gunsik Cho, Se Jin Jang
  Cancers.2022; 14(9): 2144.     CrossRef
• Patient-derived xenograft (PDX) models, applications and challenges in cancer research
  Shahrokh Abdolahi, Zeinab Ghazvinian, Samad Muhammadnejad, Mahshid Saleh, Hamid Asadzadeh Aghdaei, Kaveh Baghaei
  Journal of Translational Medicine.2022;[Epub]     CrossRef
• Patient-Derived Xenograft: A More Standard “Avatar” Model in Preclinical Studies of Gastric Cancer
  Mingtang Zeng, Chao Pi, Ke Li, Lin Sheng, Ying Zuo, Jiyuan Yuan, Yonggen Zou, Xiaomei Zhang, Wenmei Zhao, Robert J. Lee, Yumeng Wei, Ling Zhao
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Experimental approach to obtaining subcutaneous xenograft of non-small cell lung cancer
  E. A. Lukbanova, M. V. Mindar, E. A. Dzhenkova, A. Yu. Maksimov, A. S. Goncharova, Yu. S. Shatova, A. A. Maslov, A. V. Shaposhnikov, E. V. Zaikina, Yu. N. Lazutin
  Research and Practical Medicine Journal.2022; 9(2): 65.     CrossRef
• Spontaneous xenogeneicGvHDin Wilms' tumorPatient‐Derivedxenograft models and potential solutions
  Seyed Mostafa Monzavi, Ahad Muhammadnejad, Maryam Behfar, Amir Arsalan Khorsand, Samad Muhammadnejad, Abdol‐Mohammad Kajbafzadeh
  Animal Models and Experimental Medicine.2022; 5(4): 389.     CrossRef
• Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application
  Sha Liu, Fang Huang, Guoqing Ru, Yigang Wang, Bixiang Zhang, Xiaoping Chen, Liang Chu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Recent advances in the development of transplanted colorectal cancer mouse models
  Yu-Shen Yang, Chu-Yun Liu, Dan Wen, Da-Zhi Gao, Shu Lin, He-fan He, Xue-Feng Zhao
  Translational Research.2022; 249: 128.     CrossRef
• Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis
  Yeon-Sook Choi, Myung Ji Kim, Eun A. Choi, Sinae Kim, Eun ji Lee, Min Ji Park, Mi-Ju Kim, Yeon Wook Kim, Hee-Sung Ahn, Jae Yun Jung, Gayoung Jang, Yongsub Kim, Hyori Kim, Kyunggon Kim, Jin Young Kim, Seung-Mo Hong, Song Cheol Kim, Suhwan Chang
  Proceedings of the National Academy of Sciences.2022;[Epub]     CrossRef
• CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
  Licai Huang, Jing Wang, Bingliang Fang, Funda Meric-Bernstam, Jack A. Roth, Min Jin Ha
  Scientific Reports.2022;[Epub]     CrossRef
• HSSG: Identification of Cancer Subtypes Based on Heterogeneity Score of A Single Gene
  Shanchen Pang, Wenhao Wu, Yuanyuan Zhang, Shudong Wang, Muyuan Niu, Kuijie Zhang, Wenjing Yin
  Cells.2022; 11(15): 2456.     CrossRef
• Zebrafish Models of Paediatric Brain Tumours
  Faiza Basheer, Poshmaal Dhar, Rasika M. Samarasinghe
  International Journal of Molecular Sciences.2022; 23(17): 9920.     CrossRef
• Modelling metabolic diseases and drug response using stem cells and organoids
  Wenxiang Hu, Mitchell A. Lazar
  Nature Reviews Endocrinology.2022; 18(12): 744.     CrossRef
• Multifunctional stimuli-responsive hybrid nanogels for cancer therapy: Current status and challenges
  Amaal Abdulraqeb Ali, Amani Al-Othman, Mohammad H. Al-Sayah
  Journal of Controlled Release.2022; 351: 476.     CrossRef
• Predictive validity in drug discovery: what it is, why it matters and how to improve it
  Jack W. Scannell, James Bosley, John A. Hickman, Gerard R. Dawson, Hubert Truebel, Guilherme S. Ferreira, Duncan Richards, J. Mark Treherne
  Nature Reviews Drug Discovery.2022; 21(12): 915.     CrossRef
• Variants of creating heterotopic and orthotopic PDX models of human colorectal cancer
  A. A. Kiblitskaya, A. Y. Maksimov, A. S. Goncharova, Ye. M. Nepomnyashchaya, Ye. Y. Zlatnik, G. Y. Yegorov, Ye. A. Lukbanova, Ye. V. Zaikina, A. V. Volkova
  Bulletin of Siberian Medicine.2022; 21(3): 50.     CrossRef
• Multiparametric Magnetic Resonance Imaging and Metabolic Characterization of Patient-Derived Xenograft Models of Clear Cell Renal Cell Carcinoma
  Joao Piraquive Agudelo, Deepti Upadhyay, Dalin Zhang, Hongjuan Zhao, Rosalie Nolley, Jinny Sun, Shubhangi Agarwal, Robert A. Bok, Daniel B. Vigneron, James D. Brooks, John Kurhanewicz, Donna M. Peehl, Renuka Sriram
  Metabolites.2022; 12(11): 1117.     CrossRef
• Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
  Xiongfei Yu, Yiran Chen, Jun Lu, Kuifeng He, Yanyan Chen, Yongfeng Ding, Ketao Jin, Haiyong Wang, Haibin Zhang, Haohao Wang, Lisong Teng
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts
  Jessica Weiss, Nhu-An Pham, Melania Pintilie, Ming Li, Geoffrey Liu, Frances A Shepherd, Ming-Sound Tsao, Wei Xu
  Cancer Informatics.2022;[Epub]     CrossRef
• Current methods for studying metastatic potential of tumor cells
  Pavla Bouchalova, Pavel Bouchal
  Cancer Cell International.2022;[Epub]     CrossRef
• Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors
  Pankita H. Pandya, Asha Jacob Jannu, Khadijeh Bijangi-Vishehsaraei, Erika Dobrota, Barbara J. Bailey, Farinaz Barghi, Harlan E. Shannon, Niknam Riyahi, Nur P. Damayanti, Courtney Young, Rada Malko, Ryli Justice, Eric Albright, George E. Sandusky, L. Danie
  Cancers.2022; 15(1): 259.     CrossRef
• Antibody-drug conjugates: an evolving approach for melanoma treatment
  Trevor S. Anderson, Amanda L. Wooster, Ninh M. La-Beck, Dipongkor Saha, Devin B. Lowe
  Melanoma Research.2021; 31(1): 1.     CrossRef
• Establishment and Long-Term Expansion of Small Cell Lung Cancer Patient-Derived Tumor Organoids
  Seon Young Choi, Yong-Hee Cho, Da-Som Kim, Wonjun Ji, Chang-Min Choi, Jae Cheol Lee, Jin Kyung Rho, Gi Seok Jeong
  International Journal of Molecular Sciences.2021; 22(3): 1349.     CrossRef
• Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models
  Shunsuke Goto, Yukimi Sakoda, Keishi Adachi, Yoshitaka Sekido, Seiji Yano, Masatoshi Eto, Koji Tamada
  Cancer Immunology, Immunotherapy.2021; 70(9): 2503.     CrossRef
• PDX-Derived Ewing’s Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures
  Giacomo Domenici, Rodrigo Eduardo, Helena Castillo-Ecija, Gorka Orive, Ángel Montero Carcaboso, Catarina Brito
  Cancers.2021; 13(4): 879.     CrossRef
• Using the Microwell-mesh to culture microtissues in vitro and as a carrier to implant microtissues in vivo into mice
  Melissa E. Monterosso, Kathryn Futrega, William B. Lott, Ian Vela, Elizabeth D. Williams, Michael R. Doran
  Scientific Reports.2021;[Epub]     CrossRef
• The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis
  Kelly Harper, Anna Yatsyna, Martine Charbonneau, Karine Brochu-Gaudreau, Alexis Perreault, Claudio Jeldres, Patrick P. McDonald, Claire M. Dubois
  Cancers.2021; 13(5): 1093.     CrossRef
• The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
  Qian Zhang, Guoping Liu, Jibin Liu, Mu Yang, Juan Fu, Guodi Liu, Dehua Li, Zhangjie Gu, Linsong Zhang, Yingjiao Pan, Xingbing Cui, Lu Wang, Lixin Zhang, Xiaoli Tian
  Molecular Therapy - Oncolytics.2021; 20: 556.     CrossRef
• EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
  Laura V. Bownes, Adele P. Williams, Raoud Marayati, Laura L. Stafman, Hooper Markert, Colin H. Quinn, Nikita Wadhwani, Jamie M. Aye, Jerry E. Stewart, Karina J. Yoon, Elizabeth Mroczek-Musulman, Elizabeth A. Beierle, Joe W. Ramos
  PLOS ONE.2021; 16(3): e0246244.     CrossRef
• Patient-derived xenograft models for the study of benign human neoplasms
  Juliana Cristina de Souza, Lucyene Miguita, Ricardo Santiago Gomez, Carolina Cavaliéri Gomes
  Experimental and Molecular Pathology.2021; 120: 104630.     CrossRef
• Chromosome 8 gain is associated with high-grade transformation in MPNST
  Carina Dehner, Chang In Moon, Xiyuan Zhang, Zhaohe Zhou, Chris Miller, Hua Xu, Xiaodan Wan, Kuangying Yang, Jay Mashl, Sara J.C. Gosline, Yuxi Wang, Xiaochun Zhang, Abigail Godec, Paul A. Jones, Sonika Dahiya, Himanshi Bhatia, Tina Primeau, Shunqiang Li,
  JCI Insight.2021;[Epub]     CrossRef
• Cancer models in preclinical research: A chronicle review of advancement in effective cancer research
  Humna Sajjad, Saiqa Imtiaz, Tayyaba Noor, Yusra Hasan Siddiqui, Anila Sajjad, Muhammad Zia
  Animal Models and Experimental Medicine.2021; 4(2): 87.     CrossRef
• Rodent Models to Analyze the Glioma Microenvironment
  Susann Hetze, Ulrich Sure, Manfred Schedlowski, Martin Hadamitzky, Lennart Barthel
  ASN Neuro.2021;[Epub]     CrossRef
• Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer
  Jessica L. Christenson, Kathleen I. O'Neill, Michelle M. Williams, Nicole S. Spoelstra, Kenneth L. Jones, G. Devon Trahan, Jordan Reese, Elaina T. Van Patten, Anthony Elias, Joel R. Eisner, Jennifer K. Richer
  Molecular Cancer Therapeutics.2021; 20(6): 1062.     CrossRef
• Hexavalent TRAIL Fusion Protein Eftozanermin Alfa Optimally Clusters Apoptosis-Inducing TRAIL Receptors to Induce On-Target Antitumor Activity in Solid Tumors
  Darren C. Phillips, Fritz G. Buchanan, Dong Cheng, Larry R. Solomon, Yu Xiao, John Xue, Stephen K. Tahir, Morey L. Smith, Haichao Zhang, Deborah Widomski, Vivek C. Abraham, Nan Xu, Zhihong Liu, Li Zhou, Enrico DiGiammarino, Xin Lu, Nandini Rudra-Ganguly,
  Cancer Research.2021; 81(12): 3402.     CrossRef
• Cloperastine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by suppressing mitochondrial oxidative phosphorylation
  Bo Li, Yin Yu, Yanan Jiang, Lili Zhao, Ang Li, Mingzhu Li, Baoyin Yuan, Jing Lu, Ziming Dong, Jimin Zhao, Kangdong Liu
  Cell Death Discovery.2021;[Epub]     CrossRef
• Advanced Xenograft Model with Cotransplantation of Patient-Derived Organoids and Endothelial Colony-Forming Cells for Precision Medicine
  Junhye Kwon, Sungryong Oh, Misun Park, Joon Seog Kong, Sunyi Lee, Hyunsook Lee, Younjoo Kim, Kyu-Tae Kang, Ui Sup Shin, Joohee Jung, Muhammad Wasim Khan
  Journal of Oncology.2021; 2021: 1.     CrossRef
• Human circular RNA hsa_circRNA_101705 (circTXNDC11) regulates renal cancer progression by regulating MAPK/ERK pathway
  Chong-Yi Yang, Jie Wang, Jian-Qiu Zhang, Hong-miao Cai
  Bioengineered.2021; 12(1): 4432.     CrossRef
• A Review of Recent and Emerging Approaches for the Clinical Application of Cerenkov Luminescence Imaging
  Benedict Mc Larney, Magdalena Skubal, Jan Grimm
  Frontiers in Physics.2021;[Epub]     CrossRef
• Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment
  Hua Sun, Song Cao, R. Jay Mashl, Chia-Kuei Mo, Simone Zaccaria, Michael C. Wendl, Sherri R. Davies, Matthew H. Bailey, Tina M. Primeau, Jeremy Hoog, Jacqueline L. Mudd, Dennis A. Dean, Rajesh Patidar, Li Chen, Matthew A. Wyczalkowski, Reyka G. Jayasinghe,
  Nature Communications.2021;[Epub]     CrossRef
• Microdissected Tissue vs Tissue Slices—A Comparative Study of Tumor Explant Models Cultured On-Chip and Off-Chip
  Dina Dorrigiv, Kayla Simeone, Laudine Communal, Jennifer Kendall-Dupont, Amélie St-Georges-Robillard, Benjamin Péant, Euridice Carmona, Anne-Marie Mes-Masson, Thomas Gervais
  Cancers.2021; 13(16): 4208.     CrossRef
• Patient-Derived Xenograft Models in Cervical Cancer: A Systematic Review
  Tomohito Tanaka, Ruri Nishie, Shoko Ueda, Shunsuke Miyamoto, Sousuke Hashida, Hiromi Konishi, Shinichi Terada, Yuhei Kogata, Hiroshi Sasaki, Satoshi Tsunetoh, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi
  International Journal of Molecular Sciences.2021; 22(17): 9369.     CrossRef
• Generation of Antibody-Drug Conjugate Resistant Models
  Lucía Gandullo-Sánchez, Alberto Ocaña, Atanasio Pandiella
  Cancers.2021; 13(18): 4631.     CrossRef
• The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
  Ronnie Ren Jie Low, Wei Wen Lim, Paul M. Nguyen, Belinda Lee, Michael Christie, Antony W. Burgess, Peter Gibbs, Sean M. Grimmond, Frédéric Hollande, Tracy L. Putoczki
  Cancers.2021; 13(19): 4979.     CrossRef
• Methodological aspects of creation of patient-derived tumor xenografts
  A S Goncharova, A N Shevchenko, I R Dashkova, A E Anisimov
  Kazan medical journal.2021; 102(5): 694.     CrossRef
• Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review
  Ben William Johnson, Ken Takahashi, Yuen Yee Cheng
  Frontiers in Oncology.2021;[Epub]     CrossRef
• A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
  Zhongjian Chen, Chenxi Yang, Zhenying Guo, Siyu Song, Yun Gao, Ding Wang, Weimin Mao, Junping Liu
  BMC Cancer.2021;[Epub]     CrossRef
• Discovery of Novel Polycyclic Heterocyclic Derivatives from Evodiamine for the Potential Treatment of Triple-Negative Breast Cancer
  Shengtao Xu, Hong Yao, Yangyi Qiu, Manzhen Zhou, Dahong Li, Liang Wu, Dong-Hua Yang, Zhe-Sheng Chen, Jinyi Xu
  Journal of Medicinal Chemistry.2021; 64(23): 17346.     CrossRef
• Preclinical Models for the Study of Lung Cancer Pathogenesis and Therapy Development
  Anna Arnal-Estapé, Giorgia Foggetti, Jacqueline H. Starrett, Don X. Nguyen, Katerina Politi
  Cold Spring Harbor Perspectives in Medicine.2021; 11(12): a037820.     CrossRef
• Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
  Magdalena Cybula, Lin Wang, Luyao Wang, Ana Luiza Drumond-Bock, Katherine M. Moxley, Doris M. Benbrook, Camille Gunderson-Jackson, Maria J. Ruiz-Echevarria, Resham Bhattacharya, Priyabrata Mukherjee, Magdalena Bieniasz
  Cancers.2021; 13(24): 6288.     CrossRef
• NSG mice as hosts for oncological precision medicine
  Claudia Maletzki, Stephanie Bock, Philipp Fruh, Karolis Macius, Anika Witt, Friedrich Prall, Michael Linnebacher
  Laboratory Investigation.2020; 100(1): 27.     CrossRef
• Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer
  Luis Enrique Cortés-Hernández, Zahra Eslami-S, Catherine Alix-Panabières
  Molecular Aspects of Medicine.2020; 72: 100816.     CrossRef
• Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development
  Shannon R. Nelson, Chenxi Zhang, Sandra Roche, Fiona O’Neill, Niall Swan, Yonglun Luo, AnneMarie Larkin, John Crown, Naomi Walsh
  Scientific Reports.2020;[Epub]     CrossRef
• Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical application
  Rosa Maria Paragliola, Andrea Corsello, Valeria Del Gatto, Giampaolo Papi, Alfredo Pontecorvi, Salvatore Maria Corsello
  Expert Opinion on Drug Discovery.2020; 15(1): 11.     CrossRef
• Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma
  Eric R. Molina, Letitia K. Chim, Sergio Barrios, Joseph A. Ludwig, Antonios G. Mikos
  Tissue Engineering Part B: Reviews.2020; 26(3): 249.     CrossRef
• Organoid of ovarian cancer: genomic analysis and drug screening
  H.-D. Liu, B.-R. Xia, M.-Z. Jin, G. Lou
  Clinical and Translational Oncology.2020; 22(8): 1240.     CrossRef
• Mouse models of thyroid cancer: Bridging pathogenesis and novel therapeutics
  Yuchen Jin, Min Liu, Ri Sa, Hao Fu, Lin Cheng, Libo Chen
  Cancer Letters.2020; 469: 35.     CrossRef
• Pediatric Cancer Models in Zebrafish
  Mattie J. Casey, Rodney A. Stewart
  Trends in Cancer.2020; 6(5): 407.     CrossRef
• Three‐dimensional in vitro cell culture devices using patient‐derived cells for high‐throughput screening of drug combinations
  Seok‐Joon Kwon, Dongwoo Lee, Sneha Gopal, Ashlyn Ku, Hosang Moon, Jonathan S. Dordick
  MEDICAL DEVICES & SENSORS.2020;[Epub]     CrossRef

• The Use of Molecular Subtypes for Precision Therapy of Recurrent and Metastatic Gastrointestinal Stromal Tumor

  
  Peng Liu, Fengbo Tan, Heli Liu, Bin Li, Tianxiang Lei, Xianhui Zhao
  OncoTargets and Therapy.2020; Volume 13: 2433.     CrossRef
• The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
  Christophe Blanquart, Marie-Claude Jaurand, Didier Jean
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
  Sarah Meneceur, Annett Linge, Matthias Meinhardt, Sandra Hering, Steffen Löck, Rebecca Bütof, Dietmar Krex, Gabriele Schackert, Achim Temme, Michael Baumann, Mechthild Krause, Cläre von Neubeck
  Cancers.2020; 12(4): 871.     CrossRef
• The humanized mouse: Emerging translational potential
  J. Jason Morton, Nathaniel Alzofon, Antonio Jimeno
  Molecular Carcinogenesis.2020; 59(7): 830.     CrossRef
• Establishment and characterization of a cell line and patient-derived xenograft (PDX) from peritoneal metastasis of low-grade serous ovarian carcinoma
  Elien De Thaye, Koen Van de Vijver, Joni Van der Meulen, Joachim Taminau, Glenn Wagemans, Hannelore Denys, Jo Van Dorpe, Geert Berx, Wim Ceelen, Jan Van Bocxlaer, Olivier De Wever
  Scientific Reports.2020;[Epub]     CrossRef
• Update on in-vivo preclinical research models in adrenocortical carcinoma
  Adwitiya Kar, Margaret E. Wierman, Katja Kiseljak-Vassiliades
  Current Opinion in Endocrinology, Diabetes & Obesity.2020; 27(3): 170.     CrossRef
• Establishment of patient-derived xenografts from patients with gastrointestinal stromal tumors: analysis of clinicopathological characteristics related to engraftment success
  Young-Soon Na, Min-Hee Ryu, Young Soo Park, Chae-Won Lee, Ju-Kyung Lee, Yangsoon Park, Jung Min Park, Jungeun Ma, Yoon-Koo Kang
  Scientific Reports.2020;[Epub]     CrossRef
• Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients
  Shannon R. Nelson, Naomi Walsh
  Cancers.2020; 12(5): 1233.     CrossRef
• Patient-derived xenografts as compatible models for precision oncology
  Sung-Yup Cho
  Laboratory Animal Research.2020;[Epub]     CrossRef
• Emerging Challenges of Preclinical Models of Anti-tumor Immunotherapeutic Strategies Utilizing Vγ9Vδ2 T Cells
  Noémie Joalland, Emmanuel Scotet
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Comparing the fate of brain metastatic breast cancer cells in different immune compromised mice with cellular magnetic resonance imaging
  Natasha N. Knier, Amanda M. Hamilton, Paula J. Foster
  Clinical & Experimental Metastasis.2020; 37(4): 465.     CrossRef
• Solid Composite Material for Delivering Viable Cells into Skin Tissues via Detachable Dissolvable Microneedles
  Puttikorn Pukfukdee, Wijit Banlunara, Teeranut Rutwaree, Benchaphorn Limcharoen, Pritsana Sawutdeechaikul, Thitiporn Pattarakankul, Titiporn Sansureerungsikul, Pattrawadee Toprangkobsin, Asada Leelahavanichkul, Ratchathorn Panchaprateep, Pravit Asawanonda
  ACS Applied Bio Materials.2020; 3(7): 4581.     CrossRef
• Establishing metastatic patient-derived xenograft model for colorectal cancer
  Yanmei Zhang, Sau Har Lee, Cheng Wang, Yunhe Gao, Jiyang Li, Wei Xu
  Japanese Journal of Clinical Oncology.2020; 50(10): 1108.     CrossRef
• Intestinal stem cells and intestinal organoids
  Qian Zhao, Jiawei Guan, Xia Wang
  Journal of Genetics and Genomics.2020;[Epub]     CrossRef
• Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse
  Nataly Mancette Rijensky, Netta R. Blondheim Shraga, Eilon Barnea, Nir Peled, Eli Rosenbaum, Aron Popovtzer, Solomon M. Stemmer, Alejandro Livoff, Mark Shlapobersky, Neta Moskovits, Dafna Perry, Eitan Rubin, Itzhak Haviv, Arie Admon
  Molecular & Cellular Proteomics.2020; 19(8): 1360.     CrossRef
• Head and neck cancer patient-derived xenograft models – A systematic review
  Lauren F. Schuch, Felipe M. Silveira, Vivian P. Wagner, Gabriell B. Borgato, Guilherme Z. Rocha, Rogerio M. Castilho, Pablo A. Vargas, Manoela D. Martins
  Critical Reviews in Oncology/Hematology.2020; 155: 103087.     CrossRef
• ZenoFishDb v1.1: A Database for Xenotransplantation Studies in Zebrafish
  Seniye Targen, Tuğberk Kaya, M. Ender Avci, Damla Gunes, Ayse Gokce Keskus, Ozlen Konu
  Zebrafish.2020; 17(5): 305.     CrossRef
• Powerful quantifiers for cancer transcriptomics
  Dumitru Andrei Iacobas
  World Journal of Clinical Oncology.2020; 11(9): 679.     CrossRef
• Three-Dimensional Culture Systems in Gastric Cancer Research
  George Alzeeb, Jean-Philippe Metges, Laurent Corcos, Catherine Le Jossic-Corcos
  Cancers.2020; 12(10): 2800.     CrossRef
• Autologous culture method improves retention of tumors’ native properties
  Yao Tang, Qian Xu, Meiling Yan, Yimin Zhang, Ping Zhu, Xianghong Li, Limin Sang, Ming Zhang, Wenhe Huang, Lianxing Lin, Jundong Wu, Yue Xin, Junhui Fu, Li Zhang, Shuming Zhang, Jiang Gu
  Scientific Reports.2020;[Epub]     CrossRef
• Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
  Ruoshi Shi, Nikolina Radulovich, Christine Ng, Ni Liu, Hirotsugu Notsuda, Michael Cabanero, Sebastiao N. Martins-Filho, Vibha Raghavan, Quan Li, Arvind Singh Mer, Joshua C. Rosen, Ming Li, Yu-Hui Wang, Laura Tamblyn, Nhu-An Pham, Benjamin Haibe-Kains, Geo
  Clinical Cancer Research.2020; 26(5): 1162.     CrossRef
• A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts
  Adam C. Palmer, Deborah Plana, Hui Gao, Joshua M. Korn, Guizhi Yang, John Green, Xiamei Zhang, Roberto Velazquez, Margaret E. McLaughlin, David A. Ruddy, Colleen Kowal, Julie Muszynski, Caroline Bullock, Stacy Rivera, Daniel P. Rakiec, GiNell Elliott, Pau
  Cancer Research.2020; 80(19): 4278.     CrossRef
• Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma
  Eun Byeol Jo, Doopyo Hong, Young Sang Lee, Hyunjoo Lee, Jae Berm Park, Sung Joo Kim
  Translational Oncology.2019; 12(2): 269.     CrossRef
• DNA G-quadruplexes binding and antitumor activity of palladium aryl oxime ligand complexes encapsulated in either albumin or algal cellulose nanoparticles
  Nazanin Hashemzadeh Esfahani, Fatemeh Salami, Zeinab Saberi, Kazem Karami, Zohreh Mehri Lighvan, Mohammad Ramezani, Mona Alibolandi, Sara Amel Farzad, Taghi Khayamian
  Colloids and Surfaces B: Biointerfaces.2019; 176: 70.     CrossRef
• Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy
  Susmita Ghosh, Manu Prasad, Kiran Kundu, Limor Cohen, Ksenia M. Yegodayev, Jonathan Zorea, Ben-Zion Joshua, Batel Lasry, Orr Dimitstein, Anat Bahat-Dinur, Aviram Mizrachi, Vladimir Lazar, Moshe Elkabets, Angel Porgador
  Frontiers in Oncology.2019;[Epub]     CrossRef
• Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma
  Hee Sang Hwang, Heounjeong Go, Ja-Min Park, Sun Young Yoon, Jae-Lyun Lee, Se Un Jeong, Yong Mee Cho
  Laboratory Investigation.2019; 99(5): 659.     CrossRef
• Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer
  Karl Roland Ehrenberg, Jianpeng Gao, Felix Oppel, Stephanie Frank, Na Kang, Tim Kindinger, Sebastian M. Dieter, Friederike Herbst, Lino Möhrmann, Taronish D. Dubash, Erik R. Schulz, Hendrik Strakerjahn, Klara M. Giessler, Sarah Weber, Ava Oberlack, Eva-Ma
  Cells.2019; 8(2): 142.     CrossRef
• Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
  Jin-Sun Ryu, Sung Hoon Sim, In Hae Park, Eun Gyeong Lee, Eun Sook Lee, Yun-Hee Kim, Youngmee Kwon, Sun-Young Kong, Keun Seok Lee
  Cancers.2019; 11(4): 574.     CrossRef
• Transplantable zebrafish models of neuroendocrine tumors
  Germano Gaudenzi, Giovanni Vitale
  Annales d'Endocrinologie.2019; 80(3): 149.     CrossRef
• Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues
  Aoi Komatsu, Kotaro Matsumoto, Tomoki Saito, Manabu Muto, Fuyuhiko Tamanoi
  Cells.2019; 8(5): 440.     CrossRef
• Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model
  Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Ryusho Kariya, Kanha Muisuk, Kanokwan Imtawil, Yaovalux Chamgramol, Vajarabhongsa Bhudhisawasdi, Narong Khuntikeo, Ake Pugkhem, O-Tur Saeseow, Atit Silsirivanit, Chaisiri Wongkham, Sopit Wongkham, Seiji Okad
  Cells.2019; 8(5): 496.     CrossRef
• Un nouveau modèle animal d’étude du neuroblastome
  V. Castellani
  Bulletin de l'Académie Nationale de Médecine.2019; 203(5): 321.     CrossRef
• Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
  Ryan C. Gimple, Shruti Bhargava, Deobrat Dixit, Jeremy N. Rich
  Genes & Development.2019; 33(11-12): 591.     CrossRef
• Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation
  Gyu Seong Heo, Yongfeng Zhao, Deborah Sultan, Xiaohui Zhang, Lisa Detering, Hannah P. Luehmann, Xiangyu Zhang, Richen Li, Ankur Choksi, Savannah Sharp, Sidney Levingston, Tina Primeau, David E. Reichert, Guorong Sun, Babak Razani, Shunqiang Li, Katherine
  ACS Applied Materials & Interfaces.2019; 11(22): 19669.     CrossRef
• Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts
  Takeshi Kuwata, Kazuyoshi Yanagihara, Yuki Iino, Teruo Komatsu, Atsushi Ochiai, Shigeki Sekine, Hirokazu Taniguchi, Hitoshi Katai, Takahiro Kinoshita, Atsushi Ohtsu
  Cells.2019; 8(6): 585.     CrossRef
• MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex
  Anthony Ku, Conrad Chan, Sadaf Aghevlian, Zhongli Cai, David Cescon, Scott V. Bratman, Laurie Ailles, David W. Hedley, Raymond M. Reilly
  Molecular Pharmaceutics.2019; 16(8): 3559.     CrossRef
• Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology
  Vidhya M Ravi, Kevin Joseph, Julian Wurm, Simon Behringer, Nicklas Garrelfs, Paolo d’ Errico, Yashar Naseri, Pamela Franco, Melanie Meyer-Luehmann, Roman Sankowski, Mukesch Johannes Shah, Irina Mader, Daniel Delev, Marie Follo, Jürgen Beck, Oliver Schnell
  Life Science Alliance.2019; 2(4): e201900305.     CrossRef
• Pregnancy and Breast Cancer: Pathways to Understand Risk and Prevention
  Priscila F. Slepicka, Samantha L. Cyrill, Camila O. dos Santos
  Trends in Molecular Medicine.2019; 25(10): 866.     CrossRef
• Primary Tumor Site Specificity is Preserved in Patient-Derived Tumor Xenograft Models
  Lei Chen, Xiaoyong Pan, Yu-Hang Zhang, Xiaohua Hu, KaiYan Feng, Tao Huang, Yu-Dong Cai
  Frontiers in Genetics.2019;[Epub]     CrossRef
• The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology
  Lauren M. Granat, Ooha Kambhampati, Stephanie Klosek, Brian Niedzwecki, Kian Parsa, Dong Zhang
  Animal Models and Experimental Medicine.2019; 2(3): 150.     CrossRef
• Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
  Patrizia Nanni, Lorena Landuzzi, Maria Cristina Manara, Alberto Righi, Giordano Nicoletti, Camilla Cristalli, Michela Pasello, Alessandro Parra, Marianna Carrabotta, Manuela Ferracin, Arianna Palladini, Marianna L. Ianzano, Veronica Giusti, Francesca Ruzz
  Scientific Reports.2019;[Epub]     CrossRef
• Scaffold-Assisted Ectopic Transplantation of Internal Organs and Patient-Derived Tumors
  Ryan Carpenter, Hye Jeong Oh, In-Hye Ham, Daeyoung Kim, Hoon Hur, Jungwoo Lee
  ACS Biomaterials Science & Engineering.2019; 5(12): 6667.     CrossRef
• Generation and application of patient-derived xenograft models in pancreatic cancer research
  Cheng-Fang Wang, Xian-Jie Shi
  Chinese Medical Journal.2019; 132(22): 2729.     CrossRef
• Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
  Laura L. Stafman, Adele P. Williams, Raoud Marayati, Jamie M. Aye, Hooper R. Markert, Evan F. Garner, Colin H. Quinn, Shoeb B. Lallani, Jerry E. Stewart, Karina J. Yoon, Kimberly Whelan, Elizabeth A. Beierle
  Scientific Reports.2019;[Epub]     CrossRef
• Biomarkers and Preclinical Models for Adult T-Cell Leukemia-Lymphoma Treatment
  Lee Ratner
  Frontiers in Microbiology.2019;[Epub]     CrossRef
• Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts
  Arvind S. Mer, Wail Ba-Alawi, Petr Smirnov, Yi X. Wang, Ben Brew, Janosch Ortmann, Ming-Sound Tsao, David W. Cescon, Anna Goldenberg, Benjamin Haibe-Kains
  Cancer Research.2019; 79(17): 4539.     CrossRef
• COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer
  Syed Umbreen, Mudassir Meraj Banday, Anmbreen Jamroze, Adrian P. Mansini, Arsheed A. Ganaie, Marina G. Ferrari, Raihana Maqbool, Firdous H. Beigh, Paari Murugan, Colm Morrissey, Eva Corey, Badrinath R. Konety, Mohammad Saleem
  Molecular Cancer Therapeutics.2019; 18(11): 2111.     CrossRef
• Galangin’s potential as a functional food ingredient
  Kit-Kay Mak, Joe-Jen Tan, Puvaneswari Marappan, Madhu Katyayani Balijepalli, Hira Choudhury, Srinivasan Ramamurthy, Mallikarjuna Rao Pichika
  Journal of Functional Foods.2018; 46: 490.     CrossRef
• Patient-Derived Xenograft Models for Endometrial Cancer Research
  Cristian Moiola, Carlos Lopez-Gil, Silvia Cabrera, Angel Garcia, Tom Van Nyen, Daniela Annibali, Tina Fonnes, August Vidal, Alberto Villanueva, Xavier Matias-Guiu, Camilla Krakstad, Frédéric Amant, Antonio Gil-Moreno, Eva Colas
  International Journal of Molecular Sciences.2018; 19(8): 2431.     CrossRef
• Tumor xenograft animal models for esophageal squamous cell carcinoma
  Nikki P. Lee, Chung Man Chan, Lai Nar Tung, Hector K. Wang, Simon Law
  Journal of Biomedical Science.2018;[Epub]     CrossRef
• Roles of the immune system in cancer: from tumor initiation to metastatic progression
  Hugo Gonzalez, Catharina Hagerling, Zena Werb
  Genes & Development.2018; 32(19-20): 1267.     CrossRef
• Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression
  Jin-Yong He, Xiao-Hui Wei, Si-Jing Li, Yang Liu, Hao-Lin Hu, Zheng-Zheng Li, Xin-Hong Kuang, Lai Wang, Xin Shi, Sheng-Tao Yuan, Li Sun
  Cell Communication and Signaling.2018;[Epub]     CrossRef
• Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer
  Binh Thanh Vu, Sophia Allaf Shahin, Jonas Croissant, Yevhen Fatieiev, Kotaro Matsumoto, Tan Le-Hoang Doan, Tammy Yik, Shirleen Simargi, Altagracia Conteras, Laura Ratliff, Chiara Mauriello Jimenez, Laurence Raehm, Niveen Khashab, Jean-Olivier Durand, Carl
  Scientific Reports.2018;[Epub]     CrossRef
• Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer
  Amit Katz, Uri Barash, Ilanit Boyango, Sari Feld, Yaniv Zohar, Edward Hammond, Neta Ilan, Ran Kremer, Israel Vlodavsky
  Oncotarget.2018; 9(27): 19294.     CrossRef

Citations

Citations to this article as recorded by  

• Temporal Trends in Thyroid Nodule Size on Ultrasonography
  Hayley Mann, Natalia Arroyo, Vivian Hsiao, Franklin Tessler, Lori Mankowski Gettle, Yanchen Zhang, Abdullah Adil, Mary Hitchcock, Elian Massoud, Catherine Jensen, Oguzhan Alagoz, Louise Davies, Sara Fernandes-Taylor, David O. Francis
  JAMA Otolaryngology–Head & Neck Surgery.2025; 151(1): 47.     CrossRef
• A nomogram based on clinicopathological and ultrasound characteristics to predict central neck lymph node metastases in papillary thyroid cancer
  Fei Chen, Shuiping Jiang, Fan Yao, Yixi Huang, Jiaxi Cai, Jia Wei, Chengxu Li, Yanxuan Wu, Xiaolin Yi, Zhen Zhang
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Comparison of the value of ultrasound-guided fine needle aspiration biopsy and contrast-enhanced ultrasound in different sizes of thyroid nodules
  Qi Liu, Liquan Ouyang, Shengchu Zhang, Yuxia Yang
  Medicine.2024; 103(39): e39843.     CrossRef
• Thyroid Ultrasonography Screening of a Cohort of Male University Students
  Mahmoud S. Babiker, Fathelrehman A. Alamin, Mohammed Almteri, Abdullah Alradaddi, Waleed Alharbi
  Journal of Diagnostic Medical Sonography.2024;[Epub]     CrossRef
• Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study
  Jingjing Yang, Yu Sun, Xingjia Li, Yueting Zhao, Xue Han, Guofang Chen, Wenbo Ding, Ruiping Li, Jianhua Wang, Fangsen Xiao, Chao Liu, Shuhang Xu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Clinical and ultrasonography evaluation of thyroid tumor screening in symptomatic patient of Bajulmati primary care center, Banyuwangi, East Java, Indonesia
  Rosy Setiawati, Tri Wulanhandarini, Fierly Hayati, Dyah Erawati, Merlin Guntur Jaya, Andi Ahmad Thoriq, Triana Mediyawati Wijaya, Galih Nur Ismiyati, Dyan Wahyu Kusumaningrum, Belinda Koesmarsono, Agnes Triana Basja, M. Ikhsan Nugroho, Silvi Yuliana, Syad
  Medicine.2022; 101(52): e32546.     CrossRef
• The use of computed tomography as a first-line imaging modality in patients with primary hyperparathyroidism
  Mechteld C. de Jong, K. Jamal, S. Morley, T. Beale, T. Chung, S. Jawad, S. Hurel, H. Simpson, U. Srirangalingam, S. E. Baldeweg, V. Rozalén García, S. Otero, M. Shawky, T. E. Abdel-Aziz, T. R. Kurzawinski
  Hormones.2021; 20(3): 499.     CrossRef
• Sex Bias in Differentiated Thyroid Cancer
  Valentine Suteau, Mathilde Munier, Claire Briet, Patrice Rodien
  International Journal of Molecular Sciences.2021; 22(23): 12992.     CrossRef
• Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma
  Antonio Travaglino, Mirella Pace, Silvia Varricchio, Luigi Insabato, Claudia Giordano, Marco Picardi, Fabrizio Pane, Stefania Staibano, Massimo Mascolo
  American Journal of Clinical Pathology.2020; 153(2): 156.     CrossRef
• Changes in the Diagnostic Efficiency of Thyroid Fine-Needle Aspiration Biopsy during the Era of Increased Thyroid Cancer Screening in Korea
  Young Ki Lee, Kyeong Hye Park, Young Duk Song, Taemi Youk, Joo Young Nam, Sun Ok Song, Dong Yeob Shin, Eun Jig Lee
  Cancer Research and Treatment.2019; 51(4): 1430.     CrossRef
• Sonographic Criteria Predictive of Malignant Thyroid Nodules
  Carlos Miguel Oliveira, Rui Alves Costa, Miguel Patrício, Amélia Estêvão, Bruno Graça, Filipe Caseiro-Alves
  Academic Radiology.2017;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Impact of circulating lymphocyte kinetics following radiotherapy on patient survival: A model-based meta-analysis
  Thao-Nguyen Pham, Julie Coupey, Juliette Thariat, Samuel Valable
  Computers in Biology and Medicine.2025; 186: 109702.     CrossRef
• Nomograms containing body dose parameters for predicting survival in patients with nasopharyngeal carcinoma
  Jianyun Jiang, Ruiping Zhai, Fangfang Kong, Chengrun Du, Hongmei Ying
  European Archives of Oto-Rhino-Laryngology.2024; 281(1): 181.     CrossRef
• Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort study
  Wei-Wei Zhang, Jia-Yi Lin, Gao-Yuan Wang, Cheng-Long Huang, Ling-Long Tang, Yan-Ping Mao, Guan-Qun Zhou, Li-Zhi Liu, Li Tian, Ji-Bin Li, Jun Ma, Rui Guo
  Radiotherapy and Oncology.2024; 194: 110189.     CrossRef
• Reduced-Volume Irradiation of Uninvolved Neck in Patients With Nasopharyngeal Cancer: Updated Results From an Open-Label, Noninferiority, Multicenter, Randomized Phase III Trial
  Cheng-Long Huang, Ning Zhang, Wei Jiang, Fang-Yun Xie, Xiao-Qing Pei, Shao Hui Huang, Xue-Yan Wang, Yan-Ping Mao, Kun-Peng Li, Qing Liu, Ji-Bin Li, Shao-Qiang Liang, Guan-Jie Qin, Wei-Han Hu, Guan-Qun Zhou, Jun Ma, Ying Sun, Lei Chen, Ling-Long Tang
  Journal of Clinical Oncology.2024; 42(17): 2021.     CrossRef
• Immunological effects of radiopharmaceutical therapy
  Amanda G. Shea, Malick Bio Idrissou, Ana Isabel Torres, Tessa Chen, Reiner Hernandez, Zachary S. Morris, Quaovi H. Sodji
  Frontiers in Nuclear Medicine.2024;[Epub]     CrossRef
• Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma
  Sara Lillo, Alfredo Mirandola, Alessandro Vai, Anna Maria Camarda, Sara Ronchi, Maria Bonora, Rossana Ingargiola, Barbara Vischioni, Ester Orlandi
  Cancers.2024; 16(11): 2085.     CrossRef
• Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis
  Ke-gui Weng, Hai-ke Lei, De-Song Shen, Ying Wang, Xiao-Dong Zhu
  Cancer Management and Research.2024; Volume 16: 603.     CrossRef
• A prognostic nomogram for patients with III–IV nasopharyngeal carcinoma based on dynamic changes in the inflammatory and nutrition index
  Guangyi Cheng, Shiwang Yuan, Jiang Wang, Sijia Deng, Yang Wu, Yuyan Wang, Yu Shen, Liantao Li
  Clinical and Translational Oncology.2024;[Epub]     CrossRef
• Impact of Radiation Dose to Circulating Immune Cells on Tumor Control and Survival in Esophageal Cancer
  Shang Cai, Yawen Fan, Qi Guo, Yanze Sun, Peifeng Zhao, Ye Tian, Qiuhong Fan
  Cancer Biotherapy and Radiopharmaceuticals.2023; 38(6): 380.     CrossRef
• Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers
  Yasmine El Houat, Christophe Massard, Veronique Quillien, Renaud de Crevoisier, Joël Castelli
  Advances in Radiation Oncology.2023; 8(2): 101038.     CrossRef
• The prognostic predictive value of systemic immune index and systemic inflammatory response index in nasopharyngeal carcinoma: A systematic review and meta-analysis
  Li Wang, Xianfei Qin, Yu Zhang, Shouyu Xue, Xicheng Song
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy
  Ji Min Yun, Man Ki Chung, Chung Hwan Baek, Young Ik Son, Myung Ju Ahn, Dongryul Oh, Ki Won Kim, Yoon Kyoung So
  Cancers.2023; 15(4): 1248.     CrossRef
• Analysis of risk characteristics for metachronous metastasis in different period of nasopharyngeal carcinoma
  Zhaodong Fei, Huiling Hong, Ting Xu, Yiying Xu, Jiawei Chen, Xiufang Qiu, Jianming Ding, Ye Feng, Chaoxiong Huang, Li Li, Mengying Li, Chuanben Chen
  BMC Cancer.2023;[Epub]     CrossRef
• Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
  Jianjian Qiu, Hancui Lin, Dongmei Ke, Yilin Yu, Jiaying Xu, Hejin Qiu, Qunhao Zheng, Hui Li, Hongying Zheng, Lingyun Liu, Zhiping Wang, Qiwei Yao, Jiancheng Li
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Prognostic value of absolute lymphocyte count in oral cavity squamous cell carcinoma
  Rema Shah, Christina Liu, Hemali P. Shah, Benjamin L. Judson
  Laryngoscope Investigative Otolaryngology.2023; 8(4): 870.     CrossRef
• Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation
  Jinliang Zhang, Li Yang, Hui Li, Jeff W. Chan, Eric K.W. Lee, Min Liu, Lingyu Ma, Qin Liu, Jian-Yue Jin, Pingfu Fu, Zhiyuan Xu, Feng-Ming (Spring) Kong
  Advances in Radiation Oncology.2023; 8(6): 101260.     CrossRef
• Lymphopénie radio-induite : les lymphocytes comme nouvel organe à risque
  P.A. Laurent, É. Deutsch
  Cancer/Radiothérapie.2023; 27(6-7): 511.     CrossRef
• Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape
  Yuanyuan Ma, Chang Guo, Xijun Wang, Xundong Wei, Jie Ma
  Journal of Experimental & Clinical Cancer Research.2023;[Epub]     CrossRef
• CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients
  Qingfang Huang, Chao Yang, Jinmeng Pang, Biao Zeng, Pei Yang, Rongrong Zhou, Haijun Wu, Liangfang Shen, Rong Zhang, Fan Lou, Yi Jin, Albert Abdilim, Hekun Jin, Zijian Zhang, Xiaoxue Xie
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Developing the POTOMAC Model: A Novel Prediction Model to Study the Impact of Lymphopenia Kinetics on Survival Outcomes in Head and Neck Cancer Via an Ensemble Tree-Based Machine Learning Approach
  Carmen Kut, Doug Midthune, Emerson Lee, Peyton Fair, Tia Cheunkarndee, Todd McNutt, Theodore DeWeese, Carole Fakhry, Victor Kipnis, Harry Quon
  JCO Clinical Cancer Informatics.2023;[Epub]     CrossRef
• Preoperative prognostic nutritional index predicts prognosis of patients with oral cavity cancer
  Ku‐Hao Fang, Sheng‐Wei Chang, Yi‐Chan Lee, Ethan I. Huang, Chia‐Hsuan Lai, Geng‐He Chang, Ming‐Shao Tsai, Cheng‐Ming Hsu, Yao‐Te Tsai
  Oral Diseases.2022; 28(7): 1816.     CrossRef
• A comprehensive model based on temporal dynamics of peripheral T cell repertoire for predicting post-treatment distant metastasis of nasopharyngeal carcinoma
  Yajing Zhang, Yujie Zhu, Jiaqi Wang, Yi Xu, Zekun Wang, Yang Liu, Xuebing Di, Lin Feng, Ye Zhang
  Cancer Immunology, Immunotherapy.2022; 71(3): 675.     CrossRef
• Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: Study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein‐Barr virus DNA
  Li‐Ting Liu, Yu‐Jing Liang, Shan‐Shan Guo, Yao Xie, Guo‐Dong Jia, Dong‐Xiang Wen, Lin‐Quan Tang, Qiu‐Yan Chen, Hai‐Qiang Mai
  Head & Neck.2022; 44(1): 34.     CrossRef
• Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
  Chengrun Du, Mengshan Ni, Jianyun Jiang, Fangfang Kong, Ruiping Zhai, Yingchen Lv, Chaosu Hu, Hongmei Ying
  European Archives of Oto-Rhino-Laryngology.2022; 279(8): 3947.     CrossRef
• The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: A systematic review and meta-analysis
  Dongjun Dai, Qiaoying Tian, Yongjie Shui, Jinfan Li, Qichun Wei
  Radiotherapy and Oncology.2022; 168: 28.     CrossRef
• Systematic construction and external validation of an immune‐related prognostic model for nasopharyngeal carcinoma
  Weiqun Lin, Di Cao, Annan Dong, Shaobo Liang, Yongyi Zhao, Cuibing Liu, Yinghua Yan, Xiaoliu Luo, Lizhi Liu, Xinchen Zeng, Qiaowen Ou
  Head & Neck.2022; 44(5): 1086.     CrossRef
• Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer
  Fang Chen, Jian-Yue Jin, Timothy S.K. Hui, Haiman Jing, Hong Zhang, Yaqing Nong, Ying Han, Weili Wang, Lingyu Ma, Fan Yi, Qingqing Chen, Yongsheng Zhang, Pingfu Fu, Li Yang, Zhiyuan Xu, Feng-Ming Spring Kong
  Frontiers in Oncology.2022;[Epub]     CrossRef
• RuleFit-Based Nomogram Using Inflammatory Indicators for Predicting Survival in Nasopharyngeal Carcinoma, a Bi-Center Study
  Chao Luo, Shuqi Li, Qin Zhao, Qiaowen Ou, Wenjie Huang, Guangying Ruan, Shaobo Liang, Lizhi Liu, Yu Zhang, Haojiang Li
  Journal of Inflammation Research.2022; Volume 15: 4803.     CrossRef
• Head and neck cancers volume reduction: should we reduce our prophylactic node radiation to spare the antitumor immune response?
  Y. El Houat, L. Bouvier, M. Baty, X. Palard-Novello, Y. Pointreau, R. de Crevoisier, J. Castelli
  Cancer/Radiothérapie.2022; 26(6-7): 916.     CrossRef
• Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating clinical characteristics and dynamic changes in hematological and inflammatory markers
  Qin Liu, Lingyu Ma, Huangrong Ma, Li Yang, Zhiyuan Xu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers
  Ava Saidian, Isabella Dolendo, Andrew Sharabi, Tyler F. Stewart, Brent Rose, Rana R. McKay, Aditya Bagrodia, Amirali Salmasi
  Cancers.2022; 15(1): 127.     CrossRef
• Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
  FangJie Liu, YingJia Wu, JianHui Shao, Bo Qiu, SuPing Guo, QiaoTing Luo, JinYu Guo, DaQuan Wang, Chu Chu, Rui Zhou, NaiBin Chen, XinLei Ai, Hui Liu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response
  Mame Daro-Faye, Wassim Kassouf, Luis Souhami, Gautier Marcq, Fabio Cury, Tamim Niazi, Paul Sargos
  World Journal of Urology.2021; 39(5): 1331.     CrossRef
• Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes
  Hui Xu, Maosheng Lin, Yingying Hu, Li Zhang, Qiaoqiao Li, Jinhan Zhu, Shi Wang, Mian Xi
  The Oncologist.2021; 26(3): e425.     CrossRef
• Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy
  Michael I. Koukourakis, Alexandra Giatromanolaki
  Critical Reviews in Oncology/Hematology.2021; 159: 103226.     CrossRef
• Hematological toxicity in patients with solid malignant tumors treated with radiation – Temporal analysis, dose response and impact on survival
  Cynthia Terrones-Campos, Bruno Ledergerber, Ivan Richter Vogelius, Marie Helleberg, Lena Specht, Jens Lundgren
  Radiotherapy and Oncology.2021; 158: 175.     CrossRef
• Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
  Wang Jing, Yufei Liu, Hui Zhu, James Welsh, Saumil Gandhi, Melenda Jeter, Quynh Nguyen, Aileen B. Chen, Michael O'Reilly, Zhongxing Liao, Joe Y. Chang, Percy Lee, Steven H. Lin
  Clinical and Translational Radiation Oncology.2021; 28: 54.     CrossRef
• Prognostic value of neutrophils for patients with nasopharyngeal carcinoma
  Lisha Chen, Mengying Li, Ting Xu, Xiufang Qiu, Chuanben Chen
  Laryngoscope Investigative Otolaryngology.2021; 6(2): 219.     CrossRef
• The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis
  Pim J.J. Damen, Tiuri E. Kroese, Richard van Hillegersberg, Ewoud Schuit, Max Peters, Joost J.C. Verhoeff, Steven H. Lin, Peter S.N. van Rossum
  International Journal of Radiation Oncology*Biology*Physics.2021; 111(4): 936.     CrossRef
• Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma
  De-Song Shen, Chang Yan, Yu Liang, Kai-Hua Chen, Xiao-Dong Zhu
  Cancer Management and Research.2021; Volume 13: 8109.     CrossRef
• Proton therapy for locally advanced non-small cell lung cancer
  Olsi Gjyshi, Zhongxing Liao
  The British Journal of Radiology.2020;[Epub]     CrossRef
• Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis
  Jiawen Zhao, Weijia Huang, Yongxian Wu, Yihuan Luo, Bo Wu, Jiwen Cheng, Junqiang Chen, Deyun Liu, Chengyang Li
  Cancer Cell International.2020;[Epub]     CrossRef
• Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
  Qianqian Zhao, Tingting Li, Gang Chen, Zhaochong Zeng, Jian He
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram
  Peter S.N. van Rossum, Wei Deng, David M. Routman, Amy Y. Liu, Cai Xu, Yutaka Shiraishi, Max Peters, Kenneth W. Merrell, Christopher L. Hallemeier, Radhe Mohan, Steven H. Lin
  Practical Radiation Oncology.2020; 10(1): e16.     CrossRef
• Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count
  Xiaoxue Xie, Shenglan Gong, Hekun Jin, Pei Yang, Ting Xu, Yilong Cai, Chengxian Guo, Rong Zhang, Fan Lou, Wenjuan Yang, Hui Wang
  Radiation Oncology.2020;[Epub]     CrossRef
• Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer
  Yasunori Yoshino, Ayumi Taguchi, Maki Takao, Tomoko Kashiyama, Akiko Furusawa, Masaya Uno, Satoshi Okada, Nao Kino, Toshiharu Yasugi
  International Journal of Clinical Oncology.2019; 24(4): 428.     CrossRef
• Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer
  Michael D. Schad, Sunil W. Dutta, Donald M. Muller, Krishni Wijesooriya, Timothy N. Showalter
  Advances in Radiation Oncology.2019; 4(2): 323.     CrossRef
• Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
  Hwa Kyung Byun, Nalee Kim, Hong In Yoon, Seok-Gu Kang, Se Hoon Kim, Jaeho Cho, Jong Geol Baek, Jong Hee Chang, Chang-Ok Suh
  Radiation Oncology.2019;[Epub]     CrossRef
• Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma
  Hwa Kyung Byun, Nalee Kim, Sangjoon Park, Jinsil Seong
  Strahlentherapie und Onkologie.2019; 195(11): 1007.     CrossRef
• Treatment-Related Lymphopenia Predicts Pathologic Complete Response and Recurrence in Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy
  Qiaoqiao Li, Sha Zhou, Shiliang Liu, Songran Liu, Hong Yang, Lei Zhao, Mengzhong Liu, Yonghong Hu, Mian Xi
  Annals of Surgical Oncology.2019; 26(9): 2882.     CrossRef
• Assessing the interactions between radiotherapy and antitumour immunity
  Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, Florence K. Keane, Jay S. Loeffler
  Nature Reviews Clinical Oncology.2019; 16(12): 729.     CrossRef
• Overview of Hematopoietic Stem Cells in Systemic Cancer Treatment, Aging, Pregnancy, and Radiation Hormesis
  Aleksei N. Shoutko
  Advances in Molecular Imaging.2019; 09(02): 19.     CrossRef
• Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma
  Sangjoon Park, Hwa Kyung Byun, Jinsil Seong
  Liver Cancer.2019; 8(6): 468.     CrossRef
• Neutropenia during the First Cycle of Induction Chemotherapy Is Prognostic for Poor Survival in Locoregionally Advanced Nasopharyngeal Carcinoma: A Real-World Study in an Endemic Area
  Cheng Xu, Shi-Ping Yang, Yuan Zhang, Ling-Long Tang, Guan-Qun Zhou, Xu Liu, Yan-Ping Mao, Rui Guo, Wen-Fei Li, Lei Chen, Ai-Hua Lin, Ying Sun, Jun Ma
  Cancer Research and Treatment.2018; 50(3): 777.     CrossRef
• Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
  Susannah G. Ellsworth
  Advances in Radiation Oncology.2018; 3(4): 512.     CrossRef
• Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles
  Anne Rodallec, Guillaume Sicard, Raphaelle Fanciullino, Sébastien Benzekry, Bruno Lacarelle, Gerard Milano, Joseph Ciccolini
  Expert Opinion on Drug Metabolism & Toxicology.2018; : 1.     CrossRef

Citations

Citations to this article as recorded by  

• Ocular complication induced by anticancer drug S-1: association with drug concentrations in tears
  Masakazu Yamada, Tomoyuki Kamao, Atsushi Shiraishi, Jo Sakai, Yuichi Ohashi, Masashi Mimura, Yoshitsugu Inoue, Kazuyoshi Ohtomo, Tai-ichiro Chikama, Chika Miyazaki, Yuka Hosotani
  Japanese Journal of Ophthalmology.2025;[Epub]     CrossRef
• Influenza A Virus Utilizes the Nasolacrimal System to Establish Respiratory Infection after Ocular Exposure in the Swine Model
  Shubin Li, Xuebin Peng, MinJie Wang, Wenqian Wang, Yuye Liu, Qian Yang, Makoto Ozawa
  Transboundary and Emerging Diseases.2024;[Epub]     CrossRef
• Nasolacrimal Duct Obstruction in the Patients Receiving Treatment for Cancer
  Vasily D. Yartsev, Eugenia L. Atkova
  International Ophthalmology Clinics.2023; 63(3): 137.     CrossRef
• Obstrução lacrimal pós-tratamento oncológico: revisão de literatura
  Camilla Duarte Silva, Fabricio Lopes da Fonseca, Juliana Mika Kato, Suzana Matayoshi
  Revista Brasileira de Oftalmologia.2022;[Epub]     CrossRef
• A Case of Nasolacrimal Duct Obstruction During S-1 Treatment For Breast Cancer
  Hisataka Ominato, Michihisa Kono, Hidekiyo Yamaki, Takumi Kumai, Miki Takahara, Akihiro Katada, Tatsuya Hayashi
  Practica Oto-Rhino-Laryngologica.2022; 115(6): 503.     CrossRef
• Corneal nerve changes following treatment with neurotoxic anticancer drugs
  Jeremy Chung Bo Chiang, David Goldstein, Susanna B. Park, Arun V. Krishnan, Maria Markoulli
  The Ocular Surface.2021; 21: 221.     CrossRef
• The impact of anticancer drugs on the ocular surface
  Jeremy Chung Bo Chiang, Ilyanoon Zahari, Maria Markoulli, Arun V. Krishnan, Susanna B. Park, Annalese Semmler, David Goldstein, Katie Edwards
  The Ocular Surface.2020; 18(3): 403.     CrossRef
• Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients
  Hirofumi Yasui, Takeshi Kawakami, Hiroya Kashiwagi, Keita Mori, Katsuhiro Omae, Jun Kasai, Kunihiro Yoshisue, Masahiro Kawahira, Takahiro Tsushima, Nozomu Machida, Akira Fukutomi, Ken Yamaguchi
  International Journal of Clinical Oncology.2019; 24(6): 660.     CrossRef

Citations

Citations to this article as recorded by  

• Health-related Quality of Life During the First 4 Years After Non–Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort
  Ivy Beeren, Nena E. Klerks, Katja K. Aben, Jorg R. Oddens, J. Alfred Witjes, Lambertus A. Kiemeney, Alina Vrieling
  European Urology Oncology.2024; 7(4): 829.     CrossRef
• Transurethral resection of bladder tumor with Bacille Calmette-Guerin intravesical instillation for HRNMIBC and factors influencing recurrence
  An Xu
  American Journal of Translational Research.2024; 16(11): 6914.     CrossRef
• The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients: a systematic review
  E. Rammant, L. Fox, K. Beyer, N. K. Aaronson, R. Chaloner, S. De Padova, F. Liedberg, L. M. Wintner, K. Decaestecker, V. Fonteyne, N. Perdek, H. Wylie, J. W. F. Catto, T. M. Ripping, B. Holzner, M. Van Leeuwen, M. Van Hemelrijck
  Quality of Life Research.2023; 32(8): 2127.     CrossRef
• Quality of life in bladder cancer: systematic review and meta-analysis
  Sima Rafiei, Golnaz Kheradkhah, Grigorios Kotronoulas, Maryam Doustmehraban, Farnoosh Shafiei, Maryam Masoumi, Elaheh Parnian, Elmira Nosrati Sanjabad, Ahmad Ghashghaee
  BMJ Supportive & Palliative Care.2023; 13(e3): e707.     CrossRef
• Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis
  Jeongok Park, Young Deuk Choi, Kyoungjin Lee, Miae Seo, Ahyoung Cho, Sejeong Lee, Keum-hee Nam
  Asia-Pacific Journal of Oncology Nursing.2022; 9(6): 100063.     CrossRef
• Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer
  T. M. Ripping, E. Rammant, J. A. Witjes, N. K. Aaronson, M. van Hemelrijck, L. M. C. van Hoogstraten, J. Boormans, C. A. Goossens, A. G. van der Heijden, M. C. C. M. Hulshof, G. J. L. H. van Leenders, A. M. van Leliveld, R. P. Meijer, R. J. A. van Moorsel
  Health and Quality of Life Outcomes.2022;[Epub]     CrossRef
• Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer
  Theodora M. Ripping, Ellen Westhoff, Neil K. Aaronson, Mieke Van Hemelrijck, Elke Rammant, J. Alfred Witjes, Lambertus. A. Kiemeney, Katja K. H. Aben, Alina Vrieling
  Journal of Patient-Reported Outcomes.2021;[Epub]     CrossRef

• Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews

  
  Lauren J Lee, Christina S Kwon, Anna Forsythe, Carla M Mamolo, Elizabeth T Masters, Ira A Jacobs
  ClinicoEconomics and Outcomes Research.2020; Volume 12: 693.     CrossRef
• Effect of a patient education and rehabilitation program on anxiety, depression and quality of life in muscle invasive bladder cancer patients treated with adjuvant chemotherapy
  Zhonghui Li, Dan Wei, Chenxi Zhu, Qing Zhang
  Medicine.2019; 98(44): e17437.     CrossRef

Citations

Citations to this article as recorded by  

• Overall and Annual Postcolonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-Sectional Study
  Jeffrey K. Lee, James H-E. Kang, Sophie A. Merchant, Christopher D. Jensen, Nicholas E. Burr, Douglas A. Corley
  Clinical Gastroenterology and Hepatology.2024; 22(1): 188.     CrossRef
• Post-colonoscopy colorectal cancer: A population-based cohort study of fecal occult blood test-positive colonoscopies
  Bernard Denis, Alice Bertolaso, Isabelle Gendre, Philippe Perrin, Karima Hammas
  Clinics and Research in Hepatology and Gastroenterology.2024; 48(2): 102285.     CrossRef
• Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program
  Pieter H. A. Wisse, Sybrand Y. de Boer, Marco Oudkerk Pool, Jochim S Terhaar sive Droste, Claudia Verveer, Gerrit A. Meijer, Evelien Dekker, Manon C. W. Spaander
  Endoscopy.2024; 56(05): 364.     CrossRef
• Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea
  Dong Jun Kim, Nan-He Yoon, Jae Kwan Jun, Mina Suh, Sunhwa Lee, Seongju Kim, Ji Eun Kim, Hooyeon Lee
  Cancer Research and Treatment.2024; 56(4): 1164.     CrossRef
• Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region
  Chi Thi-Du Tran, Mai Vu-Tuyet Nguyen, Mo Thi Tran, Thuy Thi-Van Tuong, Quang Hong Tran, Linh Cu Le, Huong Thi-Thu Pham, Nam Chi Bui, Hien Huy Vu, Tu Thi-Cam Nguyen, Phuong Que Ta, Hien Thi-Thu Ha, Dung Tuan Trinh, Hanh Thi-My Bui, Dien Quang Trinh, Khanh
  Japanese Journal of Clinical Oncology.2022; 52(7): 707.     CrossRef
• Systematic review with meta‐analysis: the prevalence of post‐colonoscopy colorectal cancers using the World Endoscopy Organization nomenclature
  James H.‐E. Kang, Nicole Evans, Siddharth Singh, Niloy J. Samadder, Jeffrey K. Lee
  Alimentary Pharmacology & Therapeutics.2021; 54(10): 1232.     CrossRef
• Factors associated with false‐positive fecal immunochemical tests in a large German colorectal cancer screening study
  Efrat L. Amitay, Katarina Cuk, Tobias Niedermaier, Korbinian Weigl, Hermann Brenner
  International Journal of Cancer.2019; 144(10): 2419.     CrossRef
• Frequency and Characteristics of Interval Colorectal Cancer in Actual Clinical Practice: A KASID Multicenter Study
  Kyeong Ok Kim, Kyu Chan Huh, Sung Pil Hong, Won Hee Kim, Hyuk Yoon, Sang Wook Kim, Yeon Soo Kim, Jong Ha Park, Jun Lee, Bum Jae Lee, Young Sook Park
  Gut and Liver.2018; 12(5): 537.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical performance of a simulated abbreviated liver magnetic resonance imaging in combination with contrast-enhanced computed tomography for the baseline evaluation of the liver in patients with colorectal cancer
  F. Castagnoli, S.J. Withey, M. Konidari, I. Chau, A. Riddell, J. Shur, C. Messiou, D.M. Koh
  Clinical Radiology.2025; 80: 106743.     CrossRef
• Collaborative multi-feature extraction and scale-aware semantic information mining for medical image segmentation
  Ruijun Zhang, Zixuan He, Jian Zhu, Xiaochen Yuan, Guoheng Huang, Chi-Man Pun, Jianhong Peng, Junzhong Lin, Jian Zhou
  Physics in Medicine & Biology.2022; 67(20): 205008.     CrossRef
• Diagnostic Performance of Deep Learning-Based Lesion Detection Algorithm in CT for Detecting Hepatic Metastasis from Colorectal Cancer
  Kiwook Kim, Sungwon Kim, Kyunghwa Han, Heejin Bae, Jaeseung Shin, Joon Seok Lim
  Korean Journal of Radiology.2021; 22(6): 912.     CrossRef
• Application of intraoperative ultrasound in liver surgery
  Ya-Wei Xu, Hong Fu
  Hepatobiliary & Pancreatic Diseases International.2021; 20(5): 501.     CrossRef
• Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma
  Hye Jin Kim, Mi-Suk Park, Jin Yong Lee, Kyunghwa Han, Yong Eun Chung, Jin-Young Choi, Myeong-Jin Kim, Chang Moo Kang
  Cancer Research and Treatment.2019; 51(1): 24.     CrossRef
• Abbreviated Gadoxetic Acid–enhanced MRI with Second-Shot Arterial Phase Imaging for Liver Metastasis Evaluation
  Jeong Woo Kim, Chang Hee Lee, Yang Shin Park, Jongmee Lee, Kyeong Ah Kim
  Radiology: Imaging Cancer.2019; 1(1): e190006.     CrossRef
• Intraoperative Ultrasound Staging for Colorectal Liver Metastases in the Era of Liver-Specific Magnetic Resonance Imaging: Is It Still Worthwhile?
  Serena Langella, Francesco Ardito, Nadia Russolillo, Elena Panettieri, Serena Perotti, Caterina Mele, Felice Giuliante, Alessandro Ferrero
  Journal of Oncology.2019; 2019: 1.     CrossRef
• Capabilities of ¹⁸F-FDG PET/CT in the differential diagnosis of colorectal liver metastases
  M. S. Tlostanova, A. L. Dolbov, A. A. Stanzhevskii
  Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery.2019; 24(4): 18.     CrossRef
• Imagerie par résonance magnétique dans le bilan local préopératoire des cancers du rectum
  M. Djelouah, C. Durot, S. Deguelte-Lardière, J. Cohen, A. Devie, L. Protin-Catteau, C. Hoeffel
  EMC - Radiologie et imagerie médicale - Abdominale - Digestive.2019; 37(2): 1.     CrossRef

Citations

Citations to this article as recorded by  

• Mechanistic insights into the antitumoral potential and in vivo antiproliferative efficacy of a silver-based core@shell nanosystem
  Guillermo Aragoneses-Cazorla, Roberto Alvarez-Fernandez Garcia, Angelica Martinez-Lopez, Milagros Gomez Gomez, Maria Vallet-Regí, Sonia Castillo-Lluva, Blanca González, Jose L. Luque-Garcia
  International Journal of Pharmaceutics.2024; 655: 124023.     CrossRef
• Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells
  Wen-Ting Li, Xin Jin, Sheng-Jie Song, Chong Wang, Chuang Fu, Wen Jiang, Jie Bai, Zhi-Zhou Shi
  Animal Cells and Systems.2024; 28(1): 237.     CrossRef
• Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
  Yanqing Liu, Adam Yongxin Ye, Jordan Lu, Jiaxing Yang, Xiao Zheng, Xiaodong Li
  Frontiers in Oncology.2023;[Epub]     CrossRef
• HuR Affects the Radiosensitivity of Esophageal Cancer by Regulating the EMT-Related Protein Snail
  Yan Hu, Qing Li, Ke Yi, Chi Yang, Qingjun Lei, Guanghui Wang, Qianyun Wang, Xiaohui Xu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma
  An-An Li, Yu Zhang, Wei-Lai Tong, Jiang-Wei Chen, Shan-Hu Huang, Jia-Ming Liu, Zhi-Li Liu
  International Journal of General Medicine.2022; Volume 15: 6145.     CrossRef
• MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes
  Cyril Sobolewski, Laurent Dubuquoy, Noémie Legrand
  Cancers.2022; 14(14): 3516.     CrossRef
• The role of human antigen R (HuR) in modulating proliferation, senescence and radiosensitivity of skin cells
  Daojiang Yu, Yahui Feng, Zhiqiang Jiang, Tao Yan, Kai Fang, Yuhong Shi, Jie Zhang, Shuyu Zhang
  Experimental and Therapeutic Medicine.2022;[Epub]     CrossRef
• IFI35 is involved in the regulation of the radiosensitivity of colorectal cancer cells
  Yan Hu, Bing Wang, Ke Yi, Qingjun Lei, Guanghui Wang, Xiaohui Xu
  Cancer Cell International.2021;[Epub]     CrossRef
• LncRNA BBOX1‐AS1 upregulates HOXC6 expression through miR‐361‐3p and HuR to drive cervical cancer progression
  Jun Xu, Baohua Yang, Lifeng Wang, Yunheng Zhu, Xiuxiang Zhu, Ziyin Xia, Zhen Zhao, Ling Xu
  Cell Proliferation.2020;[Epub]     CrossRef
• Angustoline Inhibited Esophageal Tumors Through Regulating LKB1/AMPK/ELAVL1/LPACT2 Pathway and Phospholipid Remodeling
  Huiying Li, Cheng Zhang, Min Zhang, Qianqian Yao, Huaigu Yang, Linlin Fan, Nan Zheng
  Frontiers in Oncology.2020;[Epub]     CrossRef
• The RNA‐Binding Protein HuR in Digestive System Tumors
  Xiaoqing Song, Xin Shi, Wenjuan Li, Fa Zhang, Zhonglin Cai, Goutam Ghosh Choudhury
  BioMed Research International.2020;[Epub]     CrossRef
• Proteogenomic examination of esophageal squamous cell carcinoma (ESCC): new lines of inquiry
  Shobha Dagamajalu, Manavalan Vijayakumar, Rohan Shetty, D. A. B. Rex, Chinmaya Narayana Kotimoole, T. S. Keshava Prasad
  Expert Review of Proteomics.2020; 17(9): 649.     CrossRef
• Interleukin-18 Is a Prognostic Marker and Plays a Tumor Suppressive Role in Colon Cancer
  Xiaodong Feng, Zhijun Zhang, Peng Sun, Guanghui Song, Lu Wang, Zhenqing Sun, Ning Yuan, Qing Wang, Limin Lun, Roberta Rizzo
  Disease Markers.2020; 2020: 1.     CrossRef
• Proteomics in Drug Development: The Dawn of a New Era?
  Maria Frantzi, Agnieszka Latosinska, Harald Mischak
  PROTEOMICS – Clinical Applications.2019;[Epub]     CrossRef
• IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas
  Guanglin Cui, Zhenfeng Li, Jingli Ren, Aping Yuan
  Virchows Archiv.2019; 475(5): 579.     CrossRef
• The Multifaceted Roles of Pyroptotic Cell Death Pathways in Cancer
  Man Wang, Shuai Jiang, Yinfeng Zhang, Peifeng Li, Kun Wang
  Cancers.2019; 11(9): 1313.     CrossRef
• Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells
  Zili Zhang, Zhen Yao, Ling Wang, Hai Ding, Jiangjuan Shao, Anping Chen, Feng Zhang, Shizhong Zheng
  Autophagy.2018; 14(12): 2083.     CrossRef
• Deficiency of IL-18 Aggravates Esophageal Carcinoma Through Inhibiting IFN-γ Production by CD8+T Cells and NK Cells
  Jiantao Li, Gang Qiu, Baoshuan Fang, Xiaohui Dai, Jianhui Cai
  Inflammation.2018; 41(2): 667.     CrossRef

Citations

Citations to this article as recorded by  

• Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
  Cheng-Kuang Yang, Chi-Rei Yang, Yen-Chuan Ou, Chen-Li Cheng, Hao-Chung Ho, Kun-Yuan Chiu, Shian-Shiang Wang, Jian-Ri Li, Chuan-Shu Chen, Chi-Feng Hung, Cheng-Che Chen, Shu-Chi Wang, Chia-Yen Lin, Sheng-Chun Hung
  Oncology Letters.2023;[Epub]     CrossRef
• Comparison of the clinicopathologic features of prostate cancer in US and Chinese populations
  Lei Zhang, Xiaoyan Liu, Rong Xia, Fei Chen, Xin Wang, Jia Bao, Yongzhao Shao, Xian Lu, Yan Wang, Jili Wang, May Thu Tun, Jonathan Melamed, Hebert Lepor, Fang-Ming Deng, Dongwen Wang, Guoping Ren
  Pathology - Research and Practice.2022; 234: 153933.     CrossRef
• Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer
  Christian Ekanger, Svein Inge Helle, Daniel Heinrich, Dag Clement Johannessen, Ása Karlsdóttir, Yngve Nygård, Ole Johan Halvorsen, Lars Reisæter, Rune Kvåle, Liv Bolstad Hysing, Olav Dahl
  Advances in Radiation Oncology.2020; 5(3): 396.     CrossRef

Citations

Citations to this article as recorded by  

• Spatial Heterogeneity of PD‐L1 Expression as a Biomarker for Third‐Generation EGFR‐TKI Response in Advanced EGFR‐Mutant NSCLC
  Yidan Zhang, Yingqi Xu, Hongping Jin, Tengfei Liu, Hua Zhong, Jianlin Xu, Yuqing Lou, Runbo Zhong
  Cancer Science.2025;[Epub]     CrossRef
• The role of PD-L1 in EGFR-mutant non-small cell lung cancer
  Wentao Gao, Lingling Wang, Yanyan Zhao, Lucheng Zhu
  Discover Oncology.2025;[Epub]     CrossRef
• Immunological features of EGFR-mutant non-small cell lung cancer and clinical practice: a narrative review
  Yi Dong, Liaqat Khan, Yi Yao
  Journal of the National Cancer Center.2024; 4(4): 289.     CrossRef
• Activatable near-infrared fluorescence probe for real-time imaging of PD-L1 expression in tumors
  Hyunjin Kim, Maixian Liu, Chan Hyeok Park, Byung Il Lee, Hyonchol Jang, Yongdoo Choi
  Journal of Materials Chemistry B.2024; 12(42): 10877.     CrossRef
• Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR‐mutant non‐small cell lung cancer
  Si‐Yu Lei, Hai‐Yan Xu, Hong‐Shuai Li, Ya‐Ning Yang, Fei Xu, Jun‐Ling Li, Zhi‐Jie Wang, Pu‐Yuan Xing, Xue‐Zhi Hao, Yan Wang
  Thoracic Cancer.2023; 14(24): 2327.     CrossRef
• Association of PD‐L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR‐mutated NSCLC
  Yusuke Hamakawa, Yoko Agemi, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yukiko Nakamura, Tsuneo Shimokawa, Yusuke Saigusa, Nobuaki Kobayashi, Hiroaki Okamoto, Takeshi Kaneko
  Cancer Medicine.2023; 12(17): 17788.     CrossRef
• Determining Risk Factors Associated with Depression and Anxiety in Young Lung Cancer Patients: A Novel Optimization Algorithm
  Yu-Wei Fang, Chieh-Yu Liu
  Medicina.2021; 57(4): 340.     CrossRef
• Anti-PD1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer with Actionable Oncogenic Driver Mutations
  Edouard Dantoing, Nicolas Piton, Mathieu Salaün, Luc Thiberville, Florian Guisier
  International Journal of Molecular Sciences.2021; 22(12): 6288.     CrossRef
• Programmed Death Ligand 1 Expression and Related Markers in Pleuropulmonary Blastoma
  Zahra Alipour, Kris Ann P Schultz, Ling Chen, Anne K Harris, Ivan A Gonzalez, John Pfeifer, D Ashley Hill, Mai He, Louis P Dehner
  Pediatric and Developmental Pathology.2021; 24(6): 523.     CrossRef
• The predictive and prognostic effects of PD-L1 expression on TKI treatment and survival of EGFR-mutant NSCLC
  Bo Lan, Yongfang Wang, Jingni Wu, Kai Wang, Pingli Wang
  Medicine.2021; 100(34): e27038.     CrossRef
• The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay
  Matthew Evans, Brendan O’Sullivan, Frances Hughes, Tina Mullis, Matthew Smith, Nicola Trim, Philippe Taniere
  Pathology & Oncology Research.2020; 26(1): 79.     CrossRef
• PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancer
  Eriko Miyawaki, Haruyasu Murakami, Keita Mori, Nobuaki Mamesaya, Takahisa Kawamura, Haruki Kobayashi, Shota Omori, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Toshiaki Takahashi
  Japanese Journal of Clinical Oncology.2020; 50(5): 617.     CrossRef
• Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma
  Mai He, Brooj Abro, Madhurima Kaushal, Ling Chen, Tiffany Chen, Mercia Gondim, Weisi Yan, Julie Neidich, Louis P. Dehner, John D. Pfeifer
  Human Pathology.2020; 100: 15.     CrossRef
• Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: A single‐institute experience of 10 cases
  Yoon Ah Cho, Yoon‐La Choi, Inwoo Hwang, Kyungjong Lee, Jong Ho Cho, Joungho Han
  Thoracic Cancer.2020; 11(11): 3205.     CrossRef
• Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma
  Jang Ho Cho, Hyun Ae Jung, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
  Journal of Cancer Research and Clinical Oncology.2019; 145(5): 1341.     CrossRef
• The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer
  Yang Zhang, Yuanyuan Zeng, Ting Liu, Wenwen Du, Jianjie Zhu, Zeyi Liu, Jian-an Huang
  Respiratory Research.2019;[Epub]     CrossRef
• Association with PD-L1 Expression and Clinicopathological Features in 1000 Lung Cancers: A Large Single-Institution Study of Surgically Resected Lung Cancers with a High Prevalence of EGFR Mutation
  Lee, Kim, Sung, Lee, Han, Kim, Choi
  International Journal of Molecular Sciences.2019; 20(19): 4794.     CrossRef
• Clinical and Molecular Predictors of PD-L1 Expression in Non–Small-Cell Lung Cancer: Systematic Review and Meta-analysis
  Fausto Petrelli, Mariangela Maltese, Gianluca Tomasello, Barbara Conti, Karen Borgonovo, Mary Cabiddu, Mara Ghilardi, Michele Ghidini, Rodolfo Passalacqua, Sandro Barni, Matteo Brighenti
  Clinical Lung Cancer.2018; 19(4): 315.     CrossRef
• Status of programmed death-ligand 1 expression in sarcomas
  Hyung Kyu Park, Mingi Kim, Minjung Sung, Seung Eun Lee, Yu Jin Kim, Yoon-La Choi
  Journal of Translational Medicine.2018;[Epub]     CrossRef
• Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis
  Bo Lan, Chengxi Ma, Chengyan Zhang, Shoujie Chai, Pingli Wang, Liren Ding, Kai Wang
  Oncotarget.2018; 9(7): 7684.     CrossRef
• Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma
  Byung Soo Lee, Dong Il Park, Da Hye Lee, Jeong Eun Lee, Min-kyung Yeo, Yeon Hee Park, Dae Sik Lim, Wonyoung Choi, Da Hye Lee, Geon Yoo, Han-byul Kim, Dahyun Kang, Jae Young Moon, Sung Soo Jung, Ju Ock Kim, Sang Yeon Cho, Hee Sun Park, Chaeuk Chung
  Biochemical and Biophysical Research Communications.2017; 491(2): 493.     CrossRef

Citations

Citations to this article as recorded by  

• Correlation of Prognostic Nutritional Index and Systemic Immune-Inflammation Index with the Recurrence and Prognosis in Oral Squamous Cell Carcinoma with the Stage of III/IV
  Manjun Ye, Lixia Zhang
  International Journal of General Medicine.2024; Volume 17: 2289.     CrossRef
• Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients
  Bruce Li, Swati Sood, Melissa J. Huynh, Nicholas E. Power
  JU Open Plus.2024;[Epub]     CrossRef
• The relationship between complete blood cell count-derived inflammatory biomarkers and benign prostatic hyperplasia in middle-aged and elderly individuals in the United States: Evidence from NHANES 2001–2008
  Chengdong Shi, Hongliang Cao, Guoqiang Zeng, Lei Yang, Yuantao Wang, Alaa A. A. Aljabali
  PLOS ONE.2024; 19(7): e0306860.     CrossRef
• Evaluation of prognostic factors for late recurrence in clear cell renal carcinoma: an institutional study
  Diana Voskuil-Galoş, Tudor Călinici, Andra Piciu, Adina Nemeş
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Plasma carnitine, choline, γ-butyrobetaine, and trimethylamine-N-oxide, but not zonulin, are reduced in overweight/obese patients with pre/diabetes or impaired glycemia
  Alia Snouper, Violet Kasabri, Nailya Bulatova, Maysa Suyagh, Monther Sadder, Khaldoun Shnewer, Ismail Yousef
  International Journal of Diabetes in Developing Countries.2023; 43(4): 592.     CrossRef
• Artificial intelligence-based prediction of overall survival in metastatic renal cell carcinoma
  Ella Barkan, Camillo Porta, Simona Rabinovici-Cohen, Valentina Tibollo, Silvana Quaglini, Mimma Rizzo
  Frontiers in Oncology.2023;[Epub]     CrossRef
• The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Small Renal Cell Carcinomas after Image-Guided Cryoablation or Radio-Frequency Ablation
  Aqua Asif, Vinson Wai-Shun Chan, Filzah Hanis Osman, Jasmine Sze-Ern Koe, Alexander Ng, Oliver Edward Burton, Jon Cartledge, Michael Kimuli, Naveen Vasudev, Christy Ralph, Satinder Jagdev, Selina Bhattarai, Jonathan Smith, James Lenton, Tze Min Wah
  Cancers.2023; 15(7): 2187.     CrossRef
• A meta-analysis of the platelet-lymphocyte ratio: A notable prognostic factor in renal cell carcinoma
  Xiao Zhou, Guangcheng Luo
  The International Journal of Biological Markers.2022; 37(2): 123.     CrossRef
• Prognostic Role of Systemic Inflammatory Markers in Patients Undergoing Surgical Resection for Oral Squamous Cell Carcinoma
  Uiju Cho, Yeoun-Eun Sung, Min-Sik Kim, Youn-Soo Lee
  Biomedicines.2022; 10(6): 1268.     CrossRef
• Prognostic value of glucose to lymphocyte ratio for patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A multi-institutional, propensity score matching cohort study
  Jinliang Ni, Ziye Li, Wei Song, Houliang Zhang, Yidi Wang, Yifan Zhang, Haipeng Zhang, Guangcan Yang, Jun Xie, Keyi Wang, Bo Peng, Weipu Mao
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade
  Yasser Ged, Alejandro Sanchez, Sujata Patil, Andrea Knezevic, Emily Stein, Stacey Petruzella, Kate Weiss, Cihan Duzgol, Joshua Chaim, Oguz Akin, Marina Mourtzakis, Michael T. Paris, Jessica Scott, Fengshen Kuo, Ritesh Kotecha, A. Ari Hakimi, Chung-Han Lee
  Clinical Cancer Research.2022; 28(23): 5180.     CrossRef
• Exploratory Analysis of the Platelet-to-Lymphocyte Ratio Prognostic Value in the Adjuvant Renal Cell Cancer Setting
  Anup Patel, Alain Ravaud, Robert J Motzer, Allan J Pantuck, Michael Staehler, Bernard Escudier, Jean-François Martini, Mariajose Lechuga, Xun Lin, Daniel J George
  Future Oncology.2021; 17(4): 403.     CrossRef
• Preoperative anaemia and thrombocytosis predict adverse prognosis in non‐metastatic renal cell carcinoma with tumour thrombus
  Ruotao Xiao, Chuxiao Xu, Wei He, Lei Liu, Hongxian Zhang, Cheng Liu, Lulin Ma
  BMC Urology.2021;[Epub]     CrossRef
• Real-World Outcomes in Patients with Metastatic Renal Cell Carcinoma According to Risk Factors: The STAR-TOR Registry
  Arne Strauss, Marianne Schmid, Michael Rink, Michael Moran, Stephan Bernhardt, Marcus Hubbe, Lothar Bergmann, Katrin Schlack, Martin Boegemann
  Future Oncology.2021; 17(18): 2325.     CrossRef
• Systemic Inflammation Response Index is an Independent Prognostic Indicator for Patients with Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional Cohort Study
  Weipu Mao, Si Sun, Ting He, Xin Jin, Jianping Wu, Bin Xu, Guangyuan Zhang, Keyi Wang, Ming Chen
  Cancer Management and Research.2021; Volume 13: 6437.     CrossRef
• Can Systemic Immune-Inflammation Index Create a New Perspective for the IMDC Scoring System in Patients with Metastatic Renal Cell Carcinoma?
  Fatma Bugdayci Basal, Cengiz Karacin, Irem Bilgetekin, Omur Berna Oksuzoglu
  Urologia Internationalis.2021; 105(7-8): 666.     CrossRef
• Post-surgical Regression of Thoracic Metastases After Salvage Lobectomy for Recurrent Renal Cell Carcinoma
  Alessia Stanzi, Elena Verzoni, Margherita Ruggirello, Luigi Rolli, Ugo Pastorino
  Clinical Genitourinary Cancer.2020; 18(3): e284.     CrossRef
• Peking University Third Hospital score: a comprehensive system to predict intra-operative blood loss in radical nephrectomy and thrombectomy
  Zhuo Liu, Xun Zhao, Hong-Xian Zhang, Run-Zhuo Ma, Li-Wei Li, Shi-Ying Tang, Guo-Liang Wang, Shu-Dong Zhang, Shu-Min Wang, Xiao-Jun Tian, Lu-Lin Ma
  Chinese Medical Journal.2020; 133(10): 1166.     CrossRef
• Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma
  Guilherme Nader Marta, Pedro Isaacsson Velho, Renata R. C. Bonadio, Mirella Nardo, Sheila F. Faraj, Manoel Carlos L. de Azevedo Souza, David Q. B. Muniz, Diogo Assed Bastos, Carlos Dzik
  Pathology & Oncology Research.2020; 26(4): 2489.     CrossRef
• The Clinical Significance of Routine Risk Categorization in Metastatic Renal Cell Carcinoma and its Impact on Treatment Decision-Making: A Systematic Review
  Shouki Bazarbashi, Abdullah Alsharm, Faisal Azam, Hazem El Ashry, Jamal Zekri
  Future Oncology.2020; 16(34): 2879.     CrossRef
• Patient selection and risk factors in the changing treatment landscape of metastatic renal cell carcinoma
  Ehab Abdou, Ravi M. Pedapenki, Mohamed Abouagour, Abdul R. Zar, Emad Dawoud, Dalia Elshourbagy, Humaid O. Al-Shamsi, Enrique Grande
  Expert Review of Anticancer Therapy.2020; 20(10): 831.     CrossRef
• Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Disease-free Survival in Postnephrectomy High-risk Locoregional Renal Cell Carcinoma: Analysis of the S-TRAC Trial
  Anup Patel, Alain Ravaud, Robert J. Motzer, Allan J. Pantuck, Michael Staehler, Bernard Escudier, Jean-François Martini, Mariajose Lechuga, Xun Lin, Daniel J. George
  Clinical Cancer Research.2020; 26(18): 4863.     CrossRef
• External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model
  Pawel Chrom, Jakub Zolnierek, Lubomir Bodnar, Rafal Stec, Cezary Szczylik
  International Journal of Clinical Oncology.2019; 24(5): 526.     CrossRef
• Assessing Outcomes and Prognostic Factors for First-Line Therapy in Elderly Patients With Metastatic Renal Cell Carcinoma: Real-Life Data From a Single United Kingdom Institution
  Mario Uccello, Tasnim Alam, Haider Abbas, Ajith Nair, Jennifer Paskins, Guy Faust
  Clinical Genitourinary Cancer.2019; 17(3): e658.     CrossRef
• Towards individualized therapy for metastatic renal cell carcinoma
  Ritesh R. Kotecha, Robert J. Motzer, Martin H. Voss
  Nature Reviews Clinical Oncology.2019; 16(10): 621.     CrossRef
• The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes
  S. Albisinni, D. Pretot, W. Al Hajj Obeid, F. Aoun, T. Quackels, A. Peltier, T. Roumeguère
  Progrès en Urologie.2019; 29(8-9): 423.     CrossRef
• Prognostic Significance of Systemic Inflammatory Response in Patients with Synchronous and Metachronous Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors
  Joongwon Choi, Tae Jin Kim, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, Minyong Kang, Seong Il Seo
  The Korean Journal of Urological Oncology.2019; 17(3): 150.     CrossRef
• The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma
  Joanna Huszno, Zofia Kolosza, Jolanta Mrochem-Kwarciak, Tomasz Rutkowski, Krzysztof Skladowski
  Oncology.2019; 97(1): 7.     CrossRef
• Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis
  Bo Li, Pingting Zhou, Yujie Liu, Haifeng Wei, Xinghai Yang, Tianrui Chen, Jianru Xiao
  Clinica Chimica Acta.2018; 483: 48.     CrossRef
• Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer
  Zhenhua Huang, Yantan Liu, Chen Yang, Xiaoyin Li, Changqie Pan, Jinjun Rao, Nailin Li, Wangjun Liao, Li Lin
  BMC Cancer.2018;[Epub]     CrossRef
• The clinical use of the platelet to lymphocyte ratio and lymphocyte to monocyte ratio as prognostic factors in renal cell carcinoma: a systematic review and meta-analysis
  Xuemin Wang, Shiqiang Su, Yuanshan Guo
  Oncotarget.2017; 8(48): 84506.     CrossRef

Citations

Citations to this article as recorded by  

• Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer
  Yingying Bai, Yandong Miao, Jiangtao Wang, Jian Gan, Jiang Feng
  Biochemical Genetics.2025; 63(2): 1566.     CrossRef
• Environmental Exposure to Bisphenol A Enhances Invasiveness in Papillary Thyroid Cancer
  Chien-Yu Huang, Ren-Hao Xie, Pin-Hsuan Li, Chong-You Chen, Bo-Hong You, Yuan-Chin Sun, Chen-Kai Chou, Yen-Hsiang Chang, Wei-Che Lin, Guan-Yu Chen
  International Journal of Molecular Sciences.2025; 26(2): 814.     CrossRef
• Subchronic toxic effects of bisphenol A on the gut-liver-hormone axis in rats via intestinal flora and metabolism
  Jiaqi Wang, Ce Su, Mingqin Qian, Xin Wang, Changlan Chen, Yangcheng Liu, Wei Liu, Zheng Xiang, Baoli Xu
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Annexin A protein family: Focusing on the occurrence, progression and treatment of cancer
  Huhu Zhang, Zhe Zhang, Tingting Guo, Guang Chen, Guoxiang Liu, Qinghang Song, Guichun Li, Fenghua Xu, Xiaolei Dong, Fanghao Yang, Can Cao, Di Zhong, Shuang Li, Ya Li, Mengjun Wang, Bing Li, Lina Yang
  Frontiers in Cell and Developmental Biology.2023;[Epub]     CrossRef
• Current Evidence on Bisphenol A Exposure and the Molecular Mechanism Involved in Related Pathological Conditions
  Ylenia Della Rocca, Enrico Matteo Traini, Francesca Diomede, Luigia Fonticoli, Oriana Trubiani, Alessia Paganelli, Jacopo Pizzicannella, Guya Diletta Marconi
  Pharmaceutics.2023; 15(3): 908.     CrossRef
• ANXA6: a key molecular player in cancer progression and drug resistance
  Jinlong Cao, Shun Wan, Siyu Chen, Li Yang
  Discover Oncology.2023;[Epub]     CrossRef
• Assessment of five typical environmental endocrine disruptors and thyroid cancer risk: a meta-analysis
  Yuyao Yang, Xiaoyue Bai, Juan Lu, Ronghao Zou, Rui Ding, Xiaohui Hua
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance
  Mai K. L. Nguyen, Jaimy Jose, Mohamed Wahba, Marc Bernaus-Esqué, Andrew J. Hoy, Carlos Enrich, Carles Rentero, Thomas Grewal
  International Journal of Molecular Sciences.2022; 23(13): 7206.     CrossRef
• Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment
  Shrestha Dutta, Swatilekha Ghosh, Abhishek Mishra, Rajgourab Ghosh
  Journal of Proteins and Proteomics.2022;[Epub]     CrossRef
• A comprehensive review on the carcinogenic potential of bisphenol A: clues and evidence
  Nadeem Ghani Khan, Jacinta Correia, Divya Adiga, Padmalatha Satwadi Rai, Herman Sunil Dsouza, Sanjiban Chakrabarty, Shama Prasada Kabekkodu
  Environmental Science and Pollution Research.2021; 28(16): 19643.     CrossRef
• Valosin-Containing Protein (VCP)/p97: A Prognostic Biomarker and Therapeutic Target in Cancer
  Susan Costantini, Francesca Capone, Andrea Polo, Palmina Bagnara, Alfredo Budillon
  International Journal of Molecular Sciences.2021; 22(18): 10177.     CrossRef
• Bisphenol A Activates an Innate Viral Immune Response Pathway
  Mark L. Sowers, Hui Tang, Bing Tian, Randall Goldblum, Terumi Midoro-Horiuti, Kangling Zhang
  Journal of Proteome Research.2020; 19(2): 644.     CrossRef
• Ion-Trap Mass Spectrometric Analysis of Bisphenol A Interactions With Titanium Dioxide Nanoparticles and Milk Proteins
  Edward P.C. Lai, Hendrik Kersten, Thorsten Benter
  Molecules.2020; 25(3): 708.     CrossRef
• ANXA6 Contributes to Radioresistance by Promoting Autophagy via Inhibiting the PI3K/AKT/mTOR Signaling Pathway in Nasopharyngeal Carcinoma
  Qianping Chen, Wang Zheng, Lin Zhu, Dan Yao, Chen Wang, Yimeng Song, Songling Hu, Hongxia Liu, Yang Bai, Yan Pan, Jianghong Zhang, Jian Guan, Chunlin Shao
  Frontiers in Cell and Developmental Biology.2020;[Epub]     CrossRef
• Diverse Roles of Annexin A6 in Triple-Negative Breast Cancer Diagnosis, Prognosis and EGFR-Targeted Therapies
  Olga Y. Korolkova, Sarrah E. Widatalla, Stephen D. Williams, Diva S. Whalen, Heather K. Beasley, Josiah Ochieng, Thomas Grewal, Amos M. Sakwe
  Cells.2020; 9(8): 1855.     CrossRef
• Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors
  Sarrah E Widatalla, Olga Y Korolkova, Diva S Whalen, J Shawn Goodwin, Kevin P Williams, Josiah Ochieng, Amos M Sakwe
  Carcinogenesis.2019; 40(8): 998.     CrossRef
• Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
  Pamela D. Noyes, Katie Paul Friedman, Patience Browne, Jonathan T. Haselman, Mary E. Gilbert, Michael W. Hornung, Stan Barone, Kevin M. Crofton, Susan C. Laws, Tammy E. Stoker, Steven O. Simmons, Joseph E. Tietge, Sigmund J. Degitz
  Environmental Health Perspectives.2019;[Epub]     CrossRef
• Isobaric tags for relative and absolute quantitation‑based proteomics reveals potential novel biomarkers for the early diagnosis of acute myocardial infarction within 3�h
  Changqing Du, Yingzheng Weng, Jiangjie Lou, Guangzhong Zeng, Xiaowei Liu, Hongfeng Jin, Senna Lin, Lijiang Tang
  International Journal of Molecular Medicine.2019;[Epub]     CrossRef
• Bisphenol A and estradiol impede myoblast differentiation through down-regulating Akt signaling pathway
  Ga-Yeon Go, Sang-Jin Lee, Ayoung Jo, Jae-Rin Lee, Jong-Sun Kang, Mihi Yang, Gyu-Un Bae
  Toxicology Letters.2018; 292: 12.     CrossRef
• Determination of Highly Sensitive Biological Cell Model Systems to Screen BPA-Related Health Hazards Using Pathway Studio
  Do-Yeal Ryu, Md Rahman, Myung-Geol Pang
  International Journal of Molecular Sciences.2017; 18(9): 1909.     CrossRef

Citations

Citations to this article as recorded by  

• Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
  Yung-Sung Yeh, Ming-Yii Huang, Cheng-Jen Ma, Ching-Wen Huang, Hsiang-Lin Tsai, Yen-Cheng Chen, Ching-Chun Li, Fang-Jung Yu, Hsiang-Yao Shih, Jaw-Yuan Wang
  Journal of Oncology.2020; 2020: 1.     CrossRef
• Opportunities and limitations of CT - assessment of neoadjuvant chemoradiation therapy of gastric cancer
  T. A. Agababyan, N. K. Silanteva, V. Yu. Skoropad, S. A. Ivanov, A. D. Kaprin, Yu. A. Komin, A. Yu. Usacheva, D. D. Kudryavtsev
  Research and Practical Medicine Journal.2019; 6(4): 92.     CrossRef
• Outcomes of radiation therapy for resectable M0 gastric cancer
  Weipeng Gong, Hongwei Zhao, Shanshan Liu, Jie Guan, Xin Liu, Qingsheng Hou, Zhenyu Zhu, Hongliang Guo
  Oncotarget.2018; 9(2): 1726.     CrossRef

Citations

Citations to this article as recorded by  

• External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study
  Caroline M. van der Starre, Chris H. Bangma, Maarten J. Bijlsma, Alfons C.M. van den Bergh, Lambertus A.L.M. Kiemeney, Wietske Kievit, Kees Vos, Diederik M. Somford, Sally M. Wildeman, Katja K.H. Aben, Igle J. de Jong, Floris J. Pos, Berdine L. Heesterman
  BMC Cancer.2025;[Epub]     CrossRef
• Japanese clinical practice guidelines for prostate cancer 2023
  Yasuo Kohjimoto, Hiroji Uemura, Masahiro Yoshida, Shiro Hinotsu, Satoru Takahashi, Tsutomu Takeuchi, Kazuhiro Suzuki, Hiroshi Shinmoto, Tsutomu Tamada, Takahiro Inoue, Mikio Sugimoto, Atsushi Takenaka, Tomonori Habuchi, Hitoshi Ishikawa, Takashi Mizowaki,
  International Journal of Urology.2024; 31(11): 1180.     CrossRef
• Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review
  Berdine L. Heesterman, Katja K. H. Aben, Igle Jan de Jong, Floris J. Pos, Olga L. van der Hel
  BMC Cancer.2023;[Epub]     CrossRef
• Risk factors for prostate-specific antigen persistence in pT3aN0 prostate cancer after robot-assisted laparoscopic radical prostatectomy: a retrospective study
  Jun Seop Kim, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Change Jeong, Seong Il Seo, Hyun Moo Lee, Seong Soo Jeon
  Journal of Yeungnam Medical Science.2023; 40(4): 412.     CrossRef
• Comparison of contrast-enhanced ultrasound targeted biopsies versus standard systematic biopsies for prostate cancer correction in different PSA value groups in rural China
  Dian Yuan Lu, Lan Liu, Li Shen, Jian Rong Cai, Li Xu, Li Hua Xiang
  Clinical Hemorheology and Microcirculation.2021; 77(3): 295.     CrossRef
• Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis
  Benjamin A. Greenberger, Nicholas G. Zaorsky, Robert B. Den
  European Urology Focus.2020; 6(2): 404.     CrossRef
• Long short-term memory artificial neural network model for prediction of prostate cancer survival outcomes according to initial treatment strategy: development of an online decision-making support system
  Kyo Chul Koo, Kwang Suk Lee, Suah Kim, Choongki Min, Gyu Rang Min, Young Hwa Lee, Woong Kyu Han, Koon Ho Rha, Sung Joon Hong, Seung Choul Yang, Byung Ha Chung
  World Journal of Urology.2020; 38(10): 2469.     CrossRef
• Comparing Radiotherapy to Prostatectomy for High-Risk Prostate Cancer
  Benjamin A. Greenberger, James M. Taylor, Victor E. Chen, Robert B. Den
  The Cancer Journal.2020; 26(1): 29.     CrossRef
• Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis
  Narihiko Hayashi, Kimito Osaka, Kentaro Muraoka, Hisashi Hasumi, Kazuhide Makiyama, Keiichi Kondo, Noboru Nakaigawa, Masahiro Yao, Yuki Mukai, Madoka Sugiura, Shoko Takano, Eiko Ito, Hisashi Kaizu, Izumi Koike, Masaharu Hata, Masataka Taguri, Yasuhide Miy
  World Journal of Urology.2020; 38(10): 2477.     CrossRef
• Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
  Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, Giorgio Gandaglia, Nicola Fossati, Brian Kelly, Raj Pal, Erik Briers, Philip Cornford, Maria De Santis, Stefano Fanti, Silke Gillessen, Jeremy P. Grummet, Ann M. Henry, Thomas B.L. Lam, Michael Lar
  European Urology.2020; 77(5): 614.     CrossRef
• Updated evidence on oncological outcomes of surgery versus external beam radiotherapy for localized prostate cancer
  Satoru Taguchi, Kenshiro Shiraishi, Hiroshi Fukuhara
  Japanese Journal of Clinical Oncology.2020; 50(9): 963.     CrossRef
• Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer
  Xianghong Zhou, Kun Jin, Shi Qiu, Di Jin, Xinyang Liao, Xiang Tu, Xiaonan Zheng, Jiakun Li, Lu Yang, Qiang Wei
  Medicine.2020; 99(34): e21642.     CrossRef
• Robot or radiation? A qualitative study of the decision support needs of men with localised prostate cancer choosing between robotic prostatectomy and radiotherapy treatment
  Allan ‘Ben’ Smith, Orlando Rincones, Mark Sidhom, Pascal Mancuso, Karen Wong, Megan Berry, Dion Forstner, Leslie Bokey, Afaf Girgis
  Patient Education and Counseling.2019; 102(7): 1364.     CrossRef
• Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis
  Changhoon Song, Sang Jun Byun, Young Seok Kim, Hanjong Ahn, Seok-Soo Byun, Choung-Soo Kim, Sang Eun Lee, Jae-Sung Kim, Christopher J.D. Wallis
  PLOS ONE.2019; 14(4): e0215057.     CrossRef
• 125I low‑dose‑rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer
  Zhien Zhou, Weigang Yan, Yi Zhou, Fuquan Zhang, Hanzhong Li, Zhigang Ji
  Oncology Letters.2019;[Epub]     CrossRef
• Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy
  Do Kyung Kim, Kyo Chul Koo, Kwang Suk Lee, Yoon Soo Hah, Koon Ho Rha, Sung Joon Hong, Byung Ha Chung
  Journal of Korean Medical Science.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Incidence, risk factors and outcomes of cataract surgery after plaque brachytherapy for posterior uveal melanoma
  Viktor T. Gill, Gustav Stålhammar
  Heliyon.2024; 10(1): e23447.     CrossRef
• Brachytherapy With 15- Versus 20-mm Ruthenium 106 Plaques Without Verification of Plaque Position Is Associated With Local Tumor Recurrence and Death in Posterior Uveal Melanoma
  Gustav Stålhammar
  International Journal of Radiation Oncology*Biology*Physics.2023; 117(5): 1125.     CrossRef
• The Role of Ruthenium Compounds in Neurologic Diseases: A Minireview
  Fátima Virgínia Gama Justi, Gabriella Araújo Matos, Juan de Sá Roriz Caminha, Cássia Rodrigues Roque, Edinilton Muniz Carvalho, Márcio Wilker Soares Campelo, Ludmila Belayev, Luiz Gonzaga de França Lopes, Reinaldo Barreto Oriá
  The Journal of Pharmacology and Experimental Therapeutics.2022; 380(1): 47.     CrossRef
• Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
  Gilda Cennamo, Daniela Montorio, Luca D’ Andrea, Antonio Farella, Elide Matano, Mario Giuliano, Raffaele Liuzzi, Maria Angelica Breve, Sabino De Placido, Giovanni Cennamo
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Uveal Melanoma: A Review of the Literature and Personal Experiences
  Yong Joon Kim, Christopher Seungkyu Lee, Sung Chul Lee
  Journal of Retina.2021; 6(2): 65.     CrossRef
• Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma
  Daniel Lorenzo, María Ochoa, Josep Maria Piulats, Cristina Gutiérrez, Luis Arias, Jaume Català, María Grau, Judith Peñafiel, Estefanía Cobos, Pere Garcia-Bru, Marcos Javier Rubio, Noel Padrón-Pérez, Bruno Dias, Joan Pera, Josep Maria Caminal
  Cancer Research and Treatment.2018; 50(4): 1130.     CrossRef

Citations

Citations to this article as recorded by  

• ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition
  Marcus Borenäs, Ganesh Umapathy, Dan E. Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L. Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N. Hall, Jimmy Van den Eynden, Bengt Hallbe
  Proceedings of the National Academy of Sciences.2024;[Epub]     CrossRef
• Development of red blood cell-derived extracellular particles as a biocompatible nanocarrier of microRNA-204 (REP-204) to harness anti-neuroblastoma effect
  Wararat Chiangjong, Jirawan Panachan, Sujitra Keadsanti, David S. Newburg, Ardythe L. Morrow, Suradej Hongeng, Somchai Chutipongtanate
  Nanomedicine: Nanotechnology, Biology and Medicine.2024; 60: 102760.     CrossRef
• Elevated Expression of LGR5 and WNT Signaling Factors in Neuroblastoma Cells With Acquired Drug Resistance
  John Clark-Corrigall, Svetlana Myssina, Martin Michaelis, Jindrich Cinatl, Shafiq Ahmed, Jane Carr-Wilkinson
  Cancer Investigation.2023; 41(2): 173.     CrossRef
• Computational intelligence analysis of high-risk neuroblastoma patient health records reveals time to maximum response as one of the most relevant factors for outcome prediction
  Davide Chicco, Riccardo Haupt, Alberto Garaventa, Paolo Uva, Roberto Luksch, Davide Cangelosi
  European Journal of Cancer.2023; 193: 113291.     CrossRef
• Dinutuximab beta combined with chemotherapy in patients with relapsed or refractory neuroblastoma
  Aleksandra Wieczorek, Anna Zaniewska-Tekieli, Karoline Ehlert, Katarzyna Pawinska-Wasikowska, Walentyna Balwierz, Holger Lode
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Adaptation of the Th-MYCN Mouse Model of Neuroblastoma for Evaluation of Disseminated Disease
  Seyed M. Rahavi, Maryam Aletaha, Ali Farrokhi, Amanda Lorentzian, Philipp F. Lange, Christopher A. Maxwell, Chinten James Lim, Gregor S. D. Reid
  International Journal of Molecular Sciences.2023; 24(15): 12071.     CrossRef
• Challenging diagnosis of Mycolicibacterium cosmeticum/canariasense infection: A case report and literature review
  Daniel Grupel, Orly Sagi, Israel Nissan, Rona Grossman, Motro Yair, Jacob Moran-Gilad, Dana Danino
  Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2023; 33: 100393.     CrossRef
• Dinutuximab Beta Maintenance Therapy in Patients with High-Risk Neuroblastoma in First-Line and Refractory/Relapsed Settings—Real-World Data
  Aleksandra Wieczorek, Urszula Żebrowska, Marek Ussowicz, Agnieszka Sokół, Marzena Stypińska, Bożenna Dembowska-Bagińska, Katarzyna Pawińska-Wąsikowska, Walentyna Balwierz
  Journal of Clinical Medicine.2023; 12(16): 5252.     CrossRef
• Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors
  Kangwei Zhu, Yuren Xia, Xindi Tian, Yuchao He, Jun Zhou, Ruyu Han, Hua Guo, Tianqiang Song, Lu Chen, Xiangdong Tian
  Frontiers in Genetics.2023;[Epub]     CrossRef
• Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes
  Juan Muñoz, Cristina Larrosa, Saray Chamorro, Sara Perez-Jaume, Margarida Simao, Nazaret Sanchez-Sierra, Amalia Varo, Maite Gorostegui, Alicia Castañeda, Moira Garraus, Sandra Lopez-Miralles, Jaume Mora
  Cancers.2023; 15(19): 4837.     CrossRef
• Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation
  Diana Treis, Ganesh Umapathy, Susanne Fransson, Jikui Guan, Patricia Mendoza-García, Joachim T. Siaw, Sandra Wessman, Lena Gordon Murkes, Jakob J. E. Stenman, Anna Djos, Lotta H. M. Elfman, John Inge Johnsen, Bengt Hallberg, Ruth H. Palmer, Tommy Martinss
  JCO Precision Oncology.2022;[Epub]     CrossRef
• High-Risk Neuroblastoma: Poor Outcomes Despite Aggressive Multimodal Therapy
  Adil Abdelhamed Abbas, Alaa Mohammed Noor Samkari
  Current Cancer Therapy Reviews.2022; 18(1): 14.     CrossRef
• Multi-omics integration reveals a six-malignant cell maker gene signature for predicting prognosis in high-risk neuroblastoma
  Zijun Yan, Qiming Liu, Ziyang Cao, Jinxia Wang, Hongyang Zhang, Jiangbin Liu, Lin Zou
  Frontiers in Neuroinformatics.2022;[Epub]     CrossRef
• Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
  Nur Olgun, Emre Cecen, Dilek Ince, Deniz Kizmazoglu, Birsen Baysal, Ayse Onal, Ozhan Ozdogan, Handan Guleryuz, Riza Cetingoz, Ayse Demiral, Mustafa Olguner, Ahmet Celik, Serra Kamer, Erdener Ozer, Zekiye Altun, Safiye Aktas
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience
  P. Berlanga, C. Pasqualini, U. Pötschger, C. Sangüesa, M.R. Castellani, A. Cañete, R. Luksch, M. Elliot, G. Schreier, M. Kropf, D. Morgenstern, V. Papadakis, S. Ash, E. Ruud, P. Brock, A. Wieczorek, P. Kogner, T. Trahair, P. Ambros, T. Boterberg, V. Caste
  European Journal of Cancer.2021; 144: 1.     CrossRef
• Survival in patients with high-risk neuroblastoma treated without autologous stem cell transplant or dinutuximab beta
  Richa Jain, Amita Trehan, Prema Menon, Rakesh Kapoor, Nandita Kakkar, Srinivasan Radhika, Akshay Kumar Saxena, Bhagwant Rai Mittal, Neelam Varma, Ram Samujh, Deepak Bansal
  Pediatric Hematology and Oncology.2021; 38(4): 291.     CrossRef
• Neuroblastoma
  Christine Chung, Tom Boterberg, John Lucas, Joseph Panoff, Dominique Valteau‐Couanet, Barbara Hero, Rochelle Bagatell, Christine E. Hill‐Kayser
  Pediatric Blood & Cancer.2021;[Epub]     CrossRef
• Effect of high-dose chemotherapy plus stem cell rescue on the survival of patients with neuroblastoma modified by MYCN gene gain/amplification and remission status: a nationwide registration study in Japan
  Yuya Saito, Mitsuyoshi Urashima, Yoshiyuki Takahashi, Atsushi Ogawa, Chikako Kiyotani, Yuki Yuza, Katsuyoshi Koh, Kenichiro Watanabe, Yoshiyuki Kosaka, Hiroaki Goto, Atsushi Kikuta, Keiko Okada, Yuhki Koga, Junya Fujimura, Masami Inoue, Atsushi Sato, Yosh
  Bone Marrow Transplantation.2021; 56(9): 2173.     CrossRef
• Connectivity Map Analysis Indicates PI3K/Akt/mTOR Inhibitors as Potential Anti-Hypoxia Drugs in Neuroblastoma
  Paolo Uva, Maria Carla Bosco, Alessandra Eva, Massimo Conte, Alberto Garaventa, Loredana Amoroso, Davide Cangelosi
  Cancers.2021; 13(11): 2809.     CrossRef
• Off-label drug use in paediatric haemato-oncology patients: financial implications and proposed solutions for Belgian patients
  T. Bauters, D. Heenen, K. Norga, A. Van Damme, A. Uyttebroeck, G. Laureys
  European Journal of Pediatrics.2021; 180(9): 3067.     CrossRef
• Early Use of Dinutuximab Beta in Patients with High-Risk Neuroblastoma
  Neofit Spasov, Mariya Spasova, Stella Stabouli
  Case Reports in Pediatrics.2021; 2021: 1.     CrossRef
• Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study
  Alberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Martin Elliott, Shifra Ash, Godfrey C. F. Chan, Geneviève Laureys, Maja Beck-Popovic, Kim Vettenranta, Walentyna Balwierz, Henrik Schroeder, Cormac Owens, Ma
  Journal of Clinical Oncology.2021; 39(23): 2552.     CrossRef
• Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
  Jan Škubník, Vladimíra Svobodová Pavlíčková, Tomáš Ruml, Silvie Rimpelová
  Biology.2021; 10(9): 849.     CrossRef
• Extending the Applicability of In Ovo and Ex Ovo Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells
  Miguel Angel Merlos Rodrigo, Berta Casar, Hana Michalkova, Ana Maria Jimenez Jimenez, Zbynek Heger, Vojtech Adam
  Frontiers in Oncology.2021;[Epub]     CrossRef
• ATR inhibition enables complete tumour regression in ALK-driven NB mouse models
  Joanna Szydzik, Dan E. Lind, Badrul Arefin, Yeshwant Kurhe, Ganesh Umapathy, Joachim Tetteh Siaw, Arne Claeys, Jonatan L. Gabre, Jimmy Van den Eynden, Bengt Hallberg, Ruth H. Palmer
  Nature Communications.2021;[Epub]     CrossRef
• Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
  Marianna Avitabile, Vito Alessandro Lasorsa, Sueva Cantalupo, Antonella Cardinale, Flora Cimmino, Annalaura Montella, Dalila Capasso, Riccardo Haupt, Loredana Amoroso, Alberto Garaventa, Alessandro Quattrone, Maria Valeria Corrias, Achille Iolascon, Mario
  Journal of Cellular and Molecular Medicine.2020; 24(7): 4072.     CrossRef
• Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)
  Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Shifra Ash, Genevieve Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens, Toby Trahair, Godfrey Chi Fung Chan, Ellen Ruud, Henrik Schroeder, Maja Beck-Pop
  Cancers.2020; 12(2): 309.     CrossRef
• Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR
  F. Berthold, A. Faldum, A. Ernst, J. Boos, D. Dilloo, A. Eggert, M. Fischer, M. Frühwald, G. Henze, T. Klingebiel, C. Kratz, B. Kremens, B. Krug, I. Leuschner, M. Schmidt, R. Schmidt, R. Schumacher-Kuckelkorn, D. von Schweinitz, F.H. Schilling, J. Theisse
  Annals of Oncology.2020; 31(3): 422.     CrossRef
• Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma
  S. L. George, V. Parmar, F. Lorenzi, L. V. Marshall, Y. Jamin, E. Poon, P. Angelini, L. Chesler
  Journal of Experimental & Clinical Cancer Research.2020;[Epub]     CrossRef
• Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study
  Keith Holmes, Ulrike Pötschger, Andrew D. J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas E. Matthyssens, Martin Metzelder, Tom Monclair, Jakob Stenman, Michal Rygl, Lars Rasmussen, Jean
  Journal of Clinical Oncology.2020; 38(25): 2902.     CrossRef
• Development of differentiation modulators and targeted agents for treating neuroblastoma
  Zegao Jin, Yang Lu, Yizhe Wu, Jinxin Che, Xiaowu Dong
  European Journal of Medicinal Chemistry.2020; 207: 112818.     CrossRef
• A promoter-driven assay for INSM1-associated signaling pathway in neuroblastoma
  Chiachen Chen, Michael S. Lan
  Cellular Signalling.2020; 76: 109785.     CrossRef
• Evolving treatments in high-risk neuroblastoma
  Abhinav Kumar, John P J Rocke, B Nirmal Kumar
  Expert Opinion on Orphan Drugs.2020; 8(12): 497.     CrossRef
• Drug Targeting the Actin Cytoskeleton Potentiates the Cytotoxicity of Low Dose Vincristine by Abrogating Actin-Mediated Repair of Spindle Defects
  Yao Wang, Jeffrey H. Stear, Ashleigh Swain, Xing Xu, Nicole S. Bryce, Michael Carnell, Irina B. Alieva, Vera B. Dugina, Timothy P. Cripe, Justine Stehn, Edna C. Hardeman, Peter W. Gunning
  Molecular Cancer Research.2020; 18(7): 1074.     CrossRef
• Cardiac MRI: a Promising Diagnostic Tool to Detect Cancer Therapeutics–Related Cardiac Dysfunction
  Jasmin D. Haslbauer, Sarah Lindner, Gesine Bug, Eike Nagel, Valentina O. Puntmann
  Current Cardiovascular Imaging Reports.2019;[Epub]     CrossRef
• Therapy intensification in high-risk neuroblastoma patients with poor response to standard induction: experience of Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology
  T. V. Shamanskaya, D. Y. Kachanov, A. V. Dumacheva, M. V. Teleshova, D. V. Shevtcov, T. V. Sergeeva, A. M. Syleimanova, R. A. Moiseenko, Y. N. Likar, . Kailash, S. R. Varfolomeeva
  Pediatric Hematology/Oncology and Immunopathology.2019; 18(4): 19.     CrossRef
• Molecular mechanisms and therapeutic targets in neuroblastoma
  John Inge Johnsen, Cecilia Dyberg, Susanne Fransson, Malin Wickström
  Pharmacological Research.2018; 131: 164.     CrossRef
• Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
  Fabio Morandi, Loredana Amoroso, Alessandra Dondero, Roberta Castriconi, Stefano Parodi, Roberto Luksch, Fiorina Casale, Aurora Castellano, Alberto Garaventa, Alessandro Moretta, Cristina Bottino, Mirco Ponzoni, Maria Valeria Corrias
  OncoImmunology.2018; 7(9): e1468953.     CrossRef
• Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified Neuroblastoma
  Joshua Felgenhauer, Laura Tomino, Julia Selich-Anderson, Emily Bopp, Nilay Shah
  Neoplasia.2018; 20(10): 965.     CrossRef
• Prise en charge des neuroblastomes de haut risque : l’expérience du groupe européen SIOPEN
  Dominique Valteau-Couanet, Gudrun Schleiermacher, Sabine Sarnacki, Claudia Pasqualini
  Bulletin du Cancer.2018; 105(10): 918.     CrossRef
• Novel Therapies for Relapsed and Refractory Neuroblastoma
  Peter E. Zage
  Children.2018; 5(11): 148.     CrossRef
• Investigational drugs in phase II clinical trials for the treatment of neuroblastoma
  Loredana Amoroso, Riccardo Haupt, Alberto Garaventa, Mirco Ponzoni
  Expert Opinion on Investigational Drugs.2017; 26(11): 1281.     CrossRef

Citations

Citations to this article as recorded by  

• Oncological outcomes of surgical management for T2N0M0 glottic laryngeal squamous cell carcinoma
  Jian Zhou, Cheng‐Zhi Xu, Xiao‐Ke Zhu, Yue Yang, Liang Zhou, Hong‐Li Gong, Lei Tao
  World Journal of Otorhinolaryngology - Head and Neck Surgery.2025; 11(1): 29.     CrossRef
• Particular aspects of laser microsurgery in malignant and premalignant glottic lesions
  Mihai Tușaliu, Costinel Adrian Vrejoiu, Iulia Tiţă, Mădălina Vulpe, Adriana Lozbă, Cristian Bucur
  ORL.ro.2024; 1(62): 9.     CrossRef
• The association between initiation weekday of radiotherapy and local control in stage 1 glottic carcinoma: a retrospective analysis
  Masashi Endo, Satoru Takahashi, Yukiko Fukuda, Kohei Okada, Kazunari Ogawa, Michiko Nakamura, Masahiro Kawahara, Keiko Akahane, Eri Murakami, Chiaki Shibayama, Ryutaro Onaga, Takafumi Nagatomo, Takeharu Kanazawa, Hiroshi Nishino, Harushi Mori, Katsuyuki S
  Journal of Radiation Research.2024; 65(6): 798.     CrossRef
• The Same–Up–Down Staging System for Recurrent Early Glottic Cancer
  Giuseppe Licci, Luca Giovanni Locatello, Giandomenico Maggiore, Flavia Cozzolino, Saverio Caini, Oreste Gallo
  Cancers.2023; 15(3): 598.     CrossRef
• Kehlkopfteilresektion – eine interdisziplinäre Gratwanderung zwischen Resektion und Funktionserhalt
  Manuel Christoph Ketterer, Rainer Beck, Matthias Cohnen, Andreas Knopf
  best practice onkologie.2023; 18(5): 184.     CrossRef
• Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis
  Niema B. Razavian, Ralph B. D'Agostino, Rachel F. Shenker, Ryan T. Hughes
  International Journal of Radiation Oncology*Biology*Physics.2023; 117(3): 652.     CrossRef
• Clinical Analysis of the Treatment Outcomes of Laryngeal Cancer
  Takashi Kurita, Shun-ichi Chitose, Takeharu Ono, Mioko Fukahori, Shintaro Sueyoshi, Ryota Mihashi, Toshihiko Kawaguchi, Akira Hiraki, Hirohito Umeno
  Practica oto-rhino-laryngologica. Suppl..2023; 163: 89.     CrossRef
• Comparison of Survival Outcomes of Different Treatment Options for cT1-2, N0 Glottic Carcinoma: A Propensity Score–Weighted Analysis
  Qi-wei Liang, Liang Peng, Jing Liao, Chun-xia Huang, Wei-ping Wen, Wei Sun
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Survival study in early stages of glottis cancer, stratified by treatment
  Yolanda Lois-Ortega, Fernando García-Curdi, Héctor Vallés-Varela, Ana Muniesa-del Campo
  Acta Oto-Laryngologica.2022; 142(7-8): 627.     CrossRef
• Selective local postoperative radiotherapy for T3–T4 N0 laryngeal cancer
  Meltem Dağdelen, Merve Şahin, Tuba Kurt Çatal, Halil Cumhur Yıldırım, Songül Çavdar Karaçam, Kimia Çepni, Ömer Erol Uzel
  Strahlentherapie und Onkologie.2022; 198(11): 1025.     CrossRef
• Long-term impact of smoking cessation on new glottic cancer events in patients with early glottic cancer
  Min-Su Kim, Hong-Gyun Wu, Myung-Whun Sung, Tack-Kyun Kwon
  Acta Otorhinolaryngologica Italica.2022; 42(6): 525.     CrossRef
• Diode Laser for Laryngeal Cancer: “980 nm” and Beyond the Classic CO2
  Petros D. Karkos, Ioannis Koskinas, Marios Stavrakas, Stefanos Triaridis, Jannis Constantinidis
  Ear, Nose & Throat Journal.2021; 100(1_suppl): 19S.     CrossRef
• Radiotherapy versus partial laryngectomy in the management of early glottic cancer with anterior commissure involvement: A propensity score matched study with 256 patients
  Ruichen Li, Qi Wang, Li Yan, Yi Zhu, Shengzi Wang, Shu Tian
  Oral Oncology.2021; 116: 105230.     CrossRef
• Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients
  Gerhard Dyckhoff, Rolf Warta, Christel Herold-Mende, Elisabeth Rudolph, Peter K. Plinkert, Heribert Ramroth
  Cancers.2021; 13(7): 1601.     CrossRef
• Age as Indicator in the Selection of Surgery Modalities in Early Glottic Cancer
  Jialing Wu, Kaiyun You, Xingsheng Qiu, Ting Shen, Juanjuan Song, Changlong Chen, Yanhui Jiang, Yimin Liu
  Risk Management and Healthcare Policy.2021; Volume 14: 3223.     CrossRef
• Feasibility of single vocal cord irradiation as a treatment strategy for T1a glottic cancer
  Seung Yeun Chung, Chang Geol Lee
  Head & Neck.2020; 42(5): 854.     CrossRef
• Radiotherapy versus laser microsurgery in the treatment of early glottic cancer
  Yolanda Lois-Ortega, Fernando García-Curdi, José Miguel Sebastián-Cortés, Félix De Miguel-García, Héctor Vallés-Varela, Ana Muniesa-del Campo
  Acta Oto-Laryngologica.2020; 140(11): 954.     CrossRef
• Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
  Yajing Du, Shali Shao, Minghe Lv, Yi Zhu, Li Yan, Tiankui Qiao
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Comparison between radiotherapy and transoral laser microsurgery treatments in early-stages of glottis cancer: A five-year follow-up study
  Javier Santabárbara
  Investigación Clínica.2020; 61(4): 324.     CrossRef
• Prospective validation of an institutional treatment strategy for T1N0M0 glottic carcinoma
  Simon Beyaert, Marc Hamoir, Aline Van Maanen, Vincent Grégoire, Sandra Schmitz
  European Journal of Surgical Oncology.2019; 45(7): 1188.     CrossRef
• Prognostic factors in patients with T1 glottic cancer treated with radiotherapy
  A. Mucha-Małecka, A. Chrostowska, K. Urbanek, K. Małecki
  Strahlentherapie und Onkologie.2019; 195(9): 792.     CrossRef
• Involvement of the Anterior Commissure in Early Glottic Cancer (Tis-T2): A Review of the Literature
  Martine Hendriksma, Elisabeth V. Sjögren
  Cancers.2019; 11(9): 1234.     CrossRef
• Treatment of early-stage laryngeal cancer: A comparison of treatment options
  Brandon Jackson Baird, C. Kwang Sung, Beth M. Beadle, Vasu Divi
  Oral Oncology.2018; 87: 8.     CrossRef

Citations

Citations to this article as recorded by  

• TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors
  Joshua R. D. Pearson, Carles Puig-Saenz, Jubini E. Thomas, Lydia D. Hardowar, Murrium Ahmad, Louise C. Wainwright, Adam M. McVicar, Victoria A. Brentville, Chris J. Tinsley, A. Graham Pockley, Lindy G. Durrant, Stephanie E. B. McArdle
  Cancer Immunology, Immunotherapy.2024;[Epub]     CrossRef
• Dural Metastasis in Breast Cancer: MRI-Based Morphological Subtypes and Their Clinical Implications
  Sung Jun Ahn, Bio Joo, Mina Park, Hun Ho Park, Sang Hyun Suh, Sung Gwe Ahn, Jihwan Yoo
  Cancer Research and Treatment.2024; 56(4): 1105.     CrossRef
• Treatment Outcome of the Brain Metastases in Peri-Rolandic Area: Comparison Between Surgery and Stereotactic Radiosurgery
  Jun Hyeok Jung, Kawngwoo Park, Eun Young Kim, Chan-Jong Yoo, Gi-Taek Yee, Woo-Kyung Kim, Dong-Won Shin
  Brain Tumor Research and Treatment.2023; 11(4): 246.     CrossRef
• Mutational profiles of primary pulmonary adenocarcinoma and paired brain metastases disclose the importance of KRAS mutations
  Erik Vassella, Elham Kashani, Philipp Zens, Alexandra Kündig, Christian Fung, Amina Scherz, Evelyn Herrmann, Ekin Ermis, Ralph A. Schmid, Sabina Berezowska
  European Journal of Cancer.2021; 159: 227.     CrossRef
• Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance
  Youngkyong Kim, Sung Hwan Kim, Jong Hoon Lee, Dae Gyu Kang
  Cancer Research and Treatment.2019; 51(2): 568.     CrossRef
• Non–coplanar whole brain radiotherapy is an effective modality for parotid sparing
  Jaehyeon Park, Jae Won Park, Ji Woon Yea
  Yeungnam University Journal of Medicine.2019; 36(1): 36.     CrossRef
• Whole brain radiotherapy using four-field box technique with tilting baseplate for parotid gland sparing
  Jaehyeon Park, Ji Woon Yea
  Radiation Oncology Journal.2019; 37(1): 22.     CrossRef

Citations

Citations to this article as recorded by  

• Bioinformatic analysis and experimental validation of cuproptosis-related LncRNA as a novel biomarker for prognosis and immunotherapy of oral squamous cell carcinoma
  Shuang Liang, Lanting Ji, Zhenyuan Yu, YaHsin Cheng, Ruifang Gao, Wenpeng Yan, Fang Zhang
  Hereditas.2024;[Epub]     CrossRef
• Comparative Evaluation of Second-Line Chemotherapy Agents for Advanced Soft Tissue Sarcoma: Gemcitabine/Docetaxel, Pazopanib, and Alternatives
  Tae Hun Kim, Ki Hyuk Sung, So Hak Chung
  Journal of the Korean Orthopaedic Association.2024; 59(1): 22.     CrossRef
• Leiomyosarcoma of stomach extending to gastroesophageal junction and distal esophagus as a rare cause of dysphagia: a case report
  Lilamani Rajthala, Sagar Gyawali, Sabin Banmala, Surendra Shah
  Annals of Medicine & Surgery.2024; 86(5): 3133.     CrossRef
• Real‐World Outcomes of Patients Treated With Gemcitabine Using Standardized Dose and Rate and Docetaxel for Advanced Soft Tissue Sarcoma in an Australian Sarcoma Center
  Isabella Wilson, Madeleine Strach, Vivek Bhadri, Michelle Harrison, Whiter Tang, Peter Grimison
  Asia-Pacific Journal of Clinical Oncology.2024;[Epub]     CrossRef
• Retrospective evaluation of the role of gemcitabine‐docetaxel in well‐differentiated and dedifferentiated liposarcoma
  Prapassorn Thirasastr, Heather Lin, Behrang Amini, Wei‐Lien Wang, Jeffrey M. Cloutier, Elise F. Nassif, Emily Z. Keung, Christina L. Roland, Barry Feig, Dejka Araujo, Robert S. Benjamin, Anthony P. Conley, John A. Livingston, Joseph Ludwig, Shreyaskumar P
  Cancer Medicine.2023; 12(4): 4282.     CrossRef
• Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time
  Tuyen Duong Thanh Nguyen, Yan Wang, Tuyen N. Bui, Rossana Lazcano, Davis R. Ingram, Min Yi, Varshini Vakulabharanam, Linjie Luo, Marc A. Pina, Cansu Karakas, Mi Li, Nicole M. Kettner, Neeta Somaiah, Peter J. Hougton, Osama Mawlawi, Alexander J. Lazar, Kel
  Cancer Research.2023; 83(6): 939.     CrossRef
• A competing risk-based nomogram to predict cancer-specific survival in patients with retroperitoneal leiomyosarcoma
  Qian Fang, Guojing Cai, Guizeng Chen, Xiang Xu, Haifeng Zeng, Yulong He, Shirong Cai, Hui Wu
  Heliyon.2023; 9(6): e16867.     CrossRef
• Chemotherapeutic drugs for soft tissue sarcomas: a review
  Zhichao Tian, Weitao Yao
  Frontiers in Pharmacology.2023;[Epub]     CrossRef
• Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma
  Szu-Yun Niu, Lou Sun, Shih-Tien Hsu, Sheau-Feng Hwang, Chih-Ku Liu, Yu-Hsiang Shih, Ting-Fang Lu, Yen-Fu Chen, Li-Ching Lai, Pei-Lun Chang, Chien-Hsing Lu
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Intensity modulated radiotherapy might be effective for locally advanced esophageal carcinosarcoma: A single center’s experience and review of literature
  Siran Yang, Wenqing Wang, Nan Bi, Zongmei Zhou, Qinfu Feng, Zefen Xiao, Dongfu Chen, Jun Liang, Jima Lu, Jianyang Wang, Xin Wang, Jingbo Wang, Yong Yang, Ningning Lu, Hongxing Zhang, Luhua Wang
  Medicine.2022; 101(42): e31215.     CrossRef
• Synovial sarcoma in children: A 15-YEAR experience at a tertiary pediatric center in Argentina
  E. Rossetti, G. Gonzalez Diaz, J. Lopez Marti, S. Innocenti, W. Cacciavillano, G. Felizzia, M. Viso, M.L. Ramos, P. Zubizarreta, A. Rose
  Pediatric Hematology Oncology Journal.2021; 6(4): 175.     CrossRef
• Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas
  Dennis Christoph Harrer, Sebastian Buschauer, Ulrich Sterz, Karin Menhart, Christina Wendl, Daniel Heudobler, Matthias Grube, Tobias Pukrop, Wolfgang Herr, Martin Vogelhuber
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Gemcitabine induced cytotoxicity, DNA damage and hepatic injury in laboratory mice
  Waleed A. Q. Hailan, Faisal M. Abou-Tarboush, Khalid M. Al-Anazi, Areeba Ahmad, Ahmed Qasem, Mohammad Abul Farah
  Drug and Chemical Toxicology.2020; 43(2): 158.     CrossRef
• Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma
  Eun Byeol Jo, Doopyo Hong, Young Sang Lee, Hyunjoo Lee, Jae Berm Park, Sung Joo Kim
  Translational Oncology.2019; 12(2): 269.     CrossRef
• Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology
  Yu Jin Kim, Mingi Kim, Hyung Kyu Park, Dan Bi Yu, Kyungsoo Jung, Kyoung Song, Yoon-La Choi
  Laboratory Investigation.2019; 99(9): 1309.     CrossRef
• The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model
  Kentaro Miyake, Takashi Higuchi, Hiromichi Oshiro, Zhiying Zhang, Norihiko Sugisawa, Jun Ho Park, Sahar Razmjooei, Yuki Katsuya, Maryam Barangi, Yunfeng Li, Scott D. Nelson, Takashi Murakami, Yuki Homma, Yukihiko Hiroshima, Ryusei Matsuyama, Michael Bouve
  Biomedicine & Pharmacotherapy.2019; 117: 109093.     CrossRef
• Adipogenesis induces growth inhibition of dedifferentiated liposarcoma
  Yu Jin Kim, Dan Bi Yu, Mingi Kim, Yoon‐La Choi
  Cancer Science.2019; 110(8): 2676.     CrossRef
• Leiomyosarcoma of the Stomach with Metastasis to the Liver: A Case Report With Review of the Literature
  Varshil Mehta, Monali Rajawat, Sameer Rastogi, Ravi H Phulware, Roman Mezencev
  Future Science OA.2018;[Epub]     CrossRef
• Systemic treatment in adult uterine sarcomas
  I.M.E. Desar, P.B. Ottevanger, C. Benson, W.T.A. van der Graaf
  Critical Reviews in Oncology/Hematology.2018; 122: 10.     CrossRef
• Preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal carcinosarcoma: a case report and review of the literature
  Tomoko Yoshimoto, Shinichiro Kobayashi, Kengo Kanetaka, Kazuma Kobayashi, Yasuhiro Nagata, Michi Morita, Yuriko Isagawa, Naoe Kinoshita, Mitsuhisa Takatsuki, Susumu Eguchi
  Surgical Case Reports.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Relationship between metastasis and second primary cancers in women with breast cancer
  Chaofan Li, Mengjie Liu, Jia Li, Xixi Zhao, Yusheng Wang, Xi Chen, Weiwei Wang, Shiyu Sun, Cong Feng, Yifan Cai, Fei Wu, Chong Du, Yinbin Zhang, Shuqun Zhang, Jingkun Qu
  Frontiers in Oncology.2022;[Epub]     CrossRef
• The Potential Clinical and Economic Value of Primary Tumour Identification in Metastatic Cancer of Unknown Primary Tumour: A Population-Based Retrospective Matched Cohort Study
  Malek B. Hannouf, Eric Winquist, Salaheddin M. Mahmud, Muriel Brackstone, Sisira Sarma, George Rodrigues, Peter K. Rogan, Jeffrey S. Hoch, Gregory S. Zaric
  PharmacoEconomics - Open.2018; 2(3): 255.     CrossRef

Citations

Citations to this article as recorded by  

• Medical nanoscale materials for virus-induced cervical cancer therapeutic modalities: For targeting delivery
  Adane Adugna, Mamaru Getinet, Gashaw Azanaw Amare, Mohammed Jemal
  OpenNano.2025; 21: 100221.     CrossRef
• From Pioneering Discoveries to Innovative Therapies: A Journey Through the History and Advancements of Nanoparticles in Breast Cancer Treatment
  Fatemah Basingab, Omniah Alshahrani, Ibtehal Alansari, Nada Almarghalani, Nada Alshelali, Abeer Alsaiary, Najwa Alharbi, Kawther Zaher
  Breast Cancer: Targets and Therapy.2025; Volume 17: 27.     CrossRef
• PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model
  Wendy K. Nevala, Liyi Geng, Hui Xie, Noah A. Stueven, Svetomir N. Markovic
  International Journal of Molecular Sciences.2025; 26(7): 3295.     CrossRef
• Nano-drug delivery systems based on biodegradable polymers for the therapy of gynecological malignancies
  Keer Jin, Hanxue Zhang, Yuwei Yang, Yan Gao
  International Journal of Polymeric Materials and Polymeric Biomaterials.2024; 73(14): 1262.     CrossRef
• Dual stimuli-responsive polymeric prodrug consisting of reversible covalent bonded celastrol for tumor targeted delivery
  Jiangtao Su, Meng Rao, Heshuang Dai, Le Cai, Fan Ye, Lu Ye, Yuchen Hu, Ban Chen, Xiaoxia Guo
  Macromolecular Research.2024; 32(2): 173.     CrossRef
• Designing nanodiscs as versatile platforms for on-demand therapy
  Qianwen Mu, Haolan Deng, Xiaoyu An, Gang Liu, Chao Liu
  Nanoscale.2024; 16(5): 2220.     CrossRef
• Innovative strategies for effective paclitaxel delivery: Recent developments and prospects
  Sławomir Wileński, Agnieszka Koper, Paulina Śledzińska, Marek Bebyn, Krzysztof Koper
  Journal of Oncology Pharmacy Practice.2024; 30(2): 367.     CrossRef
• Platelet-derived drug delivery systems: Pioneering treatment for cancer, cardiovascular diseases, infectious diseases, and beyond
  Yalan Zhu, Lingling Xu, Yong Kang, Qinzhen Cheng, Yiling He, Xiaoyuan Ji
  Biomaterials.2024; 306: 122478.     CrossRef
• Nanoparticle-Based Immunotherapy for Reversing T-Cell Exhaustion
  Fei Li, Yahong Wang, Dandan Chen, Yunjie Du
  International Journal of Molecular Sciences.2024; 25(3): 1396.     CrossRef
• Delivery of Nucleic Acid Drugs for Tumor Therapy: Opportunities and Challenges
  Dandan Sun, Wenjia Tan, Jianan Zhao, Yafei Tian, Siqi Li, Zhiqi Zhang, Xinzhe Dong, Xiaonan Liu, Na Liu, Ping Jiao, Jie Ma
  Fundamental Research.2024;[Epub]     CrossRef
• Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls
  Soo Jin Park, Joo-Hyuk Son, Tae-Wook Kong, Suk-Joon Chang, Hee Seung Kim
  Frontiers in Oncology.2024;[Epub]     CrossRef
• Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments
  Anastasia Vlachou, Vijay Bhooshan Kumar, Om Shanker Tiwari, Sigal Rencus-Lazar, Yu Chen, Busra Ozguney, Ehud Gazit, Phanourios Tamamis
  ACS Applied Bio Materials.2024; 7(4): 2309.     CrossRef
• Biomarkers in Ovarian Cancer: Towards Personalized Medicine
  Carlos López-Portugués, María Montes-Bayón, Paula Díez
  Proteomes.2024; 12(1): 8.     CrossRef
• Internalization of transferrin-tagged Myxococcus xanthus encapsulins into mesenchymal stem cells
  Anna N. Gabashvili, Natalya A. Alexandrushkina, Elizaveta N. Mochalova, Daria V. Goliusova, Ekaterina N. Sapozhnikova, Pavel I. Makarevich, Petr I. Nikitin
  Experimental Biology and Medicine.2024;[Epub]     CrossRef
• Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials
  Ana Serras, Célia Faustino, Lídia Pinheiro
  Pharmaceutics.2024; 16(8): 1047.     CrossRef
• Polyesters and Polyester Nano- and Microcarriers for Drug Delivery
  Stanislaw Slomkowski, Teresa Basinska, Mariusz Gadzinowski, Damian Mickiewicz
  Polymers.2024; 16(17): 2503.     CrossRef
• Nanotheranostics for gynecological cancers: a path forward for Africa
  Mutia Kehwalla Aza, Anavami Suberu, Mahmood Balogun, Goodness Adegbola, Mohamed Alie Sankoh, Thomas Oyediran, Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Chinonyelum Emmanuel Agbo
  Medical Oncology.2024;[Epub]     CrossRef
• Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics
  Mahua Sarkar, Yang Wang, Oscar Ekpenyong, Dong Liang, Huan Xie
  WIREs Nanomedicine and Nanobiotechnology.2023;[Epub]     CrossRef
• Cancer treatment and toxicity outlook of nanoparticles
  Neetika, Mamta Sharma, Pankaj Thakur, Paras Gaur, Gokana Mohana Rani, Sarvesh Rustagi, Rishi Kumar Talreja, Vishal Chaudhary
  Environmental Research.2023; 237: 116870.     CrossRef
• Efficacy and Safety of Nanopaclitaxel Formulation for Cancer Treatment: Evidence From Randomized Clinical Trials
  Xiangmin Deng, Xiaoqin Huang, Xiaoyan Dong, Genxiang Mao, Wenmin Xing
  Nanomedicine.2023; 18(10): 833.     CrossRef
• Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers
  Tetiana Korzun, Abraham S. Moses, Parham Diba, Ariana L. Sattler, Brennan Olson, Olena R. Taratula, Tanja Pejovic, Daniel L. Marks, Oleh Taratula
  Small.2023;[Epub]     CrossRef
• Nanoprobe-based molecular imaging for tumor stratification
  Xianbin Ma, Mingchuan Mao, Jiaqi He, Chao Liang, Hai-Yan Xie
  Chemical Society Reviews.2023; 52(18): 6447.     CrossRef
• Magic shotgun over magic bullet for treatment of ovarian cancer via polymeric nanoparticles
  Bakr Ahmed, Anuradha Sharma, Zakiya Usmani, Garima Sharma, Joga Singh, Radhika Yadav, Indu Sharma, Indu Pal Kaur
  Journal of Drug Delivery Science and Technology.2023; 88: 104945.     CrossRef
• Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study
  So Hyun Nam, Shin-Wha Lee, Young-Jae Lee, Yong Man Kim
  Cancer Research and Treatment.2023; 55(4): 1346.     CrossRef
• Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations
  Aman Upaganlawar, Satish Polshettiwar, Sushil Raut, Amol Tagalpallewar, Vishal Pande
  Current Drug Metabolism.2022; 23(11): 869.     CrossRef
• Comparison of triblock copolymeric micelles based on α- and ε-poly(L-lysine): a Cornelian choice
  Franck Marquet, Viorica Patrulea, Gerrit Borchard
  Polymer Journal.2022; 54(2): 199.     CrossRef
• Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic
  Vladimir A. Ljubimov, Arshia Ramesh, Saya Davani, Moise Danielpour, Joshua J. Breunig, Keith L. Black
  Advanced Drug Delivery Reviews.2022; 181: 114033.     CrossRef
• Nanocarriers targeting the diseases of the pancreas
  Nurbanu Demirtürk, Erem Bilensoy
  European Journal of Pharmaceutics and Biopharmaceutics.2022; 170: 10.     CrossRef
• The development and progress of nanomedicine for esophageal cancer diagnosis and treatment
  Xiaokun Li, Lingmin Chen, Siyuan Luan, Jianfeng Zhou, Xin Xiao, Yushang Yang, Chengyi Mao, Pinhao Fang, Longqi Chen, Xiaoxi Zeng, Huile Gao, Yong Yuan
  Seminars in Cancer Biology.2022; 86: 873.     CrossRef
• Beyond separation: Membranes towards medicine
  Ying Xie, Zhenyu Chu, Wanqin Jin
  Journal of Membrane Science Letters.2022; 2(1): 100020.     CrossRef
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
  Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi, Fatemeh Narimani, Carly E. Wallace, Anupam Bishayee
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Gold Nanorods for Drug and Gene Delivery: An Overview of Recent Advancements
  Atieh Jahangiri-Manesh, Marziyeh Mousazadeh, Shirinsadat Taji, Abbas Bahmani, Atefeh Zarepour, Ali Zarrabi, Esmaeel Sharifi, Mostafa Azimzadeh
  Pharmaceutics.2022; 14(3): 664.     CrossRef
• Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story
  Ekati Drakopoulou, Nicholas P. Anagnou, Kalliopi I. Pappa
  Cancers.2022; 14(13): 3238.     CrossRef
• Engineering nanosystems to overcome barriers to cancer diagnosis and treatment
  Suhaila O. Alhaj-Suliman, Emad I. Wafa, Aliasger K. Salem
  Advanced Drug Delivery Reviews.2022; 189: 114482.     CrossRef
• Metabolic Signatures of Surface-Modified Poly(lactic-co-glycolic acid) Nanoparticles in Differentiated THP-1 Cells Derived with Liquid Chromatography-Mass Spectrometry-based Metabolomics
  Mohammad A. Al-natour, Salah Abdelrazig, Amir M. Ghaemmaghami, Cameron Alexander, Dong-Hyun Kim
  ACS Omega.2022; 7(33): 28806.     CrossRef
• Pathogen-derived peptides in drug targeting and its therapeutic approach
  Seok-Jun Mun, Euni Cho, Jae-Sung Kim, Chul-Su Yang
  Journal of Controlled Release.2022; 350: 716.     CrossRef
• Application of single and cooperative different delivery systems for the treatment of intervertebral disc degeneration
  Zongtai Liu, Changfeng Fu
  Frontiers in Bioengineering and Biotechnology.2022;[Epub]     CrossRef
• Engineering the Tumor Immune Microenvironment through Minimally Invasive Interventions
  Koustav Pal, Rahul A. Sheth
  Cancers.2022; 15(1): 196.     CrossRef
• Nanoparticle delivery systems to combat drug resistance in ovarian cancer
  Emily M. Miller, Timothy M. Samec, Angela A. Alexander-Bryant
  Nanomedicine: Nanotechnology, Biology and Medicine.2021; 31: 102309.     CrossRef
• Engineering precision nanoparticles for drug delivery
  Michael J. Mitchell, Margaret M. Billingsley, Rebecca M. Haley, Marissa E. Wechsler, Nicholas A. Peppas, Robert Langer
  Nature Reviews Drug Discovery.2021; 20(2): 101.     CrossRef
• Clinical applications of nanomedicines in lung cancer treatment
  Mohammad Norouzi, Pierre Hardy
  Acta Biomaterialia.2021; 121: 134.     CrossRef
• Lyophilization stabilizes clinical‐stage core‐crosslinked polymeric micelles to overcome cold chain supply challenges
  Tarun Ojha, Qizhi Hu, Claudio Colombo, Jan Wit, Michiel van Geijn, Mies J. van Steenbergen, Mahsa Bagheri, Hiltrud Königs‐Werner, Eva Miriam Buhl, Ruchi Bansal, Yang Shi, Wim E. Hennink, Gert Storm, Cristianne J. F. Rijcken, Twan Lammers
  Biotechnology Journal.2021;[Epub]     CrossRef
• Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface
  Shannon R. Tracey, Peter Smyth, Caroline J. Barelle, Christopher J. Scott
  Biochemical Society Transactions.2021; 49(5): 2253.     CrossRef
• Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies
  Ellen Cusano, Chelsea Wong, Eddy Taguedong, Marcus Vaska, Tasnima Abedin, Nancy Nixon, Safiya Karim, Patricia Tang, Daniel Y. C. Heng, Doreen Ezeife
  Current Oncology.2021; 28(6): 4894.     CrossRef
• Engineering Considerations to Produce Bioactive Compounds from Plant Cell Suspension Culture in Bioreactors
  Elizabeth Alejandra Motolinía-Alcántara, Carlos Omar Castillo-Araiza, Mario Rodríguez-Monroy, Angélica Román-Guerrero, Francisco Cruz-Sosa
  Plants.2021; 10(12): 2762.     CrossRef
• Clinical applications of nanomedicine in cancer therapy
  Mohammad Norouzi, Mehrnaz Amerian, Mahshid Amerian, Fatemeh Atyabi
  Drug Discovery Today.2020; 25(1): 107.     CrossRef
• Targeting and extending the eukaryotic druggable genome with natural products: cytoskeletal targets of natural products
  April L. Risinger, Lin Du
  Natural Product Reports.2020; 37(5): 634.     CrossRef

• Improvement of Paclitaxel-Associated Adverse Reactions (ADRs) via the Use of Nano-Based Drug Delivery Systems: A Systematic Review and Network Meta-Analysis

  
  Pi-Ling Chou, Ya-Ping Huang, Meng-Hsuan Cheng, Kun-Ming Rau, Yi-Ping Fang
  International Journal of Nanomedicine.2020; Volume 15: 1731.     CrossRef
• Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
  Duhyeong Hwang, Jacob D. Ramsey, Alexander V. Kabanov
  Advanced Drug Delivery Reviews.2020; 156: 80.     CrossRef
• Nanoparticles in precision medicine for ovarian cancer: From chemotherapy to immunotherapy
  Yuan Li, Yan Gao, Xi Zhang, Hongyan Guo, Huile Gao
  International Journal of Pharmaceutics.2020; 591: 119986.     CrossRef
• Synthesis of PCL–PEG–PCL Triblock Copolymer via Organocatalytic Ring-Opening Polymerization and Its Application as an Injectable Hydrogel—An Interdisciplinary Learning Trial
  Kaiting Wu, Lin Yu, Jiandong Ding
  Journal of Chemical Education.2020; 97(11): 4158.     CrossRef

• Phytochemical-Based Nanomedicine for Advanced Cancer Theranostics: Perspectives on Clinical Trials to Clinical Use

  
  Madhusmita Dhupal, Devasish Chowdhury
  International Journal of Nanomedicine.2020; Volume 15: 9125.     CrossRef
• Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance
  Yuxuan Dai, Xingguang Cai, Xinzhou Bi, Chunxia Liu, Na Yue, Ying Zhu, Jiaqi Zhou, Mian Fu, Wenlong Huang, Hai Qian
  European Journal of Medicinal Chemistry.2019; 171: 104.     CrossRef
• A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
  Bhumsuk Keam, Keun-Wook Lee, Se-Hoon Lee, Jin-Soo Kim, Jin Ho Kim, Hong-Gyun Wu, Keun-Yong Eom, Suzy Kim, Soon-Hyun Ahn, Eun-Jae Chung, Seong Keun Kwon, Woo-Jin Jeong, Young Ho Jung, Ji-Won Kim, Dae Seog Heo
  The Oncologist.2019; 24(6): 751.     CrossRef
• Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging
  Xiaoxue Xie, Yu Chen, Zhongyuan Chen, Yi Feng, Jing Wang, Tingting Li, Shun Li, Xiang Qin, Chunhui Wu, Chuan Zheng, Jie Zhu, Fengming You, Yiyao Liu, Hong Yang
  ACS Applied Materials & Interfaces.2019; 11(47): 43865.     CrossRef
• Micellar paclitaxel in the treatment of patients with tumors of the female reproductive system
  A. G. Kedrova, S. E. Krasilnikov, D. A. Astakhov, V. V. Kosyy
  Tumors of female reproductive system.2019; 15(3): 37.     CrossRef
• Improving Drug Delivery of Micellar Paclitaxel against Non‐Small Cell Lung Cancer by Coloading Itraconazole as a Micelle Stabilizer and a Tumor Vascular Manipulator
  Ling Zhang, Zhengsheng Liu, Chao Kong, Chun Liu, Kuan Yang, Huijun Chen, Jinfeng Huang, Feng Qian
  Small.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Korean patients with hereditary cancer: a prospective multicentre cohort study protocol exploring psychosocial and health outcomes
  Jun-Kyu Kim, Mi-Ae Jang, Jong Eun Park, Dongju Won, Jung-Sook Ha, Kyoung-Bo Kim, Boyoung Park, Sun-Young Kong
  BMJ Open.2025; 15(2): e093905.     CrossRef
• Measuring patient‐reported distress from breast magnetic resonance imaging: Development and validation of the MRI‐related distress scale (MRI‐DS)
  Danbee Kang, Sooyeon Kim, Jiyoon Han, Youngha Kim, Juhee Cho, Jeong Eon Lee, Eun Sook Ko
  Cancer Medicine.2024;[Epub]     CrossRef
• Quality of life patient/cancer survivor version in Chinese cancer survivors: A validation study
  Hai-Ying Wang, Stephen Wai Hang Kwok, Xian-Liang Liu, Tao Wang, Daniel Bressington, Yushan Shen, Qing Zhang, Hou-Qiang Huang, Jing-Yu Tan
  Asia-Pacific Journal of Oncology Nursing.2023; 10(8): 100255.     CrossRef
• Analysis of etiological factors of nursing diagnosis of impaired comfort in children and adolescents with cancer
  Tânia Alteniza Leandro, Viviane Martins da Silva, Marcos Venícios de Oliveira Lopes, Nayana Maria Gomes de Souza, Kiarelle Lourenço Penaforte, Emanuela Aparecida Teixeira Gueiros, Marisa Nascimento de Oliveira
  Journal of Advanced Nursing.2023; 79(10): 3913.     CrossRef
• Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning–Based Analysis
  Danbee Kang, Hyunsoo Kim, Juhee Cho, Zero Kim, Myungjin Chung, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jai Min Ryu, Se Kyung Lee
  JMIR Public Health and Surveillance.2023; 9: e45212.     CrossRef
• The early predictive value of frailty for health-related quality of life among elderly patients with cancer receiving curative chemotherapy
  Yi-Cheng Hu, Shih-Ying Chen, Wen-Chi Chou, Jen-Shi Chen, Li-Chueh Weng, Pei-Kwei Tsay, Woung-Ru Tang, Chong-Chi Chiu
  PLOS ONE.2023; 18(8): e0287320.     CrossRef
• The effect of web‐based intervention programs on self‐management and symptom management in patients with lymphoma: A systematic review of randomized controlled trials
  Merve Gozde Sezgin, Hicran Bektas
  Japan Journal of Nursing Science.2022;[Epub]     CrossRef
• Factors affecting the quality of life of gastric cancer survivors
  Jahyun Choi, Sanghee Kim, Mona Choi, Woo Jin Hyung
  Supportive Care in Cancer.2022; 30(4): 3215.     CrossRef
• The effect of decision support systems on pain in patients with cancer: A systematic review and meta‐analysis of randomized controlled trials
  Merve Gozde Sezgin, Hicran Bektas
  Journal of Nursing Scholarship.2022; 54(5): 578.     CrossRef
• Impact of objective financial burden and subjective financial distress on spiritual well-being and quality of life among working-age cancer survivors
  Danbee Kang, Ka Ryeong Bae, Jihyun Lim, Nayeon Kim, Sungkeun Shim, Sun Seog Kweon, Hwa Jeong Seo, Juhee Cho
  Supportive Care in Cancer.2022; 30(6): 4917.     CrossRef
• Feasibility and potential effects of breathing exercise for chronic pain management in breast cancer survivors: study protocol of a phase II randomised controlled trial
  Haiying Wang, Jing-Yu (Benjamin) Tan, Tao Wang, Xian-Liang Liu, Daniel Bressington, Si-Lin Zheng, Hou-Qiang Huang
  BMJ Open.2022; 12(12): e064358.     CrossRef
• Health-related quality of life after transoral robotic thyroidectomy in papillary thyroid carcinoma
  Chang Myeon Song, Hyang Sook Bang, Hyung Gu Kim, Hae Jin Park, Kyung Tae
  Surgery.2021; 170(1): 99.     CrossRef
• Impact of fear of cancer recurrence on survival among lymphoma patients
  Seok Jin Kim, Danbee Kang, Im Ryung Kim, Sang Eun Yoon, Won Seog Kim, Phyllis N. Butow, Eliseo Guallar, Juhee Cho
  Psycho-Oncology.2020; 29(2): 364.     CrossRef
• A return-to-work intervention protocol directed at cancer patients (self-assessment, tailored information & lifestyle management for returning to work among cancer patients, START): A multi-center, randomized controlled trial
  Ka Ryeong Bae, Danbee Kang, Jae Yoon Yi, Yeojin Ahn, Im-Ryung Kim, Sun-Seog Kweon, Jin Seok Ahn, Seok Jin Nam, Young Mog Shim, Mison Chun, Jaesung Heo, Juhee Cho
  Contemporary Clinical Trials Communications.2020; 19: 100633.     CrossRef
• Health-Related Quality of Life in Non-Hodgkin Lymphoma Survivors: A Prospective Cohort Study
  Danbee Kang, Juhee Cho, Im Ryung Kim, Mi Kyung Kim, Won Seog Kim, Seok Jin Kim
  Cancer Research and Treatment.2018; 50(4): 1051.     CrossRef

Citations

Citations to this article as recorded by  

• Economic Evaluations of Interventions Addressing Inequalities in Cancer Care: A Systematic Review
  Bedasa Taye Merga, Nikki McCaffrey, Suzanne Robinson, Ebisa Turi, Anita Lal
  Value in Health.2025; 28(2): 306.     CrossRef
• Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review
  Thomas Ward, Ruben E. Mujica-Mota, Anne E. Spencer, Antonieta Medina-Lara
  PharmacoEconomics.2022; 40(1): 45.     CrossRef
• Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
  Vakaramoko Diaby, Askal Ali, Aram Babcock, Joseph Fuhr, Dejana Braithwaite
  Journal of Managed Care & Specialty Pharmacy.2021; 27(9-a Suppl): S24.     CrossRef
• Incorporating health equity into value assessment: frameworks, promising alternatives, and future directions
  Vakaramoko Diaby, Askal Ali, Aram Babcock, Joseph Fuhr, Dejana Braithwaite
  Journal of Managed Care & Specialty Pharmacy.2021; 27(9-a Suppl): S22.     CrossRef

Citations

Citations to this article as recorded by  

• Mutational Profiling of Korean Lymphomas and Diffuse Large B-Cell Lymphoma Subtype Classification Using Targeted Panel Sequencing
  Gilsung Yoo, Jooyoung Cho, Hyeong Ju Kwon, Taesic Lee, JinJu Kim, Juwon Kim
  Archives of Medical Research.2025; 56(4): 103158.     CrossRef
• Incidence and survival rates of primary cutaneous malignancies in Korea, 1999–2019: A nationwide population‐based study
  Soon‐Hyo Kwon, Sangmin Choi, Joung Soo Kim, Sang Seok Kim, Mihn‐Sook Jue, Soo Hong Seo, Jihye Park, Mi Ryung Roh, Je‐Ho Mun, Jun Young Kim, Jee Woong Choi, Ji Won Byun, Sanghyun Park, Min Sung Kim, Seok‐Jong Lee
  The Journal of Dermatology.2024; 51(4): 532.     CrossRef
• Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
  Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Jinhang Kim, Chang-Hoon Lee, Ga-Young Song, Deok-Hwan Yang, Jae-Yong
  The Korean Journal of Internal Medicine.2024; 39(3): 501.     CrossRef
• The kappa/lambda ratio of surface immunoglobulin light chain as a valuable parameter for MRD assessment in CLL with atypical immunophenotype
  Yu Aruga, Chiaki Ikeda, Hiromichi Matsushita, Shinichi Makita, Suguru Fukuhara, Wataru Munakata, Koji Izutsu, Hirotaka Matsui
  Scientific Reports.2024;[Epub]     CrossRef
• Secondary Malignancies in Multiple Myeloma in Korean Patients: A Nationwide Population-Based Study
  Boyoung Park, Eunyoung Lee, Junghyun Yoon, YoungJu Park, Hyeon-Seok Eom
  Cancer Research and Treatment.2024; 56(3): 936.     CrossRef
• Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
  Moonho Kim, Yongchel Ahn, Heui-June Ahn, Suk-Hun Ha, Ho-Suk Oh, Jae-Seok Song, Woong-Sub Park, Sang-Wook Yi
  Annals of Hematology.2023; 102(11): 3167.     CrossRef
• Incidence Trend of Follicular Lymphoma in Taiwan Compared to Japan and Korea, 2001–2019
  Liang-Chun Chiu, Chih-Wen Lin, Hung-Ju Li, Jian-Han Chen, Fu-Cheng Chuang, Sheng-Fung Lin, Yu Chang, Yu-Chieh Su
  Journal of Clinical Medicine.2023; 12(4): 1417.     CrossRef
• Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study
  Youngwoo Jeon, Duk-Hwan Yang, Suk-Joong Oh, Jin-Hee Park, Jung-Ah Kim, Sung-Young Kim, Chul-Won Choi, Won-Sik Lee, In-Ho Kim, Yeung-Chul Mun, Gi June Min, Ki-Seong Eom, Seok-Goo Cho
  Frontiers in Oncology.2023;[Epub]     CrossRef
• Mycosis fungoides and Sézary syndrome
  Hyewon Lee
  Blood Research.2023; 58(S1): S66.     CrossRef
• A population-based analysis of hematological malignancies from a French-West-Indies cancer registry’s data (2009–2018)
  Rémi Houpert, Thierry Almont, Rostom Belahreche, Mamadi Faro, Jennie Okouango, Mylène Vestris, Jonathan Macni, Olivier Pierre-Louis, Christelle Montabord, Murielle Beaubrun-Renard, Naby Soumah, Martial Boisseau, Jacqueline Véronique-Baudin, Clarisse Joach
  BMC Cancer.2023;[Epub]     CrossRef
• A retrospective analysis of ibrutinib outcomes in relapsed or refractory mantle cell lymphoma
  Yong-Pyo Lee, Ye Ji Jung, Junhun Cho, Young Hyeh Ko, Won Seog Kim, Seok Jin Kim, Sang Eun Yoon
  Blood Research.2023; 58(4): 208.     CrossRef
• Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
  Do Young Kim, Jehyun Nam, Joo-seop Chung, Sang-Woo Kim, Ho-Jin Shin
  Cancer Research and Treatment.2022; 54(1): 301.     CrossRef
• Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data
  Yu-Chieh Su, Brian Chih-Hung Chiu, Hung-Ju Li, Wen-Chi Yang, Tsai-Yun Chen, Su-Peng Yeh, Ming-Chung Wang, Wen-Tsung Huang, Ming-Yang Lee, Sheng-Fung Lin, Carla Pegoraro
  PLOS ONE.2022; 17(3): e0265543.     CrossRef
• Stem cell transplant for mantle cell lymphoma in Taiwan
  Yu-Hung Wang, Ching-Yun Hsieh, Liang-Tsai Hsiao, Tung-Liang Lin, Yi-Chang Liu, Ming Yao, Tran-Der Tan, Bor-Sheng Ko
  Scientific Reports.2022;[Epub]     CrossRef
• Mantle cell lymphoma in 2022—A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments
  Preetesh Jain, Michael L. Wang
  American Journal of Hematology.2022; 97(5): 638.     CrossRef
• The Relationships between Physical Activity, Exercise, and Sport on the Immune System
  Pedro Forte, Luís Branquinho, Ricardo Ferraz
  International Journal of Environmental Research and Public Health.2022; 19(11): 6777.     CrossRef
• Utility of Epstein-Barr Viral Load in Blood for Diagnosing and Predicting Prognosis of Lymphoma
  Junhyup Song, Jun Yong Kim, Sinyoung Kim, Younhee Park
  The Journal of Molecular Diagnostics.2022; 24(9): 977.     CrossRef
• Advances in quantum dot-based biosensors for DNA-modifying enzymes assay
  Qian Zhang, Xinyi Zhang, Fei Ma, Chun-yang Zhang
  Coordination Chemistry Reviews.2022; 469: 214674.     CrossRef
• Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
  Shuo Liu, Weiping Liu, Huichao Li, Lei Yang, Yuqin Song, Xi Zhang, Yangyang Cheng, Qingyu Li, Haoxin Li, Ning Wang, Jun Zhu, Jiafu Ji
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma
  Nuchjira Takheaw, Gunya Sittithumcharee, Ryusho Kariya, Watchara Kasinrerk, Seiji Okada
  Cancer Immunology, Immunotherapy.2021; 70(6): 1557.     CrossRef
• Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study
  Yunsuk Choi, Jung-Hee Lee, Chul Won Jung, Jae-Cheol Jo, Jin Seok Kim, Inho Kim, Silvia Park, June-won Cheong, Sang-Hyuk Park, Sung-Yong Kim, Hong-Ghi Lee
  The Korean Journal of Internal Medicine.2021; 36(1): 194.     CrossRef
• High level of pre-treatment C-reactive protein to albumin ratio predicts inferior prognosis in diffuse large B-cell lymphoma
  Jongheon Jung, Hyewon Lee, Ja Yoon Heo, Myung Hee Chang, Eunyoung Lee, Weon Seo Park, Ju-Hyun Park, Hyeon-Seok Eom
  Scientific Reports.2021;[Epub]     CrossRef
• Real‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
  Jun Ho Yi, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Myung Hee Chang, Deok Hwan Yang, Jae‐Cheol Jo, Shin Young Hyun, Hyeon‐Seok Eom, Jeong‐Ok Lee, Ji Hyun Kwon, Sang Hoon Han, Seung‐Shin Lee, Jae‐Yong Kwak, Se Hyung Kim, Dae Sik Kim, Ji Hyun Lee, Sung Yo
  Cancer Communications.2021; 41(3): 275.     CrossRef
• A Case of Herpes Zoster Granulomatous Dermatitis: Report of Wolf's Isotopic Response
  Ji ha Yoon, Ye ji Jang, Eun joo Park, Kwang joong Kim, Kwang ho Kim
  Annals of Dermatology.2021; 33(2): 186.     CrossRef
• An Updated Review of Chronic Lymphocytic Leukemia
  Hee Jeong Cho, Sang Kyun Sohn
  The Korean Journal of Medicine.2021; 96(3): 195.     CrossRef
• Towards an Ensemble Vaccine against the Pegivirus Using Computational Modelling Approaches and Its Validation through In Silico Cloning and Immune Simulation
  Bowen Zheng, Muhammad Suleman, Zonara Zafar, Syed Shujait Ali, Syed Nouman Nasir, Namra, Zahid Hussain, Muhammad Waseem, Abbas Khan, Fakhrul Hassan, Yanjing Wang, Dongqing Wei
  Vaccines.2021; 9(8): 818.     CrossRef
• Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution
  Meejeong Kim, Hee Sang Hwang, Hyungwoo Cho, Dok Hyun Yoon, Cheolwon Suh, Chan Sik Park, Heounjeong Go, Jooryung Huh
  Journal of Pathology and Translational Medicine.2021; 55(5): 330.     CrossRef
• Trends Analysis of Non-Hodgkin Lymphoma at the National, Regional, and Global Level, 1990–2019: Results From the Global Burden of Disease Study 2019
  Wenwen Cai, Qingle Zeng, Xingxing Zhang, Weiqing Ruan
  Frontiers in Medicine.2021;[Epub]     CrossRef
• Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea
  Jun Ho Yi, Gyeong-Won Lee, Ji Hyun Lee, Kwai Han Yoo, Chul Won Jung, Dae Sik Kim, Jeong-Ok Lee, Hyeon Seok Eom, Ja Min Byun, Youngil Koh, Sung Soo Yoon, Jin Seok Kim, Jee Hyun Kong, Ho-Young Yhim, Deok-Hwan Yang, Dok Hyun Yoon, Do Hyoung Lim, Won-Sik Lee,
  BLOOD RESEARCH.2021; 56(4): 243.     CrossRef
• Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018
  Won-Ju Park, Joo-heon Park, Seunghyeon Cho, Myung Geun Shin
  BLOOD RESEARCH.2021; 56(4): 301.     CrossRef
• Prediagnostic blood levels of organochlorines and risk of non‐Hodgkin lymphoma in three prospective cohorts in China and Singapore
  Bryan A. Bassig, Xiao‐Ou Shu, Andreas Sjödin, Woon‐Puay Koh, Yu‐Tang Gao, Jennifer Adams‐Haduch, Mark Davis, Renwei Wang, Yong‐Bing Xiang, Lawrence S. Engel, Mark P. Purdue, Bu‐Tian Ji, Gong Yang, Richard S. Jones, Hilde Langseth, H. Dean Hosgood, Tom K.
  International Journal of Cancer.2020; 146(3): 839.     CrossRef
• Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients
  Young Ae Kim, Hee Young Ju, Hyeon Jin Park, Na Young Lee, Hyun Jeong Lee, Hyewon Lee, Haryeom Ghang
  British Journal of Haematology.2020; 188(5): 740.     CrossRef
• Value of multi-parameter flow cytometry immunophenotyping in T/NK-cell neoplasms in cytology specimens: A retrospective study in Chinese patients
  Yuwei Zheng, Xiaochun Wan, Xian Gui, Ying Chen, Lili Gao, Hao Zhang, Yanli Wang
  Pathology - Research and Practice.2020; 216(8): 152921.     CrossRef
• Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
  Dok Hyun Yoon, Junning Cao, Tsai-Yun Chen, Koji Izutsu, Seok Jin Kim, Yok Lam Kwong, Tong Yu Lin, Lim Soon Thye, Bing Xu, Deok Hwan Yang, Won Seog Kim
  Journal of Hematology & Oncology.2020;[Epub]     CrossRef
• Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non‐Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma
  Kyoung Ha Kim, Won Seog Kim, Seok Jin Kim, Dok Hyun Yoon, Cheolwon Suh, Hye Jin Kang, Chul Won Choi, Ho Sup Lee, Sung Hwa Bae, Jinny Park, Eun Kyung Park, Jae‐Yong Kwak, Mark Hong Lee, Byung Woog Kang, Sung‐Kyu Park, Jong‐Ho Won
  Transplant International.2020; 33(10): 1211.     CrossRef
• Recent advances in chronic lymphocytic leukemia therapy
  Jieun Uhm
  BLOOD RESEARCH.2020; 55(S1): S72.     CrossRef
• Trends of Incidence and Survival Rrates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database
  Seok-Hoo Jeong, Shin Young Hyun, Ja Sung Choi, Hee Man Kim
  Journal of Korean Medical Science.2020;[Epub]     CrossRef
• Lifestyle and risk of follicular lymphoma: a systematic review and meta-analysis of observational studies
  Michael K. Odutola, Eriobu Nnakelu, Graham G. Giles, Marina T. van Leeuwen, Claire M. Vajdic
  Cancer Causes & Control.2020; 31(11): 979.     CrossRef
• Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
  Hye Park, Eun Han, Joo O, Byung-Ock Choi, Gyeongsin Park, Seung-Eun Jung, Seung-Ah Yahng, Ki-Seong Eom, Seok-Goo Cho
  Diagnostics.2020; 10(12): 1002.     CrossRef
• Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
  Weiping Liu, Jiangmei Liu, Yuqin Song, Xiaopei Wang, Maigeng Zhou, Lijun Wang, Jun Ma, Jun Zhu
  Journal of Hematology & Oncology.2019;[Epub]     CrossRef
• Vitamin D status and risk of non-Hodgkin lymphoma: An updated meta-analysis
  Hye Yin Park, Yun-Chul Hong, Kyoungho Lee, Jaewoo Koh, Matteo Rota
  PLOS ONE.2019; 14(4): e0216284.     CrossRef
• Advances in the Treatment of Childhood Acute Lymphoblastic Leukemia
  Hyery Kim
  Clinical Pediatric Hematology-Oncology.2019; 26(1): 12.     CrossRef
• Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016
  Jongmin Sim, Takuya Takayama, Junhun Cho, Seok Jin Kim, Won Seog Kim, Howe J. Ree, Young Hyeh Ko
  Medicine.2019; 98(45): e17641.     CrossRef
• Classification of malignant lymphoma subtypes in Korean patients: a report of the 4th nationwide study
  Hye-Ra Jung, Jooryung Huh, Young-Hyeh Ko, Yoon Kyung Jeon, Sun Och Yoon, Se Hoon Kim, Woo Ick Yang, Geongsin Park, Jo Heon Kim, Jin Ho Paik, Jae Ho Han, Hee Jung Cha, Kyu Yun Jang, Bong-Kyung Shin, Young-A Kim, Ji Eun Kim, Yoo Duk Choi, Min Gyoung Park, H
  Journal of Hematopathology.2019; 12(4): 173.     CrossRef
• Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
  Weiping Liu, Jiangmei Liu, Yuqin Song, Xinying Zeng, Xiaopei Wang, Lan Mi, Cai Cai, Lijun Wang, Jun Ma, Jun Zhu
  Journal of Hematology & Oncology.2019;[Epub]     CrossRef
• Lymphoma epidemiology in Korea and the real clinical field including the Consortium for Improving Survival of Lymphoma (CISL) trial
  Kwai Han Yoo, Hyewon Lee, Cheolwon Suh
  International Journal of Hematology.2018; 107(4): 395.     CrossRef
• Subtype‐specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002‐2012
  Bor‐Sheng Ko, Li‐Ju Chen, Huai‐Hsuan Huang, Yao‐Chun Wen, Chi‐Yin Liao, Ho‐Min Chen, Fei‐Yuan Hsiao
  Cancer Medicine.2018; 7(11): 5820.     CrossRef
• Gastric follicular lymphoma: A report of 3�cases and a review of the literature
  Hee Na, Young Kim, Cheol Lee, Ji‑Young Choe, Seon Shin, Jung‑Weon Shim, Soo Min, Hyun‑Jung Kim, Jae Han, Ji Kim
  Oncology Letters.2018;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer
  Qiu-yun Luo, Jing Yang, Tian Di, Zeng-fei Xia, Lin Zhang, Wen-tao Pan, Shan Shi, Li-qiong Yang, Jian Sun, Miao-zhen Qiu, Da-jun Yang
  Acta Pharmacologica Sinica.2025; 46(4): 1082.     CrossRef
• FoxO1 Deficiency in Monocytic Myeloid‐Derived Suppressor Cells Exacerbates B Cell Dysfunction in Systemic Lupus Erythematosus
  Liping Tan, Wei Kong, Kangxing Zhou, Shuangan Wang, Jun Liang, Yayi Hou, Huan Dou
  Arthritis & Rheumatology.2025; 77(4): 423.     CrossRef
• The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway
  Anna Han, Taorui Liu, Pan Du, Mengying Wang, Jiajing Liu, Liyan Chen
  Molecular Carcinogenesis.2024; 63(4): 688.     CrossRef
• Characterization of MET Alterations in 37 Gastroesophageal Cancer Cell Lines for MET-Targeted Therapy
  Jin-Soo Kim, Mi Young Kim, Sungyoul Hong
  International Journal of Molecular Sciences.2024; 25(11): 5975.     CrossRef
• HER2-targeted therapies beyond breast cancer — an update
  Jeesun Yoon, Do-Youn Oh
  Nature Reviews Clinical Oncology.2024; 21(9): 675.     CrossRef
• Resistance to Anti-HER2 Therapies in Gastrointestinal Malignancies
  Christiana Mo, Michelle Sterpi, Hyein Jeon, Fernand Bteich
  Cancers.2024; 16(16): 2854.     CrossRef
• Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
  Maluki Radford, Hassan Abushukair, Stijn Hentzen, Ludimila Cavalcante, Anwaar Saeed
  Journal of Immunotherapy and Precision Oncology.2023; 6(3): 150.     CrossRef
• Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review
  Dionne Blangé, Charlotte I. Stroes, Sarah Derks, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven
  Cancer Treatment Reviews.2022; 108: 102418.     CrossRef
• The FOXO family of transcription factors: key molecular players in gastric cancer
  Ying Liu, Xiang Ao, Yi Jia, Xiaoge Li, Yu Wang, Jianxun Wang
  Journal of Molecular Medicine.2022; 100(7): 997.     CrossRef
• VGLL1 phosphorylation and activation promotes gastric cancer malignancy via TGF-β/ERK/RSK2 signaling
  Joo-Young Im, Da-Mi Kim, Hyunkyung Park, Mi-Jung Kang, Da-Yoon Kim, Kwan Young Chang, Bo-Kyung Kim, Misun Won
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.2021; 1868(1): 118892.     CrossRef
• The efficacy and safety of onartuzumab in patients with solid cancers: A meta-analysis of randomized trials
  BumJun Kim, Dalyong Kim, JungHan Kim, HyeongSu Kim, HyunJoo Jang
  Indian Journal of Cancer.2021; 58(2): 232.     CrossRef
• HER2-targeted therapies in gastric cancer
  Yinxing Zhu, Xuedan Zhu, Xiaowei Wei, Cuiju Tang, Wenwen Zhang
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1876(1): 188549.     CrossRef
• Current therapeutic options for gastric adenocarcinoma
  C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
  Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
• Diverse roles of FOXO family members in gastric cancer
  Yu-Han Chen, Chun-Lan Li, Wen-Jia Chen, Jing Liu, Hua-Tao Wu
  World Journal of Gastrointestinal Oncology.2021; 13(10): 1367.     CrossRef
• Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies
  Nehad M. Ayoub, Dalia R. Ibrahim, Amer E. Alkhalifa
  Medical Oncology.2021;[Epub]     CrossRef
• Fertility preservation in women with ovarian cancer: Finding new pathways: A case-control study
  Ali Khodadadian, Yasser Varghaiyan, Emad Babakhanzadeh, Iraj Alipourfard, Saeed Haghi-Daredeh, Amin Ghobadi, Mohsen Hemmati-Dinarvand, Mehrdad Talebi, Nasrin Ghasemi
  International Journal of Reproductive BioMedicine (IJRM).2021; 19(2): 157.     CrossRef
• Caveolin-1 Promotes Chemoresistance of Gastric Cancer Cells to Cisplatin by Activating WNT/β-Catenin Pathway
  Xi Wang, Bin Lu, Chunyan Dai, Yufei Fu, Ke Hao, Bing Zhao, Zhe Chen, Li Fu
  Frontiers in Oncology.2020;[Epub]     CrossRef
• Machine Learning-Guided Prediction of Antigen-Reactive In Silico Clonotypes Based on Changes in Clonal Abundance through Bio-Panning
  Duck Kyun Yoo, Seung Ryul Lee, Yushin Jung, Haejun Han, Hwa Kyoung Lee, Jerome Han, Soohyun Kim, Jisu Chae, Taehoon Ryu, Junho Chung
  Biomolecules.2020; 10(3): 421.     CrossRef
• FOXO transcription factor family in cancer and metastasis
  Yannasittha Jiramongkol, Eric W.-F. Lam
  Cancer and Metastasis Reviews.2020; 39(3): 681.     CrossRef

• In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines

  
  Hasaya Dokduang, Wassana Jamnongkarn, Bundit Promraksa, Manida Suksawat, Sureerat Padthaisong, Malinee Thanee, Jutarop Phetcharaburanin, Nisana Namwat, Sakkarn Sangkhamanon, Attapol Titapun, Narong Khuntikeo, Poramate Klanrit, Watcharin Loilome
  Drug Design, Development and Therapy.2020; Volume 14: 2319.     CrossRef
• MiR-27a promotes EMT in ovarian cancer through active Wnt/
  Li-Ya Zhang, Yuan Chen, Jue Jia, Xi Zhu, Yan He, Li-Ming Wu
  Cancer Biomarkers.2019; 24(1): 31.     CrossRef
• Role of FoxO Proteins in Cellular Response to Antitumor Agents
  Giovanni Luca Beretta, Cristina Corno, Nadia Zaffaroni, Paola Perego
  Cancers.2019; 11(1): 90.     CrossRef
• Members of FOX family could be drug targets of cancers
  Jinhua Wang, Wan Li, Ying Zhao, De Kang, Weiqi Fu, Xiangjin Zheng, Xiaocong Pang, Guanhua Du
  Pharmacology & Therapeutics.2018; 181: 183.     CrossRef
• FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
  Cristina Corno, Simone Stucchi, Michelandrea De Cesare, Nives Carenini, Serena Stamatakos, Emilio Ciusani, Lucia Minoli, Eugenio Scanziani, Christian Argueta, Yosef Landesman, Nadia Zaffaroni, Laura Gatti, Paola Perego
  Biochemical Pharmacology.2018; 147: 93.     CrossRef
• Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer
  Xuebing Yan, Linsheng Huang, Liguo Liu, Huanlong Qin, Zhenshun Song
  Cancer Medicine.2018;[Epub]     CrossRef
• Systems analysis of key genes and pathways in the progression of hepatocellular carcinoma
  Yu-Kui Shang, Fanni Li, Yi Zhang, Ze-Kun Liu, Zi-Ling Wang, Huijie Bian, Zhi-Nan Chen
  Medicine.2018; 97(23): e10892.     CrossRef
• The Dominant Role of Forkhead Box Proteins in Cancer
  Duc-Hiep Bach, Nguyen Phuoc Long, Thi-Thu-Trang Luu, Nguyen Hoang Anh, Sung Won Kwon, Sang Kook Lee
  International Journal of Molecular Sciences.2018; 19(10): 3279.     CrossRef
• HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells
  Kang-Seo Park, Yong Sang Hong, Junyoung Choi, Shinkyo Yoon, Jihoon Kang, Deokhoon Kim, Kang-Pa Lee, Hyeon-Su Im, Chang Hoon Lee, Seyoung Seo, Sang-We Kim, Dae Ho Lee, Sook Ryun Park
  BMB Reports.2018; 51(12): 660.     CrossRef
• FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells
  Yiseul Choi, Jinju Park, Young San Ko, Younghoon Kim, Jung-Soo Pyo, Bo Gun Jang, Min A Kim, Jae-Seon Lee, Mee Soo Chang, Byung Lan Lee
  Biochemical and Biophysical Research Communication.2017; 493(3): 1349.     CrossRef
• Trifluoperazine Activates FOXO1-Related Signals to Inhibit Tumor Growth in Hepatocellular Carcinoma
  Jingwen Jiang, Zhongxi Huang, Xuewu Chen, Rongcheng Luo, Hongbin Cai, Hairu Wang, Hui Zhang, Tao Sun, Yunfang Zhang
  DNA and Cell Biology.2017; 36(10): 813.     CrossRef

Citations

Citations to this article as recorded by  

• Applications and Performance of Precision ID GlobalFiler NGS STR, Identity, and Ancestry Panels in Forensic Genetics
  Sharlize Pedroza Matute, Sasitaran Iyavoo
  Genes.2024; 15(9): 1133.     CrossRef
• A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China
  Quanfei Huang, Yuwei Liao, Tao Yu, Wei Lei, Hongfeng Liang, Jianxin Wen, Qing Liu, Yu Chen, Kaisheng Huang, Lifang Jing, Xiaoyan Huang, Yuanru Liu, Xiaokang Yu, Kaichan Su, Tengfei Liu, Liye Yang, Min Huang
  Journal of Clinical Laboratory Analysis.2023;[Epub]     CrossRef
• Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study
  Joseph R. Habib, Yayun Zhu, Lingdi Yin, Ammar A. Javed, Ding Ding, Jonathan Tenior, Michael Wright, Syed Z. Ali, Richard A Burkhart, William Burns, Christopher L. Wolfgang, Eunji Shin, Jun Yu, Jin He
  Journal of Gastrointestinal Surgery.2021; 25(12): 3149.     CrossRef
• Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics
  Ziyad Khatab, George M. Yousef
  Critical Reviews in Clinical Laboratory Sciences.2021; 58(8): 546.     CrossRef

Citations

Citations to this article as recorded by  

• Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS‐JAPAN)
  Takuma Kato, Ryuji Matsumoto, Akira Yokomizo, Yoichiro Tohi, Hiroshi Fukuhara, Yoichi Fujii, Keiichiro Mori, Takuma Sato, Junichi Inokuchi, Katsuyoshi Hashine, Shinichi Sakamoto, Hidefumi Kinoshita, Koji Inoue, Toshiki Tanikawa, Takanobu Utsumi, Takayuki
  BJU International.2024; 134(4): 652.     CrossRef
• Has Active Surveillance for Prostate Cancer Become Safer? Lessons Learned from a Global Clinical Registry
  Chris Bangma, Paul Doan, Lin Zhu, Sebastiaan Remmers, Daan Nieboer, Jozien Helleman, Monique J. Roobol, Mikio Sugimoto, Byung Ha Chung, Lui Shiong Lee, Mark Frydenberg, Laurence Klotz, Michael Peacock, Antoinette Perry, Anders Bjartell, Antti Rannikko, Mi
  European Urology Oncology.2024;[Epub]     CrossRef
• Establishment of Prospective Registry of Active Surveillance for Prostate Cancer: The Korean Urological Oncology Society Database
  Gyoohwan Jung, Jung Kwon Kim, Seong Soo Jeon, Jae Hoon Chung, Cheol Kwak, Chang Wook Jeong, Hanjong Ahn, Jae Young Joung, Tae Gyun Kwon, Sung Woo Park, Seok-Soo Byun
  The World Journal of Men's Health.2023; 41(1): 110.     CrossRef
• The Role of Magnetic Resonance Imaging (MRI) and MRI-Targeted Biopsy for Active Surveillance
  Chang Wook Jeong
  Journal of Urologic Oncology.2023; 21(2): 97.     CrossRef
• Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer
  Sahyun Pak, Kyu-Won Jung, Eun-Hye Park, Young Hwii Ko, Young-Joo Won, Jae Young Joung
  Investigative and Clinical Urology.2022; 63(2): 175.     CrossRef
• Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk
  Yasmine Amrousy, Hesham Haffez, Doaa Abdou, Hanaa Atya
  Molecular Medicine Reports.2022;[Epub]     CrossRef
• A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
  Sang Hun Song, Jung Kwon Kim, Hakmin Lee, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun
  Investigative and Clinical Urology.2021; 62(1): 32.     CrossRef
• The clinical impact of strict criteria for active surveillance of prostate cancer in Korean population: Results from a prospective cohort
  Jungyo Suh, Hyeong Dong Yuk, Minyong Kang, Bum Sik Tae, Ja Hyeon Ku, Hyeon Hoe Kim, Cheol Kwak, Chang Wook Jeong
  Investigative and Clinical Urology.2021; 62(4): 430.     CrossRef
• Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
  Kerri Beckmann, Aida Santaolalla, Jozien Helleman, Peter Carroll, Byung Ha Chung, Lui Shiong Lee, Antoinette Perry, Jose Rubio-Briones, Mikio Sugimoto, Bruce Trock, Riccardo Valdagni, Prokar Dasgupta, Mieke Van Hemelrijck, Oussama Elhage, Bruce Trock, Beh
  European Urology Open Science.2021; 34: 47.     CrossRef
• Patients with Biopsy Gleason Score 3 + 4 Are Not Appropriate Candidates for Active Surveillance
  Juhyun Park, Sangjun Yoo, Min Chul Cho, Chang Wook Jeong, Ja Hyeon Ku, Cheol Kwak, Hyeon Hoe Kim, Hyeon Jeong
  Urologia Internationalis.2020; 104(3-4): 199.     CrossRef
• Current status and progress of focal therapy in Asia
  Takumi Shiraishi, Osamu Ukimura
  Current Opinion in Urology.2018; 28(6): 529.     CrossRef
• The MMP2 rs243865 polymorphism increases the risk of prostate cancer: A meta-analysis
  Kun Liu, Shuo Gu, Xuzhong Liu, Qing Sun, Yunyan Wang, Junsong Meng, Zongyuan Xu
  Oncotarget.2017; 8(42): 72933.     CrossRef

Citations

Citations to this article as recorded by  

• Locoregional Recurrence-Free Survival in Postmastectomy Breast Cancer: A Comparative Longitudinal Study of Hypofractionated Versus Conventional Fractionated Radiation Therapy
  Suma Susan Meloot, Ciniraj Raveendran, IP Yadev
  Indian Journal of Surgical Oncology.2025;[Epub]     CrossRef
• Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean Breast Cancer Patients (KROG 22-15)
  Seok-Joo Chun, Ji Hwan Jo, Yong Bae Kim, Sangjoon Park, Sung-Ja Ahn, Su Ssan Kim, Kyubo Kim, Kyung Hwan Shin
  Cancer Research and Treatment.2024; 56(2): 549.     CrossRef
• Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy
  Jong-Ho Cheun, Young Joo Lee, Jun-Hee Lee, Yungil Shin, Jung Whan Chun, Soo Yeon Baek, Hong-Kyu Kim, Han-Byoel Lee, Jonghan Yu, Byung Joo Chae, Wonshik Han, Jeong Eon Lee
  Breast Cancer Research and Treatment.2022; 194(3): 683.     CrossRef
• Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma
  Jun-Hee Lee, Hyunjun Lee, Yoon Ju Bang, Jai Min Ryu, Se Kyung Lee, Jonghan Yu, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Byung Joo Chae
  Journal of Breast Cancer.2022; 25(4): 288.     CrossRef
• Updates and Debate Concerning Margin Adequacy and Management following Breast-Conserving Surgery
  Serena Bertozzi, Ambrogio P Londero, Jose Andres Diaz Nanez, Francesco Leone, Barbara Baita, Lucia La Verghetta, Milena Nobile, Daria Almesberger, Carla Cedolini
  Clinical and Experimental Obstetrics & Gynecology.2022;[Epub]     CrossRef
• Feasibility and safety of breast-conserving surgery via a periareolar incision for cancers located far from the nipple–areolar complex: a retrospective study
  Joohyun Woo, Jihae Lee, Se Hyun Paek, Woosung Lim
  Journal of Cancer Research and Clinical Oncology.2021; 147(3): 893.     CrossRef
• Breast-conserving surgery with 3D-printed surgical guide: a single-center, prospective clinical study
  Zhen-Yu Wu, Hee Jeong Kim, Jongwon Lee, Il Yong Chung, Jisun Kim, Saebyeol Lee, Byung Ho Son, Sei-Hyun Ahn, Hak Hee Kim, Joon Beom Seo, Jae Ho Jeong, Gyungyub Gong, Namkug Kim, BeomSeok Ko
  Scientific Reports.2021;[Epub]     CrossRef
• Usefulness of 3D-surgical guides in breast conserving surgery after neoadjuvant treatment
  Han Shin Lee, Hee Jeong Kim, Il Yong Chung, Jisun Kim, Sae Byul Lee, Jong Won Lee, Byung Ho Son, Sei Hyun Ahn, Hak Hee Kim, Joon Beom Seo, Jin Hee Ahn, Gyungyub Gong, Sangwook Lee, Namkug Kim, Beom Seok Ko
  Scientific Reports.2021;[Epub]     CrossRef
• Partial chest wall radiation therapy for positive or close surgical margins after modified radical mastectomy for breast cancer without lymph node metastasis
  Naoya Ishibashi, Haruna Nishimaki, Toshiya Maebayashi, Keita Adachi, Kenichi Sakurai, Shinobu Masuda, Masaharu Hata, Masahiro Okada
  Asia-Pacific Journal of Clinical Oncology.2020; 16(1): 28.     CrossRef
• Impact of Oncotype DX Recurrence Score on the Patterns of Locoregional Recurrence in Breast Cancer (Korean Radiation Oncology Group 19-06)
  Kyubo Kim, Jinhong Jung, Kyung Hwan Shin, Jin Ho Kim, Ji Hyun Chang, Su Ssan Kim, Haeyoung Kim, Won Park, Yong Bae Kim, Jee Suk Chang
  Journal of Breast Cancer.2020; 23(3): 314.     CrossRef
• Magnetic resonance imaging based 3-dimensional printed breast surgical guide for breast-conserving surgery in ductal carcinoma in situ: a clinical trial
  Zhen-Yu Wu, Aisha Alzuhair, Heejeong Kim, Jong Won Lee, Il Yong Chung, Jisun Kim, Sae Byul Lee, Byung Ho Son, Gyungyub Gong, Hak Hee Kim, Joon Beom Seo, Sei Hyun Ahn, Namkug Kim, BeomSeok Ko
  Scientific Reports.2020;[Epub]     CrossRef
• Aktuelle chirurgische Therapie des Mammakarzinoms
  Jasmin Zeindler, Fabienne Schwab
  InFo Hämatologie + Onkologie.2019; 22(4): 15.     CrossRef
• Comparing long-term local recurrence rates of surgical and non-surgical management of close anterior margins in breast conserving surgery
  George Boundouki, Joseph Ryan Wong Sik Hee, Natalie Croghan, Katie Stocking, Andrew Pieri, Adam Critchley, Cliona C. Kirwan, James R. Harvey
  Breast Cancer Research and Treatment.2019; 176(2): 311.     CrossRef
• Therapy of isolated locoregional recurrent carcinoma of the breast
  Lena Gabriel, Marina Schmidt, Stephanie Juhasz-Böss, Patrick Melchior, Anika von Heesen, Gilda Schmidt, Nicole Kranzhöfer, Erich-Franz Solomayer, Ingolf Juhasz-Böss, Georg-Peter Breitbach
  Archives of Gynecology and Obstetrics.2019; 300(2): 365.     CrossRef

Citations

Citations to this article as recorded by  

• Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer
  Katsuji Sawai, Takanori Goi, Youhei Kimura, Kenji Koneri
  Cancers.2024; 16(8): 1556.     CrossRef
• Dynamic monitoring of carcinoembryonic antigen, CA19-9 and inflammation-based indices in patients with advanced colorectal cancer undergoing chemotherapy
  Nebojsa Manojlovic, Goran Savic, Bojan Nikolic, Nemanja Rancic
  World Journal of Clinical Cases.2022; 10(3): 899.     CrossRef
• Current Applications and Discoveries Related to the Membrane Components of Circulating Tumor Cells and Extracellular Vesicles
  Luis Enrique Cortés-Hernández, Zahra Eslami-S, Bruno Costa-Silva, Catherine Alix-Panabières
  Cells.2021; 10(9): 2221.     CrossRef
• Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway
  Jianhui Cai, Limin Xia, Jinlei Li, Shichang Ni, Huayu Song, Xiangbin Wu
  Cancer Research and Treatment.2019; 51(1): 252.     CrossRef

Citations

Citations to this article as recorded by  

• Next-generation sequencing identifies the mutational signature of double primary and metastatic malignancies: A case report
  Shiying Tang, Yixiao Deng, Yinan Yan, Jie Bai, Huiying He, Shudong Zhang, Jie Yang, Min Qiu, Xiaojun Tian
  Current Urology.2024;[Epub]     CrossRef
• Renal cell carcinoma and risk of second primary cancer: A Danish nationwide cohort study
  Maria B. Bengtsen, Dóra K. Farkas, Henrik T. Sørensen, Mette Nørgaard
  Cancer Medicine.2024;[Epub]     CrossRef
• Chance, ignorance, and the paradoxes of cancer: Richard Peto on developing preventative strategies under uncertainty
  George Davey Smith, Albert Hofman, Paul Brennan
  European Journal of Epidemiology.2023; 38(12): 1227.     CrossRef
• Better Prognosis and Survival in Esophageal Cancer Survivors After Comorbid Second Primary Malignancies: A SEER Database-Based Study
  Jiayue Ye, Sheng Hu, Wenxiong Zhang, Deyuan Zhang, Yang Zhang, Dongliang Yu, Jinhua Peng, Jianjun Xu, Yiping Wei
  Frontiers in Surgery.2022;[Epub]     CrossRef
• Effect of prior thyroid cancer on survival of primary liver cancer: a study based on the SEER database
  Hong Liu, Xin Heng, Yuan Tian, Zhongming Yang
  Scientific Reports.2022;[Epub]     CrossRef
• Being Precise About Precision Mental Health
  Peter Szatmari, Ezra Susser
  JAMA Psychiatry.2022; 79(12): 1149.     CrossRef
• Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers
  Guoqiao Zheng, Kristina Sundquist, Jan Sundquist, Tianhui Chen, Asta Försti, Otto Hemminki, Kari Hemminki
  European Urology Open Science.2021; 24: 52.     CrossRef
• miR‐34a in extracellular vesicles from bone marrow mesenchymal stem cells reduces rheumatoid arthritis inflammation via the cyclin I/ATM/ATR/p53 axis
  Huaiguo Wu, Xike Zhou, Xuedong Wang, Wei Cheng, Xinjia Hu, Yueping Wang, Bing Luo, Wenjun Huang, Juan Gu
  Journal of Cellular and Molecular Medicine.2021; 25(4): 1896.     CrossRef
• Deciphering the Risk of Developing Second Primary Thyroid Cancer Following a Primary Malignancy—Who Is at the Greatest Risk?
  Lily N. Trinh, Andrew R. Crawford, Mohammad H. Hussein, Mourad Zerfaoui, Eman A. Toraih, Gregory W. Randolph, Emad Kandil
  Cancers.2021; 13(6): 1402.     CrossRef
• Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients
  Lucie Pehalova, Denisa Krejci, Jana Halamkova, Lenka Smardova, Lenka Snajdrova, Ladislav Dusek
  Cancer Epidemiology.2021; 72: 101929.     CrossRef
• Prognosis of patients with axillary lymph node metastases from occult breast cancer: analysis of multicenter data
  Haeyoung Kim, Won Park, Su SSan Kim, Sung Ja Ahn, Yong Bae Kim, Tae Hyun Kim, Jin Hee Kim, Jin-Hwa Choi, Hae Jin Park, Jee Suk Chang, Doo Ho Choi
  Radiation Oncology Journal.2021; 39(2): 107.     CrossRef
• The Risk and Prognosis of Secondary Primary Malignancy in Lung Cancer: A Population-Based Study
  Jia Hong, Rongrong Wei, Chuang Nie, Anastasiia Leonteva, Xu Han, Xinyu Du, Jing Wang, Lin Zhu, Wenjing Tian, Haibo Zhou
  Future Oncology.2021; 17(33): 4497.     CrossRef
• Clear Cell Papillary Renal Cell Carcinoma Shares Distinct Molecular Characteristics and may be Significantly Associated With Higher Risk of Developing Second Primary Malignancy
  Xi Tian, Wen-Hao Xu, Jun-Long Wu, Hua-Lei Gan, Hong-Kai Wang, Wei-Jie Gu, Yuan-Yuan Qu, Hai-Liang Zhang, Ding-Wei Ye
  Pathology and Oncology Research.2021;[Epub]     CrossRef
• Primary Adenocarcinoma of Lung with Synchronous Renal Cell Carcinoma: A Case Report and Review of the Literature
  Sharareh Seifi, Zahra Esfahani-Monfared, Mihan Pourabdollah, Sara Haseli
  International Journal of Cancer Management.2020;[Epub]     CrossRef
• Second primary cancers in patients with oral cavity cancer included in the Korea Central Cancer Registry
  Seung-Ki Min, Sung Weon Choi, Jiwon Lim, Joo Yong Park, Kyu-Won Jung, Young-Joo Won
  Oral Oncology.2019; 95: 16.     CrossRef
• Post–Modern Epidemiology: When Methods Meet Matter
  George Davey Smith
  American Journal of Epidemiology.2019; 188(8): 1410.     CrossRef
• Prognosis of the Metachronous and Synchronous Bilateral Renal Cancer and Second Primary Cancer After the Bilateral Renal Cancer: a Population-Based Analysis
  Mierxiati Abudurexiti, Jun Wang, Ning Shao, Fang-Ning Wan, Wen-Kai Zhu, Bo Dai, Yao Zhu, Ding-Wei Ye
  SN Comprehensive Clinical Medicine.2019; 1(11): 900.     CrossRef
• Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea
  Whi-An Kwon, Jae Young Joung, Jiwon Lim, Chang-Mo Oh, Kyu-Won Jung, Sung Han Kim, Ho Kyung Seo, Weon Seo Park, Jinsoo Chung, Kang Hyun Lee, Young-Joo Won
  BMC Cancer.2018;[Epub]     CrossRef